Entry	Entry name	Status	Protein names	Gene names	Organism	Length	Gene ontology (biological process)	Gene ontology (cellular component)	Gene ontology (GO)	Gene ontology (molecular function)	Gene ontology IDs
B7QDG3	NNRE_IXOSC	reviewed	NAD(P)H-hydrate epimerase (EC 5.1.99.6) (NAD(P)HX epimerase)	ISCW022186	Ixodes scapularis (Black-legged tick) (Deer tick)	275		mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166]	NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005739; GO:0046872; GO:0052856; GO:0052857
F7FIH8	NNRE_MONDO	reviewed	NAD(P)H-hydrate epimerase (EC 5.1.99.6) (Apolipoprotein A-I-binding protein) (AI-BP) (NAD(P)HX epimerase)	NAXE AIBP APOA1BP	Monodelphis domestica (Gray short-tailed opossum)	284	nicotinamide nucleotide metabolic process [GO:0046496]; protein homotetramerization [GO:0051289]	cell body [GO:0044297]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cell body [GO:0044297]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; nicotinamide nucleotide metabolic process [GO:0046496]; protein homotetramerization [GO:0051289]	NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]	GO:0000166; GO:0005615; GO:0005654; GO:0005739; GO:0005829; GO:0005929; GO:0042803; GO:0044297; GO:0046496; GO:0046872; GO:0051289; GO:0052856; GO:0052857
O75339	CILP1_HUMAN	reviewed	Cartilage intermediate layer protein 1 (CILP-1) (Cartilage intermediate-layer protein) [Cleaved into: Cartilage intermediate layer protein 1 C1; Cartilage intermediate layer protein 1 C2]	CILP UNQ602/PRO1188	Homo sapiens (Human)	1184	cellular response to transforming growth factor beta stimulus [GO:0071560]; dephosphorylation [GO:0016311]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dephosphorylation [GO:0016311]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of SMAD protein signal transduction [GO:0060392]		GO:0005615; GO:0010629; GO:0016311; GO:0043569; GO:0060392; GO:0062023; GO:0070062; GO:0071560
Q7YRK5	COX7C_TARSY	reviewed	Cytochrome c oxidase subunit 7C, mitochondrial (Cytochrome c oxidase polypeptide VIIc)	COX7C	Tarsius syrichta (Philippine tarsier)	63		integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129]	cytochrome-c oxidase activity [GO:0004129]	GO:0004129; GO:0005743; GO:0016021
Q60520	SIN3A_MOUSE	reviewed	Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)	Sin3a Kiaa4126	Mus musculus (Mouse)	1274	DNA replication [GO:0006260]; activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; regulation of transcription, DNA-templated [GO:0006355]; response to methylglyoxal [GO:0051595]; response to organonitrogen compound [GO:0010243]; rhythmic process [GO:0048511]	Sin3 complex [GO:0016580]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]	chromatin [GO:0000785]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein deacetylase activity [GO:0033558]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; regulation of transcription, DNA-templated [GO:0006355]; response to methylglyoxal [GO:0051595]; response to organonitrogen compound [GO:0010243]; rhythmic process [GO:0048511]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; chromatin binding [GO:0003682]; protein deacetylase activity [GO:0033558]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	GO:0000122; GO:0000776; GO:0000785; GO:0000976; GO:0001102; GO:0001103; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003700; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0006476; GO:0007568; GO:0008134; GO:0010243; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0021895; GO:0030516; GO:0031937; GO:0032991; GO:0033558; GO:0034613; GO:0042754; GO:0043066; GO:0043619; GO:0044877; GO:0045666; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0071333; GO:1900181; GO:1901675; GO:1903351; GO:2000678
Q15796	SMAD2_HUMAN	reviewed	Mothers against decapentaplegic homolog 2 (MAD homolog 2) (Mothers against DPP homolog 2) (JV18-1) (Mad-related protein 2) (hMAD-2) (SMAD family member 2) (SMAD 2) (Smad2) (hSMAD2)	SMAD2 MADH2 MADR2	Homo sapiens (Human)	467	SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anterior/posterior pattern specification [GO:0009952]; cell fate commitment [GO:0045165]; common-partner SMAD protein phosphorylation [GO:0007182]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; endoderm formation [GO:0001706]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; mesoderm formation [GO:0001707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nodal signaling pathway [GO:0038092]; organ growth [GO:0035265]; pancreas development [GO:0031016]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; primary miRNA processing [GO:0031053]; protein deubiquitination [GO:0016579]; regulation of binding [GO:0051098]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; secondary palate development [GO:0062009]; signal transduction involved in regulation of gene expression [GO:0023019]; somatic stem cell population maintenance [GO:0035019]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; wound healing [GO:0042060]; zygotic specification of dorsal/ventral axis [GO:0007352]	SMAD protein complex [GO:0071141]; activin responsive factor complex [GO:0032444]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]	activin responsive factor complex [GO:0032444]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; disordered domain specific binding [GO:0097718]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; enhancer binding [GO:0035326]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; primary miRNA binding [GO:0070878]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor binding [GO:0005160]; transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity [GO:0030618]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]; activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anterior/posterior pattern specification [GO:0009952]; cell fate commitment [GO:0045165]; common-partner SMAD protein phosphorylation [GO:0007182]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; endoderm formation [GO:0001706]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; mesoderm formation [GO:0001707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nodal signaling pathway [GO:0038092]; organ growth [GO:0035265]; pancreas development [GO:0031016]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; primary miRNA processing [GO:0031053]; protein deubiquitination [GO:0016579]; regulation of binding [GO:0051098]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; secondary palate development [GO:0062009]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; wound healing [GO:0042060]; zygotic specification of dorsal/ventral axis [GO:0007352]	DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; R-SMAD binding [GO:0070412]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; disordered domain specific binding [GO:0097718]; double-stranded DNA binding [GO:0003690]; enhancer binding [GO:0035326]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; primary miRNA binding [GO:0070878]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; tau protein binding [GO:0048156]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor binding [GO:0005160]; transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity [GO:0030618]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001657; GO:0001701; GO:0001706; GO:0001707; GO:0003682; GO:0003690; GO:0003700; GO:0005160; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0007179; GO:0007182; GO:0007183; GO:0007352; GO:0007369; GO:0008134; GO:0008285; GO:0009749; GO:0009791; GO:0009952; GO:0010718; GO:0016579; GO:0017015; GO:0019902; GO:0023019; GO:0030073; GO:0030324; GO:0030325; GO:0030512; GO:0030513; GO:0030618; GO:0031016; GO:0031053; GO:0031625; GO:0032444; GO:0032924; GO:0032991; GO:0033613; GO:0034713; GO:0035019; GO:0035265; GO:0035326; GO:0035556; GO:0038092; GO:0042060; GO:0042803; GO:0045165; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0046982; GO:0048156; GO:0048340; GO:0048617; GO:0048701; GO:0051098; GO:0060039; GO:0060395; GO:0062009; GO:0070410; GO:0070411; GO:0070412; GO:0070723; GO:0070878; GO:0071141; GO:0071144; GO:0097718; GO:1900224
Q8TF20	ZN721_HUMAN	reviewed	Zinc finger protein 721	ZNF721 KIAA1982	Homo sapiens (Human)	911	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006357; GO:0046872
O70436	SMAD2_RAT	reviewed	Mothers against decapentaplegic homolog 2 (MAD homolog 2) (Mothers against DPP homolog 2) (Mad-related protein 2) (SMAD family member 2) (SMAD 2) (Smad2)	Smad2 Madh2	Rattus norvegicus (Rat)	467	SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; adrenal gland development [GO:0030325]; anterior/posterior pattern specification [GO:0009952]; cell fate commitment [GO:0045165]; common-partner SMAD protein phosphorylation [GO:0007182]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; endoderm formation [GO:0001706]; in utero embryonic development [GO:0001701]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; mesoderm formation [GO:0001707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; nodal signaling pathway [GO:0038092]; organ growth [GO:0035265]; pancreas development [GO:0031016]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; regulation of binding [GO:0051098]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; secondary palate development [GO:0062009]; signal transduction involved in regulation of gene expression [GO:0023019]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; wound healing [GO:0042060]; zygotic specification of dorsal/ventral axis [GO:0007352]	activin responsive factor complex [GO:0032444]; cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]	activin responsive factor complex [GO:0032444]; cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; disordered domain specific binding [GO:0097718]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded DNA binding [GO:0003690]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; primary miRNA binding [GO:0070878]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity [GO:0030618]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]; adrenal gland development [GO:0030325]; anterior/posterior pattern specification [GO:0009952]; cell fate commitment [GO:0045165]; common-partner SMAD protein phosphorylation [GO:0007182]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; endoderm formation [GO:0001706]; in utero embryonic development [GO:0001701]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; mesoderm formation [GO:0001707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; nodal signaling pathway [GO:0038092]; organ growth [GO:0035265]; pancreas development [GO:0031016]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; regulation of binding [GO:0051098]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; secondary palate development [GO:0062009]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; wound healing [GO:0042060]; zygotic specification of dorsal/ventral axis [GO:0007352]	DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; I-SMAD binding [GO:0070411]; R-SMAD binding [GO:0070412]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; disordered domain specific binding [GO:0097718]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; primary miRNA binding [GO:0070878]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; tau protein binding [GO:0048156]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity [GO:0030618]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]	GO:0000790; GO:0000978; GO:0001228; GO:0001657; GO:0001701; GO:0001706; GO:0001707; GO:0003682; GO:0003690; GO:0005634; GO:0005667; GO:0005737; GO:0007179; GO:0007182; GO:0007183; GO:0007352; GO:0008134; GO:0008285; GO:0009749; GO:0009791; GO:0009952; GO:0010718; GO:0017015; GO:0019902; GO:0023019; GO:0030073; GO:0030324; GO:0030325; GO:0030513; GO:0030618; GO:0031016; GO:0031625; GO:0032444; GO:0032991; GO:0033613; GO:0034713; GO:0035265; GO:0035556; GO:0038092; GO:0042060; GO:0042803; GO:0045165; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046982; GO:0048156; GO:0048340; GO:0048617; GO:0048701; GO:0051098; GO:0060039; GO:0060395; GO:0062009; GO:0070410; GO:0070411; GO:0070412; GO:0070723; GO:0070878; GO:0071144; GO:0097718; GO:1900224
P0C8G6	PV21_POMCA	reviewed	Perivitellin-2 67 kDa subunit (PcPV2 67 kDa subunit) (PcPV2-67) (PV2 MACPF subunit)		Pomacea canaliculata (Golden apple snail)	565			nutrient reservoir activity [GO:0045735]; toxin activity [GO:0090729]	nutrient reservoir activity [GO:0045735]; toxin activity [GO:0090729]	GO:0045735; GO:0090729
Q93075	TATD2_HUMAN	reviewed	Putative deoxyribonuclease TATDN2 (EC 3.1.21.-)	TATDN2 KIAA0218	Homo sapiens (Human)	761	IRE1-mediated unfolded protein response [GO:0036498]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; IRE1-mediated unfolded protein response [GO:0036498]	endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]	GO:0005634; GO:0005654; GO:0005829; GO:0016607; GO:0016888; GO:0036498; GO:0046872
Q8JIY1	ADA10_XENLA	reviewed	Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (xKuz)	adam10 kuz	Xenopus laevis (African clawed frog)	749	Notch signaling pathway [GO:0007219]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; protein phosphorylation [GO:0006468]	Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]	SH3 domain binding [GO:0017124]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]	GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0009986; GO:0016021; GO:0017124; GO:0019901; GO:0042803; GO:0046872
Q99J21	MCLN1_MOUSE	reviewed	Mucolipin-1 (Mucolipidin) (Transient receptor potential-mucolipin 1) (TRPML1)	Mcoln1	Mus musculus (Mouse)	580	adaptive immune response [GO:0002250]; autophagosome maturation [GO:0097352]; calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cellular response to calcium ion [GO:0071277]; cellular response to pH [GO:0071467]; endosomal transport [GO:0016197]; protein homotetramerization [GO:0051289]; release of sequestered calcium ion into cytosol [GO:0051209]	cell projection [GO:0042995]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cell projection [GO:0042995]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cation channel activity [GO:0005261]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; ligand-gated calcium channel activity [GO:0099604]; lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345]; adaptive immune response [GO:0002250]; autophagosome maturation [GO:0097352]; calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cellular response to calcium ion [GO:0071277]; cellular response to pH [GO:0071467]; endosomal transport [GO:0016197]; protein homotetramerization [GO:0051289]; release of sequestered calcium ion into cytosol [GO:0051209]	NAADP-sensitive calcium-release channel activity [GO:0072345]; cation channel activity [GO:0005261]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; ligand-gated calcium channel activity [GO:0099604]; lipid binding [GO:0008289]	GO:0001891; GO:0002250; GO:0005261; GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0005886; GO:0008289; GO:0016020; GO:0016021; GO:0016197; GO:0030670; GO:0031902; GO:0042995; GO:0043235; GO:0051209; GO:0051289; GO:0070588; GO:0071277; GO:0071467; GO:0072345; GO:0097352; GO:0097682; GO:0097708; GO:0098655; GO:0099604
P11414	RPB1_CRIGR	reviewed	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit)	POLR2A	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	1970	positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]	RNA polymerase II, core complex [GO:0005665]; cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; core promoter binding [GO:0001047]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; positive regulation of RNA splicing [GO:0033120]; transcription by RNA polymerase II [GO:0006366]	DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; core promoter binding [GO:0001047]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]	GO:0001047; GO:0003899; GO:0005634; GO:0005665; GO:0005719; GO:0005737; GO:0006366; GO:0033120; GO:0046872; GO:1990841
Q6PBA8	MNS1_DANRE	reviewed	Meiosis-specific nuclear structural protein 1	mns1 zgc:65845	Danio rerio (Zebrafish) (Brachydanio rerio)	486	cilium organization [GO:0044782]; meiotic cell cycle [GO:0051321]	motile cilium [GO:0031514]; nucleus [GO:0005634]	motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium organization [GO:0044782]; meiotic cell cycle [GO:0051321]		GO:0005634; GO:0031514; GO:0044782; GO:0051321
Q8N6F8	MET27_HUMAN	reviewed	Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein)	METTL27 WBSCR27	Homo sapiens (Human)	245					
Q4ZJM9	C1QL4_MOUSE	reviewed	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11) (C1qTNF11) (CTRP11)	C1ql4 C1qtnf11 Ctrp11	Mus musculus (Mouse)	238	negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]	collagen trimer [GO:0005581]; extracellular space [GO:0005615]	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]	identical protein binding [GO:0042802]	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048147; GO:0070373
O60331	PI51C_HUMAN	reviewed	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma (PIP5K1-gamma) (PtdIns(4)P-5-kinase 1 gamma) (EC 2.7.1.68) (Phosphatidylinositol 4-phosphate 5-kinase type I gamma) (PIP5KIgamma)	PIP5K1C KIAA0589	Homo sapiens (Human)	668	actin cytoskeleton organization [GO:0030036]; adherens junction assembly [GO:0034333]; cell-cell adhesion [GO:0098609]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neutrophil chemotaxis [GO:0030593]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; presynapse [GO:0098793]; ruffle membrane [GO:0032587]; uropod [GO:0001931]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; presynapse [GO:0098793]; ruffle membrane [GO:0032587]; uropod [GO:0001931]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; actin cytoskeleton organization [GO:0030036]; adherens junction assembly [GO:0034333]; cell-cell adhesion [GO:0098609]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neutrophil chemotaxis [GO:0030593]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]	1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]	GO:0001891; GO:0001931; GO:0005524; GO:0005654; GO:0005829; GO:0005925; GO:0006661; GO:0006909; GO:0010008; GO:0014066; GO:0016079; GO:0016308; GO:0030036; GO:0030593; GO:0032587; GO:0034333; GO:0048488; GO:0061024; GO:0072583; GO:0098609; GO:0098793
Q6NRT3	SMU1_XENLA	reviewed	WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog)	smu1	Xenopus laevis (African clawed frog)	513	mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]	U2-type precatalytic spliceosome [GO:0071005]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]		GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0016607; GO:0071005
Q6P0C6	LHPL2_DANRE	reviewed	LHFPL tetraspan subfamily member 2a protein	lhfpl2a zgc:77456	Danio rerio (Zebrafish) (Brachydanio rerio)	225	development of primary female sexual characteristics [GO:0046545]; development of primary male sexual characteristics [GO:0046546]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; development of primary female sexual characteristics [GO:0046545]; development of primary male sexual characteristics [GO:0046546]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]		GO:0007338; GO:0016021; GO:0046545; GO:0046546; GO:1905516
Q80U22	RUSC2_MOUSE	reviewed	Iporin (Interacting protein of Rab1) (RUN and SH3 domain-containing protein 2)	Rusc2 Kiaa0375	Mus musculus (Mouse)	1514		cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Rab GTPase binding [GO:0017137]	Rab GTPase binding [GO:0017137]	GO:0005829; GO:0017137; GO:0031410
Q8CDN6	TXNL1_MOUSE	reviewed	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	Txnl1 Trp32 Txnl	Mus musculus (Mouse)	289	cell redox homeostasis [GO:0045454]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; disulfide oxidoreductase activity [GO:0015036]; cell redox homeostasis [GO:0045454]	disulfide oxidoreductase activity [GO:0015036]	GO:0000502; GO:0005634; GO:0005737; GO:0005829; GO:0015036; GO:0045454
P42519	STAR_DROME	reviewed	Protein Star	S CG4385	Drosophila melanogaster (Fruit fly)	597	behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome membrane [GO:0031902]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye retinal cell programmed cell death [GO:0046667]; determination of dorsal identity [GO:0048263]; determination of genital disc primordium [GO:0035225]; dorsal appendage formation [GO:0046843]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; epidermal growth factor receptor ligand maturation [GO:0038004]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; ommatidial rotation [GO:0016318]; photoreceptor cell fate determination [GO:0043703]; positive regulation of protein secretion [GO:0050714]; stem cell fate commitment [GO:0048865]; stomatogastric nervous system development [GO:0007421]; visual perception [GO:0007601]		GO:0000139; GO:0001751; GO:0005783; GO:0005794; GO:0005886; GO:0006888; GO:0007421; GO:0007474; GO:0007476; GO:0007601; GO:0016197; GO:0016318; GO:0030176; GO:0031902; GO:0035225; GO:0038004; GO:0043703; GO:0046667; GO:0046843; GO:0048149; GO:0048263; GO:0048865; GO:0050714; GO:0061331; GO:0097038
P35280	RAB8A_RAT	reviewed	Ras-related protein Rab-8A	Rab8a Rab8	Rattus norvegicus (Rat)	207	Golgi vesicle fusion to target membrane [GO:0048210]; Rab protein signal transduction [GO:0032482]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of glucose import [GO:0046326]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein localization [GO:0032880]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]	Golgi apparatus [GO:0005794]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein kinase binding [GO:0019901]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; glucose homeostasis [GO:0042593]; Golgi vesicle fusion to target membrane [GO:0048210]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of glucose import [GO:0046326]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein localization [GO:0032880]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]	GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein kinase binding [GO:0019901]	GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005813; GO:0005814; GO:0005886; GO:0006886; GO:0006904; GO:0006914; GO:0007409; GO:0008021; GO:0009306; GO:0010506; GO:0014069; GO:0017157; GO:0019003; GO:0019901; GO:0030140; GO:0030425; GO:0030496; GO:0030659; GO:0030670; GO:0031410; GO:0031489; GO:0032482; GO:0032869; GO:0032880; GO:0036064; GO:0042593; GO:0043025; GO:0043197; GO:0045202; GO:0045335; GO:0046326; GO:0048169; GO:0048210; GO:0051223; GO:0055038; GO:0060271; GO:0072659; GO:0097546; GO:0097730; GO:0098887; GO:0098969; GO:0098978; GO:0099003
Q4V842	GPTC4_XENLA	reviewed	G patch domain-containing protein 4	gpatch4 gpatc4	Xenopus laevis (African clawed frog)	324			nucleic acid binding [GO:0003676]	nucleic acid binding [GO:0003676]	GO:0003676
Q6DED9	TM267_XENLA	reviewed	Transmembrane protein 267	tmem267 c5orf28	Xenopus laevis (African clawed frog)	215		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021
Q05733	DCHS_DROME	reviewed	Histidine decarboxylase (HDC) (EC 4.1.1.22)	Hdc CG3454	Drosophila melanogaster (Fruit fly)	847	catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]; thermotaxis [GO:0043052]		histidine decarboxylase activity [GO:0004398]; pyridoxal phosphate binding [GO:0030170]; catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]; thermotaxis [GO:0043052]	histidine decarboxylase activity [GO:0004398]; pyridoxal phosphate binding [GO:0030170]	GO:0004398; GO:0006520; GO:0030170; GO:0042423; GO:0043052
Q0P483	S2542_DANRE	reviewed	Mitochondrial coenzyme A transporter SLC25A42 (Solute carrier family 25 member 42)	slc25a42 zgc:153304	Danio rerio (Zebrafish) (Brachydanio rerio)	321	ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349]; mitochondrial membrane organization [GO:0007006]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; adenosine-diphosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228]; ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349]; mitochondrial membrane organization [GO:0007006]	ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; adenosine-diphosphatase activity [GO:0043262]; coenzyme A transmembrane transporter activity [GO:0015228]	GO:0005347; GO:0005739; GO:0005743; GO:0007006; GO:0015217; GO:0015228; GO:0015866; GO:0015867; GO:0016021; GO:0035349; GO:0043262; GO:0080121; GO:0080122
Q91WQ9	CALL4_MOUSE	reviewed	Calmodulin-like protein 4 (Calmodulin-related) (CALM-Rel)	Calml4	Mus musculus (Mouse)	153	calcium-mediated signaling [GO:0019722]		calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]	calcium ion binding [GO:0005509]	GO:0005509; GO:0019722
P18910	ANPRA_RAT	reviewed	Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)	Npr1	Rattus norvegicus (Rat)	1057	cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; cell surface receptor signaling pathway [GO:0007166]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0010753; GO:0016021; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0035556; GO:0042417; GO:0043235; GO:0048662
P32018	COEA1_CHICK	reviewed	Collagen alpha-1(XIV) chain (Undulin)	COL14A1	Gallus gallus (Chicken)	1888	cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]		GO:0003429; GO:0005581; GO:0005615; GO:0007155; GO:0031012; GO:0062023
Q9GYQ4	GCY8_CAEEL	reviewed	Receptor-type guanylate cyclase gcy-8 (EC 4.6.1.2)	gcy-8 C49H3.1	Caenorhabditis elegans	1152	cGMP biosynthetic process [GO:0006182]; detection of temperature stimulus [GO:0016048]; intracellular signal transduction [GO:0035556]; microvillus organization [GO:0032528]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]	cilium [GO:0005929]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]	cilium [GO:0005929]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; cGMP biosynthetic process [GO:0006182]; detection of temperature stimulus [GO:0016048]; intracellular signal transduction [GO:0035556]; microvillus organization [GO:0032528]; receptor guanylyl cyclase signaling pathway [GO:0007168]; signal transduction [GO:0007165]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005929; GO:0006182; GO:0007165; GO:0007168; GO:0016021; GO:0016048; GO:0031528; GO:0032528; GO:0035556; GO:0040040; GO:0043052; GO:0044306; GO:0046872
Q06547	GABP1_HUMAN	reviewed	GA-binding protein subunit beta-1 (GABP subunit beta-1) (GABPB-1) (GABP subunit beta-2) (GABPB-2) (Nuclear respiratory factor 2) (Transcription factor E4TF1-47) (Transcription factor E4TF1-53)	GABPB1 E4TF1B GABPB GABPB2	Homo sapiens (Human)	395	mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; transcription regulatory region DNA binding [GO:0044212]; mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; transcription regulatory region DNA binding [GO:0044212]	GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0007005; GO:0036464; GO:0044212; GO:0045944; GO:0046982
P35903	ACHC_ACHFU	reviewed	Achacin		Achatina fulica (Giant African snail) (Lissachatina fulica)	531	defense response to bacterium [GO:0042742]		oxidoreductase activity [GO:0016491]; defense response to bacterium [GO:0042742]	oxidoreductase activity [GO:0016491]	GO:0016491; GO:0042742
Q17043	APLY_APLKU	reviewed	Aplysianin-A		Aplysia kurodai (Kuroda's sea hare)	556	defense response to bacterium [GO:0042742]		oxidoreductase activity [GO:0016491]; defense response to bacterium [GO:0042742]	oxidoreductase activity [GO:0016491]	GO:0016491; GO:0042742
Q5H8C4	VP13A_MOUSE	reviewed	Vacuolar protein sorting-associated protein 13A (Chorea-acanthocytosis protein homolog) (Chorein)	Vps13a Chac Kiaa0986	Mus musculus (Mouse)	3166	autophagy [GO:0006914]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176]	dense core granule [GO:0031045]; extrinsic component of membrane [GO:0019898]	dense core granule [GO:0031045]; extrinsic component of membrane [GO:0019898]; autophagy [GO:0006914]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176]		GO:0006623; GO:0006914; GO:0007399; GO:0007626; GO:0019898; GO:0031045; GO:0035176; GO:0045053
Q4UMH6	Y381_RICFE	reviewed	Putative ankyrin repeat protein RF_0381	RF_0381	Rickettsia felis (strain ATCC VR-1525 / URRWXCal2) (Rickettsia azadi)	1179	guanosine tetraphosphate metabolic process [GO:0015969]		guanosine tetraphosphate metabolic process [GO:0015969]		GO:0015969
Q4PZA2	ECE1_MOUSE	reviewed	Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)	Ece1	Mus musculus (Mouse)	769	apoptotic process [GO:0006915]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; endothelin maturation [GO:0034959]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; response to hypoxia [GO:0001666]; substance P catabolic process [GO:0010814]	Golgi apparatus [GO:0005794]; Weibel-Palade body [GO:0033093]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; vesicle [GO:0031982]	cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; endothelin maturation [GO:0034959]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to hypoxia [GO:0001666]; substance P catabolic process [GO:0010814]	endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0001666; GO:0001921; GO:0004175; GO:0004222; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0006508; GO:0006915; GO:0007507; GO:0008217; GO:0008270; GO:0009897; GO:0009986; GO:0010613; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016021; GO:0016485; GO:0016486; GO:0030141; GO:0031410; GO:0031982; GO:0033093; GO:0034959; GO:0042447; GO:0042733; GO:0042803; GO:0043583; GO:0043950; GO:0045745; GO:0048471; GO:0060037; GO:0070372; GO:0097746
Q9ERE8	TLRN1_MOUSE	reviewed	Talin rod domain-containing protein 1 (Mesoderm development candidate 1)	Tlnrd1 Mesdc1	Mus musculus (Mouse)	362			actin binding [GO:0003779]	actin binding [GO:0003779]	GO:0003779
Q6PEE2	CTIF_MOUSE	reviewed	CBP80/20-dependent translation initiation factor	Ctif Gm672 Kiaa0427	Mus musculus (Mouse)	600	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446]	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446]	RNA binding [GO:0003723]; translation activator activity [GO:0008494]	GO:0000184; GO:0003723; GO:0005829; GO:0006446; GO:0008494; GO:0048471
Q709C8	VP13C_HUMAN	reviewed	Vacuolar protein sorting-associated protein 13C	VPS13C KIAA1421	Homo sapiens (Human)	3753	Golgi to endosome transport [GO:0006895]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; Golgi to endosome transport [GO:0006895]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		GO:0005737; GO:0005741; GO:0005829; GO:0006623; GO:0006895; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1905090
Q80V70	MEGF6_MOUSE	reviewed	Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)	Megf6 Egfl3	Mus musculus (Mouse)	1572		collagen-containing extracellular matrix [GO:0062023]	collagen-containing extracellular matrix [GO:0062023]; calcium ion binding [GO:0005509]	calcium ion binding [GO:0005509]	GO:0005509; GO:0062023
P22129	RB11B_DIPOM	reviewed	Ras-related protein Rab-11B (ORA3)		Diplobatis ommata (Ocellated electric ray) (Discopyge ommata)	218	cellular response to acidic pH [GO:0071468]; constitutive secretory pathway [GO:0045054]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; melanosome transport [GO:0032402]; receptor recycling [GO:0001881]; regulated exocytosis [GO:0045055]; regulation of anion transport [GO:0044070]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to plasma membrane [GO:1990126]; transferrin transport [GO:0033572]	cell junction [GO:0030054]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	cell junction [GO:0030054]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to acidic pH [GO:0071468]; constitutive secretory pathway [GO:0045054]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; melanosome transport [GO:0032402]; receptor recycling [GO:0001881]; regulated exocytosis [GO:0045055]; regulation of anion transport [GO:0044070]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to plasma membrane [GO:1990126]; transferrin transport [GO:0033572]	GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0001881; GO:0003924; GO:0005525; GO:0008021; GO:0019003; GO:0030054; GO:0030670; GO:0030672; GO:0032402; GO:0033572; GO:0035773; GO:0044070; GO:0045054; GO:0045055; GO:0045335; GO:0055038; GO:0071468; GO:1990126; GO:2000008; GO:2001135
Q8CHL0	FZD5_RAT	reviewed	Frizzled-5 (Fz-5)	Fzd5	Rattus norvegicus (Rat)	585	canonical Wnt signaling pathway [GO:0060070]; non-canonical Wnt signaling pathway [GO:0035567]; presynapse assembly [GO:0099054]	Golgi membrane [GO:0000139]; axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]	axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; non-canonical Wnt signaling pathway [GO:0035567]; presynapse assembly [GO:0099054]	G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; lipid binding [GO:0008289]	GO:0000139; GO:0004930; GO:0005886; GO:0008289; GO:0016021; GO:0017147; GO:0030054; GO:0030424; GO:0030425; GO:0035567; GO:0042813; GO:0043204; GO:0045202; GO:0060070; GO:0098978; GO:0099054
Q5DWN0	GFI1_CANLF	reviewed	Zinc finger protein Gfi-1 (Growth factor independence 1)	GFI1	Canis lupus familiaris (Dog) (Canis familiaris)	422	cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]	nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; transcriptional repressor complex [GO:0017053]	nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]	DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]	GO:0001227; GO:0010956; GO:0010977; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0034121; GO:0044212; GO:0046872; GO:0051569; GO:0070105; GO:0071222
P23508	CRCM_HUMAN	reviewed	Colorectal mutant cancer protein (Protein MCC)	MCC	Homo sapiens (Human)	829	Wnt signaling pathway [GO:0016055]; establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	signaling receptor activity [GO:0038023]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0016055; GO:0030027; GO:0038023; GO:0045184; GO:0050680; GO:0090090
Q8K4C0	FMO5_RAT	reviewed	Dimethylaniline monooxygenase [N-oxide-forming] 5 (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (FMO 5)	Fmo5	Rattus norvegicus (Rat)	533		endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]	N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]	GO:0004497; GO:0004499; GO:0005789; GO:0016021; GO:0050660; GO:0050661
A6NKF1	SAC31_HUMAN	reviewed	SAC3 domain-containing protein 1 (SAC3 homology domain-containing protein 1)	SAC3D1 SHD1	Homo sapiens (Human)	404	cell division [GO:0051301]; centrosome duplication [GO:0051298]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; spindle assembly [GO:0051225]		GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0051225; GO:0051298; GO:0051301
B4F766	DYM_RAT	reviewed	Dymeclin	Dym	Rattus norvegicus (Rat)	674	Golgi organization [GO:0007030]; bone development [GO:0060348]	Golgi apparatus [GO:0005794]; cytoplasm [GO:0005737]; membrane [GO:0016020]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; bone development [GO:0060348]; Golgi organization [GO:0007030]		GO:0005737; GO:0005794; GO:0007030; GO:0016020; GO:0060348
O45782	ARD17_CAEEL	reviewed	Arrestin domain-containing protein 17 (Calcineurin-interacting protein 1)	arrd-17 cnp-1 T12D8.4	Caenorhabditis elegans	426	behavior [GO:0007610]		protein phosphatase 2B binding [GO:0030346]; behavior [GO:0007610]	protein phosphatase 2B binding [GO:0030346]	GO:0007610; GO:0030346
Q9W734	SMAD6_CHICK	reviewed	Mothers against decapentaplegic homolog 6 (MAD homolog 6) (Mothers against DPP homolog 6) (SMAD family member 6) (SMAD 6) (Smad6)	SMAD6 MADH6	Gallus gallus (Chicken)	431	cell-substrate adhesion [GO:0031589]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of cell proliferation in dorsal spinal cord [GO:1902832]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of spinal cord association neuron differentiation by negative regulation of canonical Wnt signaling pathway [GO:1902844]; regulation of neurogenesis [GO:0050767]; transforming growth factor beta receptor signaling pathway [GO:0007179]	endosome [GO:0005768]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]	endosome [GO:0005768]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; cell-substrate adhesion [GO:0031589]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of cell proliferation in dorsal spinal cord [GO:1902832]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of spinal cord association neuron differentiation by negative regulation of canonical Wnt signaling pathway [GO:1902844]; regulation of neurogenesis [GO:0050767]; transforming growth factor beta receptor signaling pathway [GO:0007179]	DNA-binding transcription factor activity [GO:0003700]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]	GO:0003682; GO:0003700; GO:0005634; GO:0005667; GO:0005768; GO:0007179; GO:0010693; GO:0031589; GO:0032331; GO:0044212; GO:0046872; GO:0050767; GO:1902832; GO:1902844
Q5R9C7	SC11A_PONAB	reviewed	Signal peptidase complex catalytic subunit SEC11A (EC 3.4.21.89) (Endopeptidase SP18) (Microsomal signal peptidase 18 kDa subunit) (SPase 18 kDa subunit) (SEC11 homolog A) (SEC11-like protein 1) (SPC18)	SEC11A SEC11L1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	179	signal peptide processing [GO:0006465]	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]	integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; serine-type peptidase activity [GO:0008236]; signal peptide processing [GO:0006465]	serine-type peptidase activity [GO:0008236]	GO:0005787; GO:0006465; GO:0008236; GO:0016021
O35182	SMAD6_MOUSE	reviewed	Mothers against decapentaplegic homolog 6 (MAD homolog 6) (Mothers against DPP homolog 6) (Mad homolog 7) (SMAD family member 6) (SMAD 6) (Smad6)	Smad6 Madh6 Madh7 Msmad6	Mus musculus (Mouse)	495	BMP signaling pathway [GO:0030509]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; cardiac vascular smooth muscle cell development [GO:0060948]; cell-substrate adhesion [GO:0031589]; coronary vasculature development [GO:0060976]; coronary vasculature morphogenesis [GO:0060977]; fat cell differentiation [GO:0045444]; heart valve development [GO:0003170]; immune response [GO:0006955]; mitral valve morphogenesis [GO:0003183]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of vasoconstriction [GO:0045907]; pulmonary valve morphogenesis [GO:0003184]; response to estrogen [GO:0043627]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; ventricular septum development [GO:0003281]; zygotic specification of dorsal/ventral axis [GO:0007352]	Golgi apparatus [GO:0005794]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; DNA-binding transcription factor activity [GO:0003700]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity [GO:0030617]; type I activin receptor binding [GO:0070698]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; BMP signaling pathway [GO:0030509]; cardiac vascular smooth muscle cell development [GO:0060948]; cell-substrate adhesion [GO:0031589]; coronary vasculature development [GO:0060976]; coronary vasculature morphogenesis [GO:0060977]; fat cell differentiation [GO:0045444]; heart valve development [GO:0003170]; immune response [GO:0006955]; mitral valve morphogenesis [GO:0003183]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of vasoconstriction [GO:0045907]; pulmonary valve morphogenesis [GO:0003184]; response to estrogen [GO:0043627]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; ventricular septum development [GO:0003281]; zygotic specification of dorsal/ventral axis [GO:0007352]	DNA-binding transcription factor activity [GO:0003700]; I-SMAD binding [GO:0070411]; R-SMAD binding [GO:0070412]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity [GO:0030617]; type I activin receptor binding [GO:0070698]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]	GO:0000978; GO:0001657; GO:0003148; GO:0003170; GO:0003180; GO:0003183; GO:0003184; GO:0003281; GO:0003682; GO:0003700; GO:0005634; GO:0005667; GO:0005794; GO:0005829; GO:0006955; GO:0007179; GO:0007352; GO:0008285; GO:0010991; GO:0016604; GO:0030279; GO:0030509; GO:0030512; GO:0030514; GO:0030617; GO:0031589; GO:0031625; GO:0032496; GO:0032991; GO:0034616; GO:0034713; GO:0035904; GO:0042802; GO:0043066; GO:0043627; GO:0044212; GO:0045444; GO:0045668; GO:0045907; GO:0046872; GO:0060394; GO:0060948; GO:0060976; GO:0060977; GO:0070410; GO:0070411; GO:0070412; GO:0070698; GO:0097756; GO:1902895
Q55E58	PATS1_DICDI	reviewed	Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)	pats1 DDB_G0269250	Dictyostelium discoideum (Slime mold)	3184	cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]	actomyosin [GO:0042641]	actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]	GO:0000281; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0006470; GO:0042641; GO:0099139
P14618	KPYM_HUMAN	reviewed	Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58)	PKM OIP3 PK2 PK3 PKM2	Homo sapiens (Human)	531	ATP biosynthetic process [GO:0006754]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; pyruvate biosynthetic process [GO:0042866]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403]	cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]	cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; ATP biosynthetic process [GO:0006754]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; pyruvate biosynthetic process [GO:0042866]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; MHC class II protein complex binding [GO:0023026]; RNA binding [GO:0003723]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; thyroid hormone binding [GO:0070324]	GO:0000287; GO:0001666; GO:0001889; GO:0003723; GO:0004743; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005929; GO:0006096; GO:0006754; GO:0007584; GO:0009629; GO:0012501; GO:0014870; GO:0016301; GO:0023026; GO:0030955; GO:0031100; GO:0031982; GO:0032869; GO:0034774; GO:0042802; GO:0042866; GO:0043312; GO:0043403; GO:0043531; GO:0045296; GO:0051289; GO:0061621; GO:0062023; GO:0070062; GO:0070324; GO:1902912; GO:1903561; GO:1903672; GO:1904813
Q8IRI6	GTR1_DROME	reviewed	Glucose transporter type 1	Glut1 CG43946	Drosophila melanogaster (Fruit fly)	1440	carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643]; glucose homeostasis [GO:0042593]; positive regulation of peptide hormone secretion [GO:0090277]	transmembrane transporter activity [GO:0022857]	GO:0008643; GO:0016021; GO:0022857; GO:0042593; GO:0090277
Q19AE6	ACHA4_MUSPF	reviewed	Neuronal acetylcholine receptor subunit alpha-4	CHRNA4	Mustela putorius furo (European domestic ferret) (Mustela furo)	627	DNA repair [GO:0006281]; behavioral response to nicotine [GO:0035095]; cognition [GO:0050890]; nervous system process [GO:0050877]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; postsynaptic membrane [GO:0045211]	acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; postsynaptic membrane [GO:0045211]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; behavioral response to nicotine [GO:0035095]; cognition [GO:0050890]; DNA repair [GO:0006281]; nervous system process [GO:0050877]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]	GO:0001666; GO:0005892; GO:0006281; GO:0006979; GO:0007165; GO:0015464; GO:0022848; GO:0030054; GO:0035095; GO:0045211; GO:0050877; GO:0050890
Q92824	PCSK5_HUMAN	reviewed	Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase 5) (PC5) (Proprotein convertase 6) (PC6) (hPC6) (Subtilisin/kexin-like protease PC5)	PCSK5 PC5 PC6	Homo sapiens (Human)	1860	anterior/posterior pattern specification [GO:0009952]; cardiac septum development [GO:0003279]; cell-cell signaling [GO:0007267]; coronary vasculature development [GO:0060976]; cytokine biosynthetic process [GO:0042089]; determination of left/right symmetry [GO:0007368]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; nerve growth factor processing [GO:0032455]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of lipoprotein lipase activity [GO:0051004]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058]	Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; anterior/posterior pattern specification [GO:0009952]; cardiac septum development [GO:0003279]; cell-cell signaling [GO:0007267]; coronary vasculature development [GO:0060976]; cytokine biosynthetic process [GO:0042089]; determination of left/right symmetry [GO:0007368]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; nerve growth factor processing [GO:0032455]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of lipoprotein lipase activity [GO:0051004]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058]	endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]	GO:0001822; GO:0002001; GO:0003279; GO:0004175; GO:0004252; GO:0005576; GO:0005615; GO:0005794; GO:0005796; GO:0005802; GO:0006465; GO:0007267; GO:0007368; GO:0007507; GO:0007566; GO:0008233; GO:0009952; GO:0016020; GO:0016485; GO:0016486; GO:0019058; GO:0030141; GO:0030173; GO:0030323; GO:0032455; GO:0035108; GO:0042089; GO:0042277; GO:0043043; GO:0048566; GO:0048706; GO:0051004; GO:0060976
Q5UPJ3	YL116_MIMIV	reviewed	Uncharacterized protein L116	MIMI_L116	Acanthamoeba polyphaga mimivirus (APMV)	563					
Q13591	SEM5A_HUMAN	reviewed	Semaphorin-5A (Semaphorin-F) (Sema F)	SEMA5A SEMAF	Homo sapiens (Human)	1074	axon extension [GO:0048675]; axonal fasciculation [GO:0007413]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell signaling [GO:0007267]; diencephalon development [GO:0021536]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endothelial cell apoptotic process [GO:2000352]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron projection guidance [GO:0097485]; positive chemotaxis [GO:0050918]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein kinase B signaling [GO:0051897]; semaphorin-plexin signaling pathway [GO:0071526]; signal clustering [GO:1990256]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparan sulfate proteoglycan binding [GO:0043395]; semaphorin receptor binding [GO:0030215]; syndecan binding [GO:0045545]; axon extension [GO:0048675]; axonal fasciculation [GO:0007413]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell signaling [GO:0007267]; diencephalon development [GO:0021536]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endothelial cell apoptotic process [GO:2000352]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron projection guidance [GO:0097485]; positive chemotaxis [GO:0050918]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein kinase B signaling [GO:0051897]; semaphorin-plexin signaling pathway [GO:0071526]; signal clustering [GO:1990256]	chemorepellent activity [GO:0045499]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparan sulfate proteoglycan binding [GO:0043395]; semaphorin receptor binding [GO:0030215]; syndecan binding [GO:0045545]	GO:0001755; GO:0001938; GO:0002043; GO:0005886; GO:0007155; GO:0007162; GO:0007267; GO:0007399; GO:0007413; GO:0016020; GO:0016021; GO:0021536; GO:0030215; GO:0030335; GO:0030836; GO:0035373; GO:0043395; GO:0045499; GO:0045545; GO:0045766; GO:0048675; GO:0048842; GO:0048843; GO:0050918; GO:0051897; GO:0060326; GO:0070062; GO:0071526; GO:0090263; GO:0097485; GO:1990256; GO:2000352; GO:2001028
P98060	NAS35_CAEEL	reviewed	Zinc metalloproteinase dpy-31 (EC 3.4.24.-) (Nematode astacin 35) (Procollagen C-proteinase) (Tollish protein 2)	dpy-31 nas-35 toh-2 R151.5	Caenorhabditis elegans	592	cuticle development involved in collagen and cuticulin-based cuticle molting cycle [GO:0042338]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cuticle development involved in collagen and cuticulin-based cuticle molting cycle [GO:0042338]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005576; GO:0008270; GO:0042338
Q5RDU4	PARP6_PONAB	reviewed	Protein mono-ADP-ribosyltransferase PARP6 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 17) (ARTD17) (Poly [ADP-ribose] polymerase 6) (PARP-6)	PARP6	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	610	protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]		NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]	NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]	GO:0003950; GO:0070213; GO:0140289; GO:1990404
P51143	SC6A2_BOVIN	reviewed	Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2)	SLC6A2 NORADR	Bos taurus (Bovine)	615	dopamine uptake involved in synaptic transmission [GO:0051583]; norepinephrine transport [GO:0015874]	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]; norepinephrine:sodium symporter activity [GO:0005334]; dopamine uptake involved in synaptic transmission [GO:0051583]; norepinephrine transport [GO:0015874]	dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]; norepinephrine:sodium symporter activity [GO:0005334]	GO:0005328; GO:0005330; GO:0005334; GO:0005886; GO:0005887; GO:0015874; GO:0032809; GO:0042734; GO:0043005; GO:0046872; GO:0051583
P23253	TCNA_TRYCR	reviewed	Sialidase (EC 3.2.1.18) (Major surface antigen) (Neuraminidase) (NA)	TCNA	Trypanosoma cruzi	1162	metabolic process [GO:0008152]; pathogenesis [GO:0009405]	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; metabolic process [GO:0008152]; pathogenesis [GO:0009405]	exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]	GO:0005886; GO:0008152; GO:0009405; GO:0031225; GO:0052794; GO:0052795; GO:0052796
Q96PR1	KCNC2_HUMAN	reviewed	Potassium voltage-gated channel subfamily C member 2 (Shaw-like potassium channel) (Voltage-gated potassium channel Kv3.2)	KCNC2	Homo sapiens (Human)	638	cellular response to ammonium ion [GO:0071242]; cellular response to nitric oxide [GO:0071732]; cellular response to toxic substance [GO:0097237]; globus pallidus development [GO:0021759]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of insulin secretion [GO:0050796]; response to amine [GO:0014075]; response to ethanol [GO:0045471]; response to light intensity [GO:0009642]; response to magnesium ion [GO:0032026]; response to nerve growth factor [GO:1990089]; response to organic cyclic compound [GO:0014070]	apical plasma membrane [GO:0016324]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]	apical plasma membrane [GO:0016324]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; voltage-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249]; cellular response to ammonium ion [GO:0071242]; cellular response to nitric oxide [GO:0071732]; cellular response to toxic substance [GO:0097237]; globus pallidus development [GO:0021759]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of insulin secretion [GO:0050796]; response to amine [GO:0014075]; response to ethanol [GO:0045471]; response to light intensity [GO:0009642]; response to magnesium ion [GO:0032026]; response to nerve growth factor [GO:1990089]; response to organic cyclic compound [GO:0014070]	delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; voltage-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005886; GO:0005887; GO:0008076; GO:0009642; GO:0014070; GO:0014075; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0021759; GO:0030054; GO:0030424; GO:0030425; GO:0030673; GO:0031982; GO:0032026; GO:0032590; GO:0032809; GO:0038060; GO:0042734; GO:0043025; GO:0043195; GO:0043204; GO:0044325; GO:0045202; GO:0045211; GO:0045471; GO:0050796; GO:0051260; GO:0051291; GO:0071242; GO:0071732; GO:0071805; GO:0097237; GO:0099508; GO:1903818; GO:1990089
Q6B4J5	EXSA_BACCE	reviewed	Spore coat assembly protein ExsA	exsA	Bacillus cereus	643	sporulation resulting in formation of a cellular spore [GO:0030435]		sporulation resulting in formation of a cellular spore [GO:0030435]		GO:0030435
Q9VZW5	FMAR_DROME	reviewed	FMRFamide receptor (DFR) (DrmFMRFa-R)	FMRFaR FR CG2114	Drosophila melanogaster (Fruit fly)	549	G protein-coupled receptor signaling pathway [GO:0007186]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]	GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021
Q52118	YMO3_PANSE	reviewed	Uncharacterized protein in mobD 3'region		Pantoea stewartii subsp. stewartii (Erwinia stewartii)	295					
O88799	ZAN_MOUSE	reviewed	Zonadhesin	Zan	Mus musculus (Mouse)	5376	binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; regulation of binding of sperm to zona pellucida [GO:2000359]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix binding [GO:0050840]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; regulation of binding of sperm to zona pellucida [GO:2000359]	extracellular matrix binding [GO:0050840]	GO:0005886; GO:0007155; GO:0007339; GO:0016021; GO:0050840; GO:2000359
O74452	SCW1_SCHPO	reviewed	Cell wall integrity protein scw1 (Strong cell wall protein 1)	scw1 SPCC16C4.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	561	mRNA splicing, via spliceosome [GO:0000398]; regulation of fungal-type cell wall biogenesis [GO:0032995]	U1 snRNP [GO:0005685]; cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; U1 snRNP [GO:0005685]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]; regulation of fungal-type cell wall biogenesis [GO:0032995]	RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]	GO:0000398; GO:0003723; GO:0005685; GO:0005737; GO:0030619; GO:0032995
Q03277	PO11_BRACO	reviewed	Retrovirus-related Pol polyprotein from type-1 retrotransposable element R1 (Retrovirus-related Pol polyprotein from type I retrotransposable element R1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)		Bradysia coprophila (Dark-winged fungus gnat) (Sciara coprophila)	1004			endonuclease activity [GO:0004519]; RNA-directed DNA polymerase activity [GO:0003964]	RNA-directed DNA polymerase activity [GO:0003964]; endonuclease activity [GO:0004519]	GO:0003964; GO:0004519
P31689	DNJA1_HUMAN	reviewed	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	Homo sapiens (Human)	397	DNA damage response, detection of DNA damage [GO:0042769]; androgen receptor signaling pathway [GO:0030521]; flagellated sperm motility [GO:0030317]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998]	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; C3HC4-type RING finger domain binding [GO:0055131]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; flagellated sperm motility [GO:0030317]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998]	ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; C3HC4-type RING finger domain binding [GO:0055131]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; Tat protein binding [GO:0030957]; chaperone binding [GO:0051087]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0001664; GO:0001671; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0015630; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051082; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259
Q27516	C13A8_CAEEL	reviewed	Putative cytochrome P450 CYP13A8 (EC 1.14.-.-)	cyp-13A8 cyp13a8 T10B9.4	Caenorhabditis elegans	509			heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]	heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]	GO:0004497; GO:0005506; GO:0016705; GO:0020037
Q7YRH6	PEMT_BOVIN	reviewed	Phosphatidylethanolamine N-methyltransferase (PEAMT) (PEMT) (EC 2.1.1.17) (EC 2.1.1.71) (Phospholipid methyltransferase) (PLMT)	PEMT PEMT2	Bos taurus (Bovine)	199	phosphatidylcholine biosynthetic process [GO:0006656]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; phosphatidyl-N-dimethylethanolamine N-methyltransferase activity [GO:0080101]; phosphatidyl-N-methylethanolamine N-methyltransferase activity [GO:0000773]; phosphatidylethanolamine N-methyltransferase activity [GO:0004608]; phosphatidylcholine biosynthetic process [GO:0006656]	phosphatidyl-N-dimethylethanolamine N-methyltransferase activity [GO:0080101]; phosphatidyl-N-methylethanolamine N-methyltransferase activity [GO:0000773]; phosphatidylethanolamine N-methyltransferase activity [GO:0004608]	GO:0000773; GO:0004608; GO:0005789; GO:0006656; GO:0016021; GO:0031966; GO:0080101
Q96WV6	YHU2_SCHPO	reviewed	Uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02	SPBPJ4664.02	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	3971		anchored component of external side of plasma membrane [GO:0031362]; external side of cell wall [GO:0010339]	anchored component of external side of plasma membrane [GO:0031362]; external side of cell wall [GO:0010339]; cell adhesion mediator activity [GO:0098631]	cell adhesion mediator activity [GO:0098631]	GO:0010339; GO:0031362; GO:0098631
A2RRS8	CEP78_XENTR	reviewed	Centrosomal protein of 78 kDa (Cep78)	cep78	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	727	cilium organization [GO:0044782]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium organization [GO:0044782]		GO:0005813; GO:0005814; GO:0036064; GO:0044782
Q02440	MYO5A_CHICK	reviewed	Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain p190) (Myosin-V)	MYO5A	Gallus gallus (Chicken)	1829	cellular response to insulin stimulus [GO:0032869]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192]	Golgi membrane [GO:0000139]; filamentous actin [GO:0031941]; insulin-responsive compartment [GO:0032593]; myosin complex [GO:0016459]	filamentous actin [GO:0031941]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; minus-end directed microfilament motor activity [GO:0060001]; cellular response to insulin stimulus [GO:0032869]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192]	ATP binding [GO:0005524]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; minus-end directed microfilament motor activity [GO:0060001]	GO:0000139; GO:0000146; GO:0005516; GO:0005524; GO:0016192; GO:0016459; GO:0031941; GO:0032593; GO:0032869; GO:0051015; GO:0060001; GO:0072659
Q9ULV0	MYO5B_HUMAN	reviewed	Unconventional myosin-Vb	MYO5B KIAA1119	Homo sapiens (Human)	1848	endosomal transport [GO:0016197]; protein transport [GO:0015031]; renal water homeostasis [GO:0003091]; vesicle-mediated transport [GO:0016192]	apical cortex [GO:0045179]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; protein-containing complex [GO:0032991]	apical cortex [GO:0045179]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; protein-containing complex [GO:0032991]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; renal water homeostasis [GO:0003091]; vesicle-mediated transport [GO:0016192]	ATP binding [GO:0005524]; Rab GTPase binding [GO:0017137]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0003091; GO:0005516; GO:0005524; GO:0015031; GO:0016192; GO:0016197; GO:0016459; GO:0017137; GO:0030659; GO:0032991; GO:0045179; GO:0051015; GO:0070062
P27115	MGAT1_RABIT	reviewed	Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)	MGAT1 GNT1	Oryctolagus cuniculus (Rabbit)	447	mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; protein N-acetylglucosaminyltransferase activity [GO:0016262]	GO:0000139; GO:0003827; GO:0005797; GO:0006013; GO:0006487; GO:0016021; GO:0016262; GO:0018279; GO:0030145
Q86XX4	FRAS1_HUMAN	reviewed	Extracellular matrix protein FRAS1	FRAS1 KIAA1500	Homo sapiens (Human)	4008	cell communication [GO:0007154]; embryonic limb morphogenesis [GO:0030326]; metanephros morphogenesis [GO:0003338]; morphogenesis of an epithelium [GO:0002009]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skin development [GO:0043588]	basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; embryonic limb morphogenesis [GO:0030326]; metanephros morphogenesis [GO:0003338]; morphogenesis of an epithelium [GO:0002009]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skin development [GO:0043588]	extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]	GO:0002009; GO:0003338; GO:0005201; GO:0005604; GO:0005886; GO:0007154; GO:0015031; GO:0016021; GO:0030326; GO:0043588; GO:0046872; GO:0060021
Q6IWZ0	OXLA_APLCA	reviewed	L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2) (Escapin)		Aplysia californica (California sea hare)	535	defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; killing of cells of other organism [GO:0031640]; oxidation-reduction process [GO:0055114]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; L-amino-acid oxidase activity [GO:0001716]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; killing of cells of other organism [GO:0031640]; oxidation-reduction process [GO:0055114]	L-amino-acid oxidase activity [GO:0001716]	GO:0001716; GO:0005576; GO:0006952; GO:0031640; GO:0042742; GO:0050832; GO:0055114
P49641	MA2A2_HUMAN	reviewed	Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)	MAN2A2 MANA2X	Homo sapiens (Human)	1150	N-glycan processing [GO:0006491]; mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]	alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]	GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0016021; GO:0016799; GO:0030246; GO:0046872
Q6DIB5	MEG10_MOUSE	reviewed	Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10)	Megf10	Mus musculus (Mouse)	1147	apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]	Notch binding [GO:0005112]; complement component C1q binding [GO:0001849]; scavenger receptor activity [GO:0005044]	GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742
Q71LX4	TLN2_MOUSE	reviewed	Talin-2	Tln2	Mus musculus (Mouse)	2375	cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; fascia adherens [GO:0005916]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; fascia adherens [GO:0005916]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016]	actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]	GO:0001726; GO:0005200; GO:0005737; GO:0005856; GO:0005886; GO:0005916; GO:0005925; GO:0007016; GO:0007155; GO:0045202; GO:0051015
Q99ML9	RN111_MOUSE	reviewed	E3 ubiquitin-protein ligase Arkadia (EC 2.3.2.27) (RING finger protein 111) (RING-type E3 ubiquitin transferase Arkadia)	Rnf111	Mus musculus (Mouse)	989	DNA repair [GO:0006281]; pattern specification process [GO:0007389]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; ubiquitin-dependent protein catabolic process [GO:0006511]	PML body [GO:0016605]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332]; SUMO polymer binding [GO:0032184]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; DNA repair [GO:0006281]; pattern specification process [GO:0007389]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]	SMAD binding [GO:0046332]; SUMO polymer binding [GO:0032184]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006511; GO:0007389; GO:0016567; GO:0016605; GO:0030511; GO:0030579; GO:0031398; GO:0032184; GO:0032991; GO:0045893; GO:0046332; GO:0046872; GO:0061630
Q6AY25	TMED3_RAT	reviewed	Transmembrane emp24 domain-containing protein 3 (p24 family protein gamma-4) (p24gamma4)	Tmed3	Rattus norvegicus (Rat)	221	Golgi organization [GO:0007030]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]	COPI vesicle coat [GO:0030126]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]	COPI vesicle coat [GO:0030126]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]		GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0016021; GO:0030126; GO:0030134; GO:0032580; GO:0033116
D3ZTX0	TMED7_RAT	reviewed	Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27)	Tmed7	Rattus norvegicus (Rat)	226	Golgi organization [GO:0007030]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]	COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]	COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]		GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0012507; GO:0016021; GO:0030134; GO:0030663; GO:0033116
A4IGM4	DHI1L_XENTR	reviewed	Hydroxysteroid 11-beta-dehydrogenase 1-like protein (EC 1.1.1.-) (11-beta-hydroxysteroid dehydrogenase type 3) (11-DH3) (11-beta-HSD3)	hsd11b1l hsd3	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	286		extracellular region [GO:0005576]	extracellular region [GO:0005576]; oxidoreductase activity [GO:0016491]	oxidoreductase activity [GO:0016491]	GO:0005576; GO:0016491
Q96HA9	PX11C_HUMAN	reviewed	Peroxisomal membrane protein 11C (Peroxin-11C) (Peroxisomal biogenesis factor 11C) (Protein PEX11 homolog gamma) (PEX11-gamma)	PEX11G PEX11C	Homo sapiens (Human)	241	peroxisome fission [GO:0016559]; regulation of peroxisome size [GO:0044375]	integral component of peroxisomal membrane [GO:0005779]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	integral component of peroxisomal membrane [GO:0005779]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; peroxisome fission [GO:0016559]; regulation of peroxisome size [GO:0044375]		GO:0005777; GO:0005779; GO:0016559; GO:0031231; GO:0032991; GO:0044375
Q8K1R7	NEK9_MOUSE	reviewed	Serine/threonine-protein kinase Nek9 (EC 2.7.11.1) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9)	Nek9 Nercc	Mus musculus (Mouse)	984	cell cycle [GO:0007049]; cell division [GO:0051301]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0007049; GO:0019901; GO:0046872; GO:0051301
Q8VCV9	MF4B1_MOUSE	reviewed	Sodium-dependent glucose transporter 1A (Major facilitator superfamily domain-containing protein 4B1)	Mfsd4b1 Naglt1a	Mus musculus (Mouse)	425	sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]	GO:0005355; GO:0006814; GO:0015293; GO:0016021; GO:0016324
Q4V891	POC5_RAT	reviewed	Centrosomal protein POC5 (Protein of centriole 5)	Poc5	Rattus norvegicus (Rat)	558	cell cycle [GO:0007049]	centriole [GO:0005814]; centrosome [GO:0005813]	centriole [GO:0005814]; centrosome [GO:0005813]; cell cycle [GO:0007049]		GO:0005813; GO:0005814; GO:0007049
O94986	CE152_HUMAN	reviewed	Centrosomal protein of 152 kDa (Cep152)	CEP152 KIAA0912	Homo sapiens (Human)	1710	G2/M transition of mitotic cell cycle [GO:0000086]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; ciliary basal body-plasma membrane docking [GO:0097711]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; deuterosome [GO:0098536]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; deuterosome [GO:0098536]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; protein kinase binding [GO:0019901]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; ciliary basal body-plasma membrane docking [GO:0097711]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	protein kinase binding [GO:0019901]	GO:0000086; GO:0000242; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0010389; GO:0019901; GO:0051298; GO:0097711; GO:0098535; GO:0098536
Q5ZJ85	PRPF3_CHICK	reviewed	U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3)	PRPF3 RCJMB04_20b24	Gallus gallus (Chicken)	684	mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]	U4/U6 x U5 tri-snRNP complex [GO:0046540]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]		GO:0000244; GO:0000398; GO:0005634; GO:0005681; GO:0016607; GO:0046540
Q96PH1	NOX5_HUMAN	reviewed	NADPH oxidase 5 (EC 1.6.3.-)	NOX5	Homo sapiens (Human)	765	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]	NADPH oxidase complex [GO:0043020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; defense response [GO:0006952]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]	NADP binding [GO:0050661]; calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]	GO:0001525; GO:0001935; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0006952; GO:0008283; GO:0010155; GO:0015252; GO:0016175; GO:0020037; GO:0034599; GO:0042554; GO:0043012; GO:0043020; GO:0050660; GO:0050661; GO:0050663; GO:0055114; GO:0061640; GO:2000379
Q8TA94	ZN563_HUMAN	reviewed	Zinc finger protein 563	ZNF563	Homo sapiens (Human)	476	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006357; GO:0046872
O05389	YRBE_BACSU	reviewed	Uncharacterized oxidoreductase YrbE (EC 1.-.-.-)	yrbE BSU27770	Bacillus subtilis (strain 168)	341	NADPH regeneration [GO:0006740]		oxidoreductase activity [GO:0016491]; NADPH regeneration [GO:0006740]	oxidoreductase activity [GO:0016491]	GO:0006740; GO:0016491
O75197	LRP5_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7)	LRP5 LR3 LRP7	Homo sapiens (Human)	1615	Norrin signaling pathway [GO:0110135]; adipose tissue development [GO:0060612]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cholesterol homeostasis [GO:0042632]; endocytosis [GO:0006897]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; toxin transport [GO:1901998]	Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cholesterol homeostasis [GO:0042632]; endocytosis [GO:0006897]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; toxin transport [GO:1901998]	Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]	GO:0001702; GO:0002053; GO:0002076; GO:0005783; GO:0005886; GO:0006007; GO:0006897; GO:0008217; GO:0008284; GO:0009952; GO:0016021; GO:0017147; GO:0042632; GO:0042813; GO:0043235; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048539; GO:0060042; GO:0060070; GO:0060349; GO:0060444; GO:0060612; GO:0061178; GO:0061304; GO:0071901; GO:0071936; GO:0110135; GO:1901998; GO:1904928; GO:1990851; GO:1990909
P59222	SREC2_MOUSE	reviewed	Scavenger receptor class F member 2 (Scavenger receptor expressed by endothelial cells 2 protein) (SREC-II)	Scarf2 Srec2	Mus musculus (Mouse)	833	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]	scavenger receptor activity [GO:0005044]	GO:0005044; GO:0007157; GO:0016021
P22105	TENX_HUMAN	reviewed	Tenascin-X (TN-X) (Hexabrachion-like protein)	TNXB HXBL TNX TNXB1 TNXB2 XB	Homo sapiens (Human)	4244	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]	collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]	GO:0005178; GO:0005201; GO:0005576; GO:0005615; GO:0007155; GO:0008201; GO:0030036; GO:0030199; GO:0031012; GO:0032963; GO:0048251; GO:0062023; GO:0070062; GO:0098633
Q8TB03	CX038_HUMAN	reviewed	Uncharacterized protein CXorf38	CXorf38	Homo sapiens (Human)	319					
O15016	TRI66_HUMAN	reviewed	Tripartite motif-containing protein 66	TRIM66 C11orf29 KIAA0298	Homo sapiens (Human)	1216	negative regulation of transcription, DNA-templated [GO:0045892]	aggresome [GO:0016235]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	aggresome [GO:0016235]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]	chromatin binding [GO:0003682]; zinc ion binding [GO:0008270]	GO:0003682; GO:0005634; GO:0005654; GO:0008270; GO:0016235; GO:0045892
O16374	GALT1_CAEEL	reviewed	Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)	galt-1 M03F8.4	Caenorhabditis elegans	425	N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]; N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]	UDP-galactosyltransferase activity [GO:0035250]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]	GO:0003831; GO:0006491; GO:0016021; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872
P83088	FUCTC_DROME	reviewed	Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)	FucTC CG40305	Drosophila melanogaster (Fruit fly)	425	fucosylation [GO:0036065]; protein glycosylation [GO:0006486]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]	alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]	GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920
P97603	NEO1_RAT	reviewed	Neogenin (Fragment)	Neo1 Ngn	Rattus norvegicus (Rat)	1377	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; iron ion homeostasis [GO:0055072]; negative regulation of neuron death [GO:1901215]; positive regulation of BMP signaling pathway [GO:0030513]	integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]	integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; iron ion homeostasis [GO:0055072]; negative regulation of neuron death [GO:1901215]; positive regulation of BMP signaling pathway [GO:0030513]	signaling receptor activity [GO:0038023]	GO:0005887; GO:0007155; GO:0007411; GO:0030513; GO:0038023; GO:0043025; GO:0055072; GO:1901215
O15164	TIF1A_HUMAN	reviewed	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	TRIM24 RNF82 TIF1 TIF1A	Homo sapiens (Human)	1050	calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]	cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]	cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]	chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796
Q96EQ9	PRDM9_MOUSE	reviewed	Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.43) (Hybrid sterility protein 1) (Meiosis-induced factor containing a PR/SET domain and zinc-finger motif) (PR domain zinc finger protein 9) (PR domain-containing protein 9)	Prdm9 Hst1 Meisetz	Mus musculus (Mouse)	843	histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; meiotic gene conversion [GO:0006311]; nucleosome positioning [GO:0016584]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]	chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; meiotic gene conversion [GO:0006311]; nucleosome positioning [GO:0016584]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]	DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]	GO:0000977; GO:0003700; GO:0005634; GO:0005654; GO:0005694; GO:0006311; GO:0007283; GO:0010844; GO:0010845; GO:0016571; GO:0016584; GO:0018024; GO:0031490; GO:0034968; GO:0042800; GO:0043565; GO:0044212; GO:0045944; GO:0046872; GO:0060903
Q29042	FCN1_PIG	reviewed	Ficolin-1 (Ficolin-A) (Ficolin-alpha)	FCN1	Sus scrofa (Pig)	326	innate immune response [GO:0045087]	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; innate immune response [GO:0045087]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0005576; GO:0005581; GO:0005886; GO:0030246; GO:0045087; GO:0046872
O76080	ZFAN5_HUMAN	reviewed	AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216)	ZFAND5 ZA20D2 ZNF216	Homo sapiens (Human)	213		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005737; GO:0008270
P52656	T2AG_DROME	reviewed	Transcription initiation factor IIA subunit 2 (General transcription factor IIA subunit 2) (TFIIA p14 subunit) (TFIIA-14) (Transcription initiation factor IIA gamma chain) (TFIIA-gamma) (dTFIIA-S)	TfIIA-S CG5163	Drosophila melanogaster (Fruit fly)	106	RNA polymerase II preinitiation complex assembly [GO:0051123]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleus [GO:0005634]; transcription factor TFIIA complex [GO:0005672]	nucleus [GO:0005634]; transcription factor TFIIA complex [GO:0005672]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005672; GO:0006366; GO:0006367; GO:0017025; GO:0045944; GO:0051091; GO:0051123
A8Y1P7	BRE4_CAEBR	reviewed	Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT)	bre-4 CBG22165	Caenorhabditis briggsae	384	carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]	metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]	GO:0005975; GO:0006486; GO:0016021; GO:0016757; GO:0046872
Q9C0G6	DYH6_HUMAN	reviewed	Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)	DNAH6 DNAHC6 DNHL1 HL2 KIAA1697	Homo sapiens (Human)	4158	microtubule-based movement [GO:0007018]	cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]	cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]	ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045503; GO:0045505; GO:0051959
Q7L1S5	CHST9_HUMAN	reviewed	Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2)	CHST9 UNQ2549/PRO6175	Homo sapiens (Human)	443	carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]	Golgi membrane [GO:0000139]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]	extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]	N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001537; GO:0005576; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030203; GO:0030206; GO:0042446
B9EKR1	PTPRZ_MOUSE	reviewed	Receptor-type tyrosine-protein phosphatase zeta (R-PTP-zeta) (EC 3.1.3.48)	Ptprz1	Mus musculus (Mouse)	2312	axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; synapse [GO:0045202]	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; fibroblast growth factor binding [GO:0017134]; integrin binding [GO:0005178]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]	fibroblast growth factor binding [GO:0017134]; integrin binding [GO:0005178]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]	GO:0002244; GO:0004725; GO:0005178; GO:0005615; GO:0005737; GO:0005886; GO:0006470; GO:0007409; GO:0007413; GO:0007611; GO:0008285; GO:0010812; GO:0010976; GO:0016020; GO:0016791; GO:0017134; GO:0030027; GO:0030175; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0031012; GO:0031226; GO:0031641; GO:0032587; GO:0035335; GO:0043025; GO:0043197; GO:0043524; GO:0045202; GO:0045211; GO:0048146; GO:0048709; GO:0048714; GO:0048814; GO:0050731; GO:0070445; GO:0072534; GO:0098978; GO:0099061; GO:1900006; GO:1900149; GO:1901216; GO:2000171; GO:2001224
O97758	ZO1_CANLF	reviewed	Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1)	TJP1 ZO1	Canis lupus familiaris (Dog) (Canis familiaris)	1769	bicellular tight junction assembly [GO:0070830]; cellular response to calcium ion [GO:0071277]	bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; plasma membrane [GO:0005886]	bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; bicellular tight junction assembly [GO:0070830]; cellular response to calcium ion [GO:0071277]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005886; GO:0005911; GO:0005921; GO:0005923; GO:0009986; GO:0031410; GO:0070830; GO:0071277
Q8IUN9	CLC10_HUMAN	reviewed	C-type lectin domain family 10 member A (C-type lectin superfamily member 14) (Macrophage lectin 2) (CD antigen CD301)	CLEC10A CLECSF13 CLECSF14 HML	Homo sapiens (Human)	316	adaptive immune response [GO:0002250]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; adaptive immune response [GO:0002250]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]	carbohydrate binding [GO:0030246]	GO:0002223; GO:0002250; GO:0005886; GO:0006897; GO:0016021; GO:0030246; GO:0045087
P18106	FER_DROME	reviewed	Tyrosine-protein kinase Fer (EC 2.7.10.2)	FER fps Fps85D HD-179 CG8874	Drosophila melanogaster (Fruit fly)	1325	actin filament bundle assembly [GO:0051017]; axon guidance [GO:0007411]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, elongation of leading edge cells [GO:0007394]; regulation of cell population proliferation [GO:0042127]	adherens junction [GO:0005912]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipid binding [GO:0005543]; protein tyrosine kinase activity [GO:0004713]; actin filament bundle assembly [GO:0051017]; axon guidance [GO:0007411]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, elongation of leading edge cells [GO:0007394]; regulation of cell population proliferation [GO:0042127]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipid binding [GO:0005543]; protein tyrosine kinase activity [GO:0004713]	GO:0004713; GO:0004715; GO:0005524; GO:0005543; GO:0005886; GO:0005912; GO:0007391; GO:0007394; GO:0007411; GO:0019898; GO:0031234; GO:0042127; GO:0046664; GO:0051017
P46023	GR101_LYMST	reviewed	G-protein coupled receptor GRL101		Lymnaea stagnalis (Great pond snail) (Helix stagnalis)	1115		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021
P43446	WN10A_DANRE	reviewed	Protein Wnt-10a	wnt10a wnt-10a	Danio rerio (Zebrafish) (Brachydanio rerio)	442	Wnt signaling pathway [GO:0016055]; cell fate commitment [GO:0045165]; neuron differentiation [GO:0030182]; odontogenesis [GO:0042476]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; frizzled binding [GO:0005109]; cell fate commitment [GO:0045165]; neuron differentiation [GO:0030182]; odontogenesis [GO:0042476]; Wnt signaling pathway [GO:0016055]	frizzled binding [GO:0005109]	GO:0005109; GO:0005615; GO:0016055; GO:0030182; GO:0042476; GO:0045165
Q9Y345	SC6A5_HUMAN	reviewed	Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5)	SLC6A5 GLYT2 NET1	Homo sapiens (Human)	797	chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]	glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]	glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission, glycinergic [GO:0060012]	glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]	GO:0005886; GO:0007268; GO:0015375; GO:0016021; GO:0046872; GO:0060012; GO:0098690; GO:0099056; GO:1903804
Q9Z0E6	GBP2_MOUSE	reviewed	Guanylate-binding protein 2 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (mGBP-2) (mGBP2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2)	Gbp2	Mus musculus (Mouse)	589	adhesion of symbiont to host [GO:0044406]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; protein localization to nucleus [GO:0034504]; response to bacterium [GO:0009617]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; symbiont-containing vacuole membrane [GO:0020005]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; symbiont-containing vacuole membrane [GO:0020005]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; adhesion of symbiont to host [GO:0044406]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; protein localization to nucleus [GO:0034504]; response to bacterium [GO:0009617]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]	GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0009617; GO:0015629; GO:0020005; GO:0031410; GO:0034504; GO:0035458; GO:0042803; GO:0042832; GO:0044406; GO:0048471; GO:0050830; GO:0071222; GO:0071346
Q61107	GBP4_MOUSE	reviewed	Guanylate-binding protein 4 (EC 3.6.5.-) (GTP-binding protein 3) (GBP-3) (GTP-binding protein 4) (GBP-4) (Guanine nucleotide-binding protein 4) (Guanylate-binding protein 3)	Gbp4 Gbp3	Mus musculus (Mouse)	620	adhesion of symbiont to host [GO:0044406]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]	Golgi membrane [GO:0000139]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; symbiont-containing vacuole membrane [GO:0020005]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; symbiont-containing vacuole membrane [GO:0020005]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; adhesion of symbiont to host [GO:0044406]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]	GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0020005; GO:0031410; GO:0035458; GO:0042803; GO:0042832; GO:0044406; GO:0048471; GO:0050830; GO:0071346
Q63663	GBP2_RAT	reviewed	Guanylate-binding protein 1 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2) (p67)	Gbp2	Rattus norvegicus (Rat)	589	cellular response to interferon-gamma [GO:0071346]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]	Golgi membrane [GO:0000139]; cytoplasmic vesicle [GO:0031410]; perinuclear region of cytoplasm [GO:0048471]; symbiont-containing vacuole membrane [GO:0020005]	cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; symbiont-containing vacuole membrane [GO:0020005]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-gamma [GO:0071346]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0000139; GO:0003924; GO:0005525; GO:0020005; GO:0031410; GO:0042832; GO:0048471; GO:0050830; GO:0071346
Q61555	FBN2_MOUSE	reviewed	Fibrillin-2 [Cleaved into: Fibrillin-2 C-terminal peptide]	Fbn2 Fbn-2	Mus musculus (Mouse)	2907	bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023
O35806	LTBP2_RAT	reviewed	Latent-transforming growth factor beta-binding protein 2 (LTBP-2)	Ltbp2	Rattus norvegicus (Rat)	1764	supramolecular fiber organization [GO:0097435]; transforming growth factor beta receptor signaling pathway [GO:0007179]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; microfibril binding [GO:0050436]; supramolecular fiber organization [GO:0097435]; transforming growth factor beta receptor signaling pathway [GO:0007179]	calcium ion binding [GO:0005509]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; microfibril binding [GO:0050436]	GO:0005509; GO:0005576; GO:0007179; GO:0008201; GO:0019838; GO:0050436; GO:0097435
B3EWY9	MLP_ACRMI	reviewed	Mucin-like protein (Fragment)		Acropora millepora (Staghorn coral) (Heteropora millepora)	1594	cell-matrix adhesion [GO:0007160]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]	calcium ion binding [GO:0005509]	GO:0005509; GO:0007160; GO:0016021
Q5R5C1	UROM_PONAB	reviewed	Uromodulin [Cleaved into: Uromodulin, secreted form]	UMOD	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	641	excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; spindle pole [GO:0000922]	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; IgG binding [GO:0019864]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]	IgG binding [GO:0019864]; calcium ion binding [GO:0005509]	GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0007157; GO:0007159; GO:0007588; GO:0016323; GO:0016324; GO:0019864; GO:0031225; GO:0050801; GO:0060170; GO:0072218; GO:0072221; GO:0072233; GO:1990266
B1WBU4	ZBT8A_RAT	reviewed	Zinc finger and BTB domain-containing protein 8A	Zbtb8a	Rattus norvegicus (Rat)	441		nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872
P35556	FBN2_HUMAN	reviewed	Fibrillin-2 [Cleaved into: Fibrillin-2 C-terminal peptide]	FBN2	Homo sapiens (Human)	2912	bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; extracellular matrix organization [GO:0030198]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; extracellular matrix organization [GO:0030198]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]	calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]	GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0030023; GO:0030198; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023
P31396	HR3_DROME	reviewed	Probable nuclear hormone receptor HR3 (dHR3) (Nuclear receptor subfamily 1 group F member 4)	Hr3 Hr46 CG11823	Drosophila melanogaster (Fruit fly)	487	metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]	nucleus [GO:0005634]	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]	RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; nuclear receptor activity [GO:0004879]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000977; GO:0003707; GO:0004879; GO:0005634; GO:0007552; GO:0008270; GO:0016319; GO:0040034; GO:0045944
D3YXG0	HMCN1_MOUSE	reviewed	Hemicentin-1 (Fibulin-6) (FIBL-6)	Hmcn1	Mus musculus (Mouse)	5634	cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]	calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]	GO:0005509; GO:0005576; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0009617; GO:0030054; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023
B2DFG5	DTHAD_DELSH	reviewed	D-threo-3-hydroxyaspartate dehydratase (D-THA DH) (D-THA dehydratase) (EC 4.3.1.27) (Threo-3-hydroxy-D-aspartate ammonia-lyase)	dthadh	Delftia sp. (strain HT23)	380			ammonia-lyase activity [GO:0016841]; pyridoxal phosphate binding [GO:0030170]	ammonia-lyase activity [GO:0016841]; pyridoxal phosphate binding [GO:0030170]	GO:0016841; GO:0030170
Q2VLG6	C163A_CANLF	reviewed	Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)]	CD163 M130	Canis lupus familiaris (Dog) (Canis familiaris)	1133	acute-phase response [GO:0006953]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; acute-phase response [GO:0006953]	scavenger receptor activity [GO:0005044]	GO:0005044; GO:0005576; GO:0006953; GO:0009897; GO:0016021
P28271	ACOC_MOUSE	reviewed	Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1)	Aco1 Ireb1 Irebp	Mus musculus (Mouse)	889	cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099]	Golgi apparatus [GO:0005794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099]	3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; RNA binding [GO:0003723]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; iron-sulfur cluster binding [GO:0051536]; mRNA 5'-UTR binding [GO:0048027]; metal ion binding [GO:0046872]	GO:0003723; GO:0003994; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006417; GO:0006879; GO:0009791; GO:0010040; GO:0010468; GO:0030350; GO:0043231; GO:0046872; GO:0048027; GO:0050892; GO:0051536; GO:0051538; GO:0051539
Q8BIW1	PRUN1_MOUSE	reviewed	Exopolyphosphatase PRUNE1 (EC 3.6.1.1) (PRUNEM1)	Prune1 Prune	Mus musculus (Mouse)	454	polyphosphate catabolic process [GO:0006798]; regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; exopolyphosphatase activity [GO:0004309]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; tubulin binding [GO:0015631]; polyphosphate catabolic process [GO:0006798]; regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767]	exopolyphosphatase activity [GO:0004309]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; tubulin binding [GO:0015631]	GO:0004309; GO:0004427; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006798; GO:0015631; GO:0016791; GO:0031113; GO:0046872; GO:0050767
Q0IHU9	PRUN2_XENTR	reviewed	Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1)	Prune2 Bmcc1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	316	apoptotic process [GO:0006915]; polyphosphate catabolic process [GO:0006798]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; exopolyphosphatase activity [GO:0004309]; apoptotic process [GO:0006915]; polyphosphate catabolic process [GO:0006798]	exopolyphosphatase activity [GO:0004309]	GO:0004309; GO:0005737; GO:0006798; GO:0006915
Q6UXD5	SE6L2_HUMAN	reviewed	Seizure 6-like protein 2	SEZ6L2 PSK UNQ1903/PRO4349	Homo sapiens (Human)	910		endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005789; GO:0005886; GO:0016021
P33316	DUT_HUMAN	reviewed	Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial (dUTPase) (EC 3.6.1.23) (dUTP pyrophosphatase)	DUT	Homo sapiens (Human)	252	DNA replication [GO:0006260]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; nucleobase-containing compound metabolic process [GO:0006139]; nucleobase-containing small molecule interconversion [GO:0015949]	extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; DNA replication [GO:0006260]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; nucleobase-containing compound metabolic process [GO:0006139]; nucleobase-containing small molecule interconversion [GO:0015949]	RNA binding [GO:0003723]; dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0003723; GO:0004170; GO:0005634; GO:0005654; GO:0005739; GO:0006139; GO:0006226; GO:0006260; GO:0015949; GO:0046081; GO:0070062
O75973	C1QRF_HUMAN	reviewed	C1q-related factor (C1q and tumor necrosis factor-related protein 14) (C1q/TNF-related protein 14) (Complement component 1 Q subcomponent-like 1)	C1QL1 C1QRF CRF CTRP14	Homo sapiens (Human)	258	locomotory behavior [GO:0007626]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; neuron remodeling [GO:0016322]	climbing fiber [GO:0044301]; collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; presynapse [GO:0098793]; synaptic cleft [GO:0043083]	climbing fiber [GO:0044301]; collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; presynapse [GO:0098793]; synaptic cleft [GO:0043083]; signaling receptor binding [GO:0005102]; locomotory behavior [GO:0007626]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; neuron remodeling [GO:0016322]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005581; GO:0005737; GO:0007626; GO:0016322; GO:0043083; GO:0044301; GO:0061743; GO:0098793; GO:0099558
O88281	MEGF6_RAT	reviewed	Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)	Megf6 Egfl3	Rattus norvegicus (Rat)	1574		extracellular region [GO:0005576]	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576
Q66T72	PSIP1_FELCA	reviewed	PC4 and SFRS1-interacting protein (LEDGF/p75) (Lens epithelium-derived growth factor) (Transcription coactivator p75)	PSIP1 LEDGF	Felis catus (Cat) (Felis silvestris catus)	530	mRNA 5'-splice site recognition [GO:0000395]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]	nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]	nuclear heterochromatin [GO:0005720]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; supercoiled DNA binding [GO:0097100]; transcription coactivator activity [GO:0003713]; mRNA 5'-splice site recognition [GO:0000395]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]	activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; supercoiled DNA binding [GO:0097100]; transcription coactivator activity [GO:0003713]	GO:0000395; GO:0003682; GO:0003713; GO:0005654; GO:0005720; GO:0006979; GO:0009408; GO:0033613; GO:0035327; GO:0045944; GO:0097100
Q26636	CATL_SARPE	reviewed	Cathepsin L (EC 3.4.22.15) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]		Sarcophaga peregrina (Flesh fly) (Boettcherisca peregrina)	339	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]	lysosome [GO:0005764]	lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]	cysteine-type peptidase activity [GO:0008234]	GO:0005764; GO:0007275; GO:0008234; GO:0030154
Q8TD23	ZN675_HUMAN	reviewed	Zinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein)	ZNF675 TIZ	Homo sapiens (Human)	568	I-kappaB kinase/NF-kappaB signaling [GO:0007249]; bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]	DNA binding [GO:0003677]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0000122; GO:0003677; GO:0005634; GO:0007249; GO:0008270; GO:0010804; GO:0019221; GO:0031625; GO:0032088; GO:0043508; GO:0045453; GO:0045671; GO:0046329; GO:0048471; GO:2000660; GO:2000678
Q9GKL8	CATL1_CHLAE	reviewed	Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) (Major excreted protein) (MEP) [Cleaved into: Cathepsin L1 heavy chain; Cathepsin L1 light chain]	CTSL CTSL1	Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)	333	viral entry into host cell [GO:0046718]	lysosome [GO:0005764]	lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; viral entry into host cell [GO:0046718]	cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0005764; GO:0046718
A0MSJ1	CRA1B_DANRE	reviewed	Collagen alpha-1(XXVII) chain B	col27a1b col27a1	Danio rerio (Zebrafish) (Brachydanio rerio)	1658	bone mineralization [GO:0030282]; extracellular matrix organization [GO:0030198]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501]	collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; bone mineralization [GO:0030282]; extracellular matrix organization [GO:0030198]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501]	extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]	GO:0001501; GO:0005201; GO:0005581; GO:0005615; GO:0030198; GO:0030282; GO:0031012; GO:0046872; GO:0048570
Q66PG1	LARG2_DANRE	reviewed	LARGE xylosyl- and glucuronyltransferase 2 (EC 2.4.-.-) (Glycosyltransferase-like 1B) [Includes: Xylosyltransferase LARGE2 (EC 2.4.2.-); Beta-1,3-glucuronyltransferase LARGE2 (EC 2.4.1.-)]	large2 gyltl1b si:ch211-206g24.1 si:ch211-282n12.1	Danio rerio (Zebrafish) (Brachydanio rerio)	750	protein O-linked mannosylation [GO:0035269]; protein glycosylation [GO:0006486]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; xylosyltransferase activity [GO:0042285]; protein glycosylation [GO:0006486]; protein O-linked mannosylation [GO:0035269]	glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; transferase activity, transferring glycosyl groups [GO:0016757]; xylosyltransferase activity [GO:0042285]	GO:0000139; GO:0005794; GO:0006486; GO:0015020; GO:0016021; GO:0016757; GO:0035269; GO:0042285; GO:0046872
P49013	FBP3_STRPU	reviewed	Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III)	EGF3	Strongylocentrotus purpuratus (Purple sea urchin)	570		extracellular space [GO:0005615]	extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]	biotin binding [GO:0009374]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005615; GO:0009374
E9Q5G3	KIF23_MOUSE	reviewed	Kinesin-like protein KIF23	Kif23	Mus musculus (Mouse)	953	actomyosin contractile ring assembly [GO:0000915]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]	Flemming body [GO:0090543]; centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; actomyosin contractile ring assembly [GO:0000915]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000281; GO:0000915; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0045171; GO:0051256; GO:0072383; GO:0072686; GO:0090543; GO:0097149
Q95116	TSP2_BOVIN	reviewed	Thrombospondin-2 (Corticotropin-induced secreted protein) (CISP)	THBS2 TSP-2 TSP2	Bos taurus (Bovine)	1170	cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]	collagen-containing extracellular matrix [GO:0062023]	collagen-containing extracellular matrix [GO:0062023]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]	GO:0005509; GO:0007155; GO:0008201; GO:0016525; GO:0062023
P34457	YMD3_CAEEL	reviewed	Putative uncharacterized transposon-derived protein F54H12.3	F54H12.3	Caenorhabditis elegans	286	DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074
Q9D0S9	HINT2_MOUSE	reviewed	Histidine triad nucleotide-binding protein 2, mitochondrial (HINT-2) (EC 3.-.-.-) (HINT-3)	Hint2	Mus musculus (Mouse)	163	apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694]	mitochondrion [GO:0005739]; nucleolus [GO:0005730]	mitochondrion [GO:0005739]; nucleolus [GO:0005730]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694]	hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005730; GO:0005739; GO:0006694; GO:0006915; GO:0016042; GO:0016787; GO:2000757
P97742	CPT1A_MOUSE	reviewed	Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A)	Cpt1a Cpt-1 Cpt1	Mus musculus (Mouse)	773	carnitine metabolic process [GO:0009437]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; glucose metabolic process [GO:0006006]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; protein homooligomerization [GO:0051260]; regulation of fatty acid oxidation [GO:0046320]; regulation of insulin secretion [GO:0050796]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; triglyceride metabolic process [GO:0006641]	integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]; carnitine metabolic process [GO:0009437]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; glucose metabolic process [GO:0006006]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; protein homooligomerization [GO:0051260]; regulation of fatty acid oxidation [GO:0046320]; regulation of insulin secretion [GO:0050796]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; triglyceride metabolic process [GO:0006641]	carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]	GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0005743; GO:0006006; GO:0006635; GO:0006641; GO:0009437; GO:0014070; GO:0016021; GO:0030855; GO:0031307; GO:0032000; GO:0042493; GO:0042755; GO:0042802; GO:0043231; GO:0046320; GO:0050796; GO:0051260; GO:0071398; GO:1990698
P09645	TBA8_CHICK	reviewed	Tubulin alpha-8 chain (Fragment)		Gallus gallus (Chicken)	324	microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017
Q32MH5	F214A_HUMAN	reviewed	Protein FAM214A	FAM214A KIAA1370	Homo sapiens (Human)	1076					
Q99081	HTF4_HUMAN	reviewed	Transcription factor 12 (TCF-12) (Class B basic helix-loop-helix protein 20) (bHLHb20) (DNA-binding protein HTF4) (E-box-binding protein) (Transcription factor HTF-4)	TCF12 BHLHB20 HEB HTF4	Homo sapiens (Human)	682	immune response [GO:0006955]; muscle organ development [GO:0007517]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of transcription by RNA polymerase II [GO:0006357]	RNA polymerase II transcription factor complex [GO:0090575]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; enhancer binding [GO:0035326]; HMG box domain binding [GO:0071837]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; immune response [GO:0006955]; muscle organ development [GO:0007517]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; HMG box domain binding [GO:0071837]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; bHLH transcription factor binding [GO:0043425]; cAMP response element binding [GO:0035497]; enhancer binding [GO:0035326]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0006955; GO:0007517; GO:0008134; GO:0016607; GO:0035326; GO:0035497; GO:0042803; GO:0043231; GO:0043425; GO:0045666; GO:0045944; GO:0046332; GO:0046982; GO:0070888; GO:0071837; GO:0090575; GO:1902036
Q6A098	SBP2L_MOUSE	reviewed	Selenocysteine insertion sequence-binding protein 2-like (SECIS-binding protein 2-like)	Secisbp2l Kiaa0256	Mus musculus (Mouse)	1086	selenocysteine incorporation [GO:0001514]	ribonucleoprotein complex [GO:1990904]	ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; selenocysteine incorporation [GO:0001514]	mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]	GO:0001514; GO:0003730; GO:0035368; GO:0043021; GO:1990904
P41809	HKR1_YEAST	reviewed	Signaling mucin HKR1 (Hansenula MRAKII killer toxin-resistant protein 1)	HKR1 YDR420W	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1802	(1->3)-beta-D-glucan biosynthetic process [GO:0006075]; cellular bud site selection [GO:0000282]; establishment of cell polarity [GO:0030010]; fungal-type cell wall organization [GO:0031505]; hyperosmotic response [GO:0006972]; osmosensory signaling pathway via Sho1 osmosensor [GO:0007232]; signal transduction involved in filamentous growth [GO:0001402]	cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; site of polarized growth [GO:0030427]	cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; site of polarized growth [GO:0030427]; osmosensor activity [GO:0005034]; (1->3)-beta-D-glucan biosynthetic process [GO:0006075]; cellular bud site selection [GO:0000282]; establishment of cell polarity [GO:0030010]; fungal-type cell wall organization [GO:0031505]; hyperosmotic response [GO:0006972]; osmosensory signaling pathway via Sho1 osmosensor [GO:0007232]; signal transduction involved in filamentous growth [GO:0001402]	osmosensor activity [GO:0005034]	GO:0000282; GO:0001402; GO:0005034; GO:0005576; GO:0005886; GO:0005887; GO:0006075; GO:0006972; GO:0007232; GO:0009986; GO:0030010; GO:0030427; GO:0031505
P10079	FBP1_STRPU	reviewed	Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)	EGF1	Strongylocentrotus purpuratus (Purple sea urchin)	1064		apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]	apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; biotin binding [GO:0009374]; calcium ion binding [GO:0005509]	biotin binding [GO:0009374]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579
Q641F3	COLA1_XENLA	reviewed	Collagen alpha-1(XXI) chain	col21a1	Xenopus laevis (African clawed frog)	957		collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]	collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]		GO:0005576; GO:0005581; GO:0005737
P16157	ANK1_HUMAN	reviewed	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	ANK1 ANK	Homo sapiens (Human)	1881	cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]	M band [GO:0031430]; Z disc [GO:0030018]; axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]	axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]	ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043194; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659
Q9Y2C9	TLR6_HUMAN	reviewed	Toll-like receptor 6 (CD antigen CD286)	TLR6	Homo sapiens (Human)	796	MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cell activation [GO:0001775]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; detection of diacyl bacterial lipopeptide [GO:0042496]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1 beta secretion [GO:0050702]; microglial cell activation [GO:0001774]; negative regulation of interleukin-8 secretion [GO:2000483]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; nitric oxide metabolic process [GO:0046209]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of macrophage activation [GO:0043032]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; signal transduction [GO:0007165]; toll-like receptor 6 signaling pathway [GO:0034150]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; toll-like receptor signaling pathway [GO:0002224]	Golgi apparatus [GO:0005794]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355]; cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cell [GO:0005623]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cell activation [GO:0001775]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; detection of diacyl bacterial lipopeptide [GO:0042496]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1 beta secretion [GO:0050702]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-8 secretion [GO:2000483]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; nitric oxide metabolic process [GO:0046209]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; signal transduction [GO:0007165]; toll-like receptor 6 signaling pathway [GO:0034150]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]	Toll-like receptor 2 binding [GO:0035663]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]	GO:0001540; GO:0001774; GO:0001775; GO:0002224; GO:0002755; GO:0004888; GO:0005102; GO:0005623; GO:0005794; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007165; GO:0007250; GO:0010628; GO:0030670; GO:0034136; GO:0034150; GO:0035355; GO:0035663; GO:0035666; GO:0038023; GO:0038124; GO:0042496; GO:0042742; GO:0042802; GO:0043032; GO:0043123; GO:0043235; GO:0043507; GO:0045087; GO:0045121; GO:0045410; GO:0045429; GO:0046209; GO:0046982; GO:0050702; GO:0051092; GO:0071723; GO:0071726; GO:0140052; GO:1900017; GO:1900227; GO:1903223; GO:1903428; GO:1904646; GO:2000483
Q9UPN9	TRI33_HUMAN	reviewed	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	TRIM33 KIAA1113 RFG7 TIF1G	Homo sapiens (Human)	1127	negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]	DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; co-SMAD binding [GO:0070410]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000122; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0008270; GO:0016567; GO:0017015; GO:0030514; GO:0045892; GO:0070410; GO:0070412
Q6ZSB9	ZBT49_HUMAN	reviewed	Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509)	ZBTB49 ZNF509	Homo sapiens (Human)	765	cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]	metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]	GO:0001223; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007050; GO:0008134; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872
P97798	NEO1_MOUSE	reviewed	Neogenin	Neo1 Ngn	Mus musculus (Mouse)	1493	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; iron ion homeostasis [GO:0055072]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron death [GO:1901215]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of axon regeneration [GO:0048679]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]	Golgi apparatus [GO:0005794]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]	cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; iron ion homeostasis [GO:0055072]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron death [GO:1901215]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of axon regeneration [GO:0048679]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]	BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023]	GO:0001764; GO:0005654; GO:0005794; GO:0005886; GO:0005887; GO:0006355; GO:0007155; GO:0007411; GO:0007520; GO:0009986; GO:0016020; GO:0030513; GO:0038023; GO:0039706; GO:0043025; GO:0045296; GO:0048679; GO:0048681; GO:0050709; GO:0055072; GO:0070700; GO:0097708; GO:0098797; GO:1901215; GO:2001222
P51122	AN32A_BOVIN	reviewed	Acidic leucine-rich nuclear phosphoprotein 32 family member A (Leucine-rich acidic nuclear protein) (LANP) (Potent heat-stable protein phosphatase 2A inhibitor I1PP2A)	ANP32A LANP PHAP1	Bos taurus (Bovine)	249	nucleocytoplasmic transport [GO:0006913]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; histone binding [GO:0042393]; nucleocytoplasmic transport [GO:0006913]	histone binding [GO:0042393]	GO:0005634; GO:0005737; GO:0005783; GO:0006913; GO:0016363; GO:0042393; GO:0048471
Q8BVG4	DPP9_MOUSE	reviewed	Dipeptidyl peptidase 9 (DP9) (EC 3.4.14.5) (Dipeptidyl peptidase IX) (DPP IX) (Dipeptidyl peptidase-like protein 9) (DPLP9)	Dpp9	Mus musculus (Mouse)	862		cytosol [GO:0005829]	cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; identical protein binding [GO:0042802]; serine-type peptidase activity [GO:0008236]	aminopeptidase activity [GO:0004177]; identical protein binding [GO:0042802]; serine-type peptidase activity [GO:0008236]	GO:0004177; GO:0005829; GO:0008236; GO:0042802
Q6AYG0	RRNAD_RAT	reviewed	Protein RRNAD1	Rrnad1	Rattus norvegicus (Rat)	475		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021
Q7TP47	HNRPQ_RAT	reviewed	Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Liver regeneration-related protein LRRG077) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein)	Syncrip Hnrpq Ab2-339	Rattus norvegicus (Rat)	533	CRD-mediated mRNA stabilization [GO:0070934]; RNA splicing [GO:0008380]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; negative regulation of mRNA modification [GO:0090367]; positive regulation of translation [GO:0045727]	CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; histone pre-mRNA 3'end processing complex [GO:0071204]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proximal dendrite [GO:1990635]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; histone pre-mRNA 3'end processing complex [GO:0071204]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proximal dendrite [GO:1990635]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; circadian rhythm [GO:0007623]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA processing [GO:0006397]; negative regulation of mRNA modification [GO:0090367]; positive regulation of translation [GO:0045727]; RNA splicing [GO:0008380]	RNA binding [GO:0003723]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]	GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005783; GO:0006397; GO:0007623; GO:0008380; GO:0016020; GO:0043025; GO:0045727; GO:0048027; GO:0070934; GO:0070937; GO:0071204; GO:0090367; GO:1990635; GO:1990904
Q6AX44	FBCDA_XENLA	reviewed	Fibrinogen C domain-containing protein 1-A	fibcd1-a	Xenopus laevis (African clawed frog)	457		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872]	chitin binding [GO:0008061]; metal ion binding [GO:0046872]	GO:0008061; GO:0016021; GO:0046872
P35285	RB22A_MOUSE	reviewed	Ras-related protein Rab-22A (Rab-22) (Rab-14)	Rab22a Rab22	Mus musculus (Mouse)	194	Rab protein signal transduction [GO:0032482]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; regulation of vesicle size [GO:0097494]	actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of vesicle size [GO:0097494]	GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0001726; GO:0003924; GO:0005525; GO:0005769; GO:0005770; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0010008; GO:0015629; GO:0019003; GO:0030670; GO:0032482; GO:0045335; GO:0097494
P15305	DYHC_ONCMY	reviewed	Dynein heavy chain (DYHC) (Fragment)		Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)	515		cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]	cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; motor activity [GO:0003774]	motor activity [GO:0003774]	GO:0003774; GO:0005737; GO:0005874; GO:0030286; GO:0031514
Q04592	PCSK5_MOUSE	reviewed	Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase 5) (PC5) (Proprotein convertase 6) (PC6) (Subtilisin-like proprotein convertase 6) (SPC6) (Subtilisin/kexin-like protease PC5)	Pcsk5	Mus musculus (Mouse)	1877	anterior/posterior pattern specification [GO:0009952]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; cytokine biosynthetic process [GO:0042089]; determination of left/right symmetry [GO:0007368]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of integrin activation [GO:0033625]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of smooth muscle cell-matrix adhesion [GO:1905609]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein processing [GO:0016485]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058]	Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; proximal dendrite [GO:1990635]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; proximal dendrite [GO:1990635]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; anterior/posterior pattern specification [GO:0009952]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; cytokine biosynthetic process [GO:0042089]; determination of left/right symmetry [GO:0007368]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of integrin activation [GO:0033625]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of smooth muscle cell-matrix adhesion [GO:1905609]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein processing [GO:0016485]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058]	endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]	GO:0001822; GO:0002001; GO:0003279; GO:0004175; GO:0004252; GO:0005615; GO:0005788; GO:0005794; GO:0005797; GO:0005802; GO:0005886; GO:0006465; GO:0007368; GO:0007507; GO:0007566; GO:0008233; GO:0009952; GO:0016020; GO:0016485; GO:0016486; GO:0019058; GO:0030141; GO:0030173; GO:0030323; GO:0033625; GO:0035108; GO:0042089; GO:0042277; GO:0043043; GO:0043204; GO:0048566; GO:0048706; GO:0060976; GO:1904754; GO:1905609; GO:1990635; GO:2001046
Q3T0B7	RS27L_BOVIN	reviewed	40S ribosomal protein S27-like	RPS27L	Bos taurus (Bovine)	84	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic G1 DNA damage checkpoint [GO:0031571]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation activator activity [GO:0008494]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic G1 DNA damage checkpoint [GO:0031571]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation activator activity [GO:0008494]	GO:0000028; GO:0003735; GO:0005634; GO:0006412; GO:0006978; GO:0008494; GO:0008656; GO:0022627; GO:0031571; GO:0042771; GO:0046872
P43006	EAA2_MOUSE	reviewed	Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2)	Slc1a2 Eaat2 Glt1	Mus musculus (Mouse)	572	D-aspartate import across plasma membrane [GO:0070779]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; adult behavior [GO:0030534]; anion transmembrane transport [GO:0098656]; cellular response to extracellular stimulus [GO:0031668]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neurotransmitter reuptake [GO:0098810]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; visual behavior [GO:0007632]	axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]	axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; anion transmembrane transporter activity [GO:0008509]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; adult behavior [GO:0030534]; anion transmembrane transport [GO:0098656]; cellular response to extracellular stimulus [GO:0031668]; D-aspartate import across plasma membrane [GO:0070779]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neurotransmitter reuptake [GO:0098810]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; visual behavior [GO:0007632]	L-glutamate transmembrane transporter activity [GO:0005313]; anion transmembrane transporter activity [GO:0008509]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; metal ion binding [GO:0046872]	GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0007399; GO:0007632; GO:0008509; GO:0009416; GO:0009611; GO:0009986; GO:0010259; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030424; GO:0030534; GO:0030673; GO:0031668; GO:0035264; GO:0042493; GO:0042734; GO:0043005; GO:0043197; GO:0043198; GO:0043200; GO:0045202; GO:0046326; GO:0046872; GO:0070207; GO:0070779; GO:0098656; GO:0098712; GO:0098810; GO:0098978; GO:0099056
Q8IV35	WDR49_HUMAN	reviewed	WD repeat-containing protein 49	WDR49	Homo sapiens (Human)	697					
Q49B93	SC5AC_MOUSE	reviewed	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)	Slc5a12 Smct2	Mus musculus (Mouse)	619	sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	lactate transmembrane transporter activity [GO:0015129]; symporter activity [GO:0015293]	GO:0006814; GO:0015129; GO:0015293; GO:0016021; GO:0016324
Q7LGC8	CHST3_HUMAN	reviewed	Carbohydrate sulfotransferase 3 (EC 2.8.2.17) (Chondroitin 6-O-sulfotransferase 1) (C6ST-1) (Chondroitin 6-sulfotransferase) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0) (GST-0)	CHST3	Homo sapiens (Human)	479	N-acetylglucosamine metabolic process [GO:0006044]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; sulfur compound metabolic process [GO:0006790]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]	N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; chondroitin 6-sulfotransferase activity [GO:0008459]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0008146; GO:0008459; GO:0016021; GO:0030206
G5EFJ9	UN103_CAEEL	reviewed	Potassium voltage-gated channel unc-103 (Ether-a-go-go-related gene potassium channel homolog) (ERG homolog) (Eag-related protein homolog) (Ether-a-go-go-related protein homolog) (Uncoordinated protein 103)	unc-103 C30D11.1	Caenorhabditis elegans	829	mating behavior [GO:0007617]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of oviposition [GO:0046662]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel activity [GO:0005249]; mating behavior [GO:0007617]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of oviposition [GO:0046662]	voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005887; GO:0006937; GO:0007617; GO:0034765; GO:0042391; GO:0046662; GO:0071805
Q589G5	PRTG_CHICK	reviewed	Protogenin	PRTG	Gallus gallus (Chicken)	1187	multicellular organism development [GO:0007275]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; multicellular organism development [GO:0007275]		GO:0007275; GO:0016021
P83111	LACTB_HUMAN	reviewed	Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)	LACTB MRPL56 UNQ843/PRO1781	Homo sapiens (Human)	547	lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]	identical protein binding [GO:0042802]; peptidase activity [GO:0008233]	GO:0005739; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0019216; GO:0042802
Q5F364	MRP1_CHICK	reviewed	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	ABCC1 MRP1 RCJMB04_32d20	Gallus gallus (Chicken)	1525	transmembrane transport [GO:0055085]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]	GO:0005524; GO:0005774; GO:0016020; GO:0016021; GO:0016323; GO:0016887; GO:0042626; GO:0055085
P16066	ANPRA_HUMAN	reviewed	Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)	NPR1 ANPRA	Homo sapiens (Human)	1061	body fluid secretion [GO:0007589]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; cell surface receptor signaling pathway [GO:0007166]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016021; GO:0016525; GO:0016941; GO:0017046; GO:0019901; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1903779
P16067	ANPRB_RAT	reviewed	Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B)	Npr2	Rattus norvegicus (Rat)	1047	bone development [GO:0060348]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]	GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0022414; GO:0042802; GO:0051447; GO:0060348; GO:0097011; GO:1900194
Q967R6	CPEB_APLCA	reviewed	Cytoplasmic polyadenylation element-binding protein (CPE-binding protein) (CPEB)		Aplysia californica (California sea hare)	687	positive regulation of translation [GO:0045727]; regulation of protein localization [GO:0032880]; regulation of synaptic plasticity [GO:0048167]; regulation of translation at synapse, modulating synaptic transmission [GO:0099547]	cell junction [GO:0030054]; neuron projection [GO:0043005]; neuronal ribonucleoprotein granule [GO:0071598]; serotonergic synapse [GO:0099154]	cell junction [GO:0030054]; neuron projection [GO:0043005]; neuronal ribonucleoprotein granule [GO:0071598]; serotonergic synapse [GO:0099154]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; translation activator activity [GO:0008494]; translation regulator activity [GO:0045182]; positive regulation of translation [GO:0045727]; regulation of protein localization [GO:0032880]; regulation of synaptic plasticity [GO:0048167]; regulation of translation at synapse, modulating synaptic transmission [GO:0099547]	identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; translation activator activity [GO:0008494]; translation regulator activity [GO:0045182]	GO:0003729; GO:0003730; GO:0008494; GO:0030054; GO:0032880; GO:0042802; GO:0043005; GO:0045182; GO:0045727; GO:0048167; GO:0071598; GO:0099154; GO:0099547
A0JNC0	TMOD1_BOVIN	reviewed	Tropomodulin-1 (Erythrocyte tropomodulin) (E-Tmod)	TMOD1	Bos taurus (Bovine)	359	adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]	COP9 signalosome [GO:0008180]; actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; membrane [GO:0016020]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]	actin filament [GO:0005884]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; membrane [GO:0016020]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]; adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]	GO:0003779; GO:0005523; GO:0005865; GO:0005884; GO:0006936; GO:0008180; GO:0008344; GO:0016020; GO:0030016; GO:0030017; GO:0030239; GO:0030863; GO:0051015; GO:0051694; GO:0070307
P17972	KCNAW_DROME	reviewed	Potassium voltage-gated channel protein Shaw (Shaw2)	Shaw SHAW2 CG2822	Drosophila melanogaster (Fruit fly)	498	potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]	delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0043025; GO:0051260; GO:0071805
Q8C5K5	CX038_MOUSE	reviewed	Uncharacterized protein CXorf38 homolog		Mus musculus (Mouse)	320					
P40818	UBP8_HUMAN	reviewed	Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)	USP8 KIAA0055 UBPY	Homo sapiens (Human)	1118	Ras protein signal transduction [GO:0007265]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein deubiquitination [GO:0016579]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]	SH3 domain binding [GO:0017124]; cadherin binding [GO:0045296]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000281; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0045296; GO:0070536; GO:0071108; GO:0071549; GO:0090263; GO:0098978; GO:0099576; GO:1990090
Q9ERE7	MESD_MOUSE	reviewed	LRP chaperone MESD (LDLR chaperone MESD) (Mesoderm development candidate 2) (Mesoderm development protein)	Mesd Mesdc2	Mus musculus (Mouse)	224	Wnt signaling pathway [GO:0016055]; mesoderm development [GO:0007498]; phagocytosis [GO:0006909]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; protein localization to cell surface [GO:0034394]	endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; mesoderm development [GO:0007498]; phagocytosis [GO:0006909]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; protein localization to cell surface [GO:0034394]; Wnt signaling pathway [GO:0016055]	identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]	GO:0005783; GO:0005886; GO:0006457; GO:0006909; GO:0007498; GO:0016055; GO:0034394; GO:0042802; GO:0050750; GO:1904395
P0C6Y7	PRDM9_RAT	reviewed	Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.43) (PR domain zinc finger protein 9) (PR domain-containing protein 9)	Prdm9	Rattus norvegicus (Rat)	796	meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]	chromosome [GO:0005694]; nucleus [GO:0005634]	chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; meiotic cell cycle [GO:0051321]; nucleosome positioning [GO:0016584]; positive regulation of reciprocal meiotic recombination [GO:0010845]	DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]	GO:0000977; GO:0003700; GO:0005634; GO:0005694; GO:0010844; GO:0010845; GO:0016584; GO:0018024; GO:0031490; GO:0042800; GO:0043565; GO:0044212; GO:0046872; GO:0051321
P23640	RB27A_RAT	reviewed	Ras-related protein Rab-27A (Rab-27) (GTP-binding protein Ram) (Ram p25)	Rab27a Rab27	Rattus norvegicus (Rat)	221	Rab protein signal transduction [GO:0032482]; antigen processing and presentation [GO:0019882]; blood coagulation [GO:0007596]; complement-dependent cytotoxicity [GO:0097278]; cytotoxic T cell degranulation [GO:0043316]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; intracellular protein transport [GO:0006886]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; multivesicular body organization [GO:0036257]; multivesicular body sorting pathway [GO:0071985]; natural killer cell degranulation [GO:0043320]; positive regulation of constitutive secretory pathway [GO:1903435]; positive regulation of exocytosis [GO:0045921]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulated secretory pathway [GO:1903307]; protein targeting [GO:0006605]	Golgi apparatus [GO:0005794]; Weibel-Palade body [GO:0033093]; apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; exocytic vesicle [GO:0070382]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; photoreceptor outer segment [GO:0001750]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]	apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; photoreceptor outer segment [GO:0001750]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; Weibel-Palade body [GO:0033093]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]; antigen processing and presentation [GO:0019882]; blood coagulation [GO:0007596]; complement-dependent cytotoxicity [GO:0097278]; cytotoxic T cell degranulation [GO:0043316]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; intracellular protein transport [GO:0006886]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; multivesicular body organization [GO:0036257]; multivesicular body sorting pathway [GO:0071985]; natural killer cell degranulation [GO:0043320]; positive regulation of constitutive secretory pathway [GO:1903435]; positive regulation of exocytosis [GO:0045921]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulated secretory pathway [GO:1903307]; protein targeting [GO:0006605]; Rab protein signal transduction [GO:0032482]	GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]	GO:0001750; GO:0003924; GO:0005525; GO:0005764; GO:0005794; GO:0006605; GO:0006886; GO:0006887; GO:0007596; GO:0010628; GO:0016324; GO:0019003; GO:0019882; GO:0019904; GO:0030141; GO:0030318; GO:0030425; GO:0030667; GO:0031489; GO:0032402; GO:0032482; GO:0032585; GO:0033093; GO:0036257; GO:0042470; GO:0043316; GO:0043320; GO:0045921; GO:0050766; GO:0070382; GO:0071985; GO:0097278; GO:1903307; GO:1903428; GO:1903435; GO:1990182
Q8T5G8	CHS_MELAT	reviewed	Chitin synthase (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase)		Meloidogyne artiellia (British root-knot nematode)	1851	embryo development ending in birth or egg hatching [GO:0009792]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; embryo development ending in birth or egg hatching [GO:0009792]	chitin synthase activity [GO:0004100]	GO:0004100; GO:0005886; GO:0009792; GO:0016021
Q8WXD9	CSKI1_HUMAN	reviewed	Caskin-1 (CASK-interacting protein 1)	CASKIN1 KIAA1306	Homo sapiens (Human)	1431	signal transduction [GO:0007165]	cytoplasm [GO:0005737]; membrane [GO:0016020]	cytoplasm [GO:0005737]; membrane [GO:0016020]; identical protein binding [GO:0042802]; signal transduction [GO:0007165]	identical protein binding [GO:0042802]	GO:0005737; GO:0007165; GO:0016020; GO:0042802
Q0V9L3	CELF4_XENTR	reviewed	CUGBP Elav-like family member 4 (CELF-4) (Bruno-like protein 4) (CUG-BP- and ETR-3-like factor 4) (RNA-binding protein BRUNOL-4)	celf4 brunol4	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	424	mRNA splice site selection [GO:0006376]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]	RNA binding [GO:0003723]; mRNA binding [GO:0003729]	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0048026; GO:1990904
Q9UF56	FXL17_HUMAN	reviewed	F-box/LRR-repeat protein 17 (F-box and leucine-rich repeat protein 17) (F-box only protein 13)	FBXL17 FBL17 FBX13 FBXO13	Homo sapiens (Human)	701	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of smoothened signaling pathway [GO:0008589]	SCF ubiquitin ligase complex [GO:0019005]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of smoothened signaling pathway [GO:0008589]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		GO:0000209; GO:0005634; GO:0005737; GO:0005829; GO:0006515; GO:0007399; GO:0008589; GO:0014033; GO:0016567; GO:0019005; GO:0031146; GO:0043161
Q5F4B8	S46A3_CHICK	reviewed	Solute carrier family 46 member 3	SLC46A3 RCJMB04_1c21	Gallus gallus (Chicken)	464	transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085]		GO:0016021; GO:0055085
Q9QZ85	IIGP1_MOUSE	reviewed	Interferon-inducible GTPase 1 (EC 3.6.5.-)	Iigp1 Irga6	Mus musculus (Mouse)	413	cellular response to interferon-beta [GO:0035458]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; regulation of autophagy [GO:0010506]; response to bacterium [GO:0009617]	Golgi cisterna membrane [GO:0032580]; endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965]; symbiont-containing vacuole membrane [GO:0020005]	endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; nuclear membrane [GO:0031965]; symbiont-containing vacuole membrane [GO:0020005]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; cellular response to interferon-beta [GO:0035458]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; regulation of autophagy [GO:0010506]; response to bacterium [GO:0009617]	GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]	GO:0003924; GO:0005525; GO:0005789; GO:0006952; GO:0009617; GO:0010506; GO:0019003; GO:0019221; GO:0020005; GO:0031965; GO:0032580; GO:0035458; GO:0042802; GO:0042832; GO:0045087; GO:0050829
B3EWZ5	MLRP1_ACRMI	reviewed	MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1) (Fragment)		Acropora millepora (Staghorn coral) (Heteropora millepora)	5145		extracellular region [GO:0005576]; membrane [GO:0016020]	extracellular region [GO:0005576]; membrane [GO:0016020]		GO:0005576; GO:0016020
Q9D845	TEX9_MOUSE	reviewed	Testis-expressed protein 9 (Testis-specifically expressed protein 1) (Tsec-1)	Tex9	Mus musculus (Mouse)	387					
Q2KHR2	RFX7_HUMAN	reviewed	DNA-binding protein RFX7 (Regulatory factor X 7) (Regulatory factor X domain-containing protein 2)	RFX7 RFXDC2	Homo sapiens (Human)	1363	regulation of transcription by RNA polymerase II [GO:0006357]	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]	GO:0000790; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357
P48664	EAA4_HUMAN	reviewed	Excitatory amino acid transporter 4 (Sodium-dependent glutamate/aspartate transporter) (Solute carrier family 1 member 6)	SLC1A6 EAAT4	Homo sapiens (Human)	564	L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; aspartate transmembrane transport [GO:0015810]; chemical synaptic transmission [GO:0007268]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; neurotransmitter uptake [GO:0001504]; regulation of membrane potential [GO:0042391]	Golgi apparatus [GO:0005794]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; plasma membrane [GO:0005886]	glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; plasma membrane [GO:0005886]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-aspartate transmembrane transporter activity [GO:0015183]; metal ion binding [GO:0046872]; aspartate transmembrane transport [GO:0015810]; chemical synaptic transmission [GO:0007268]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter uptake [GO:0001504]; regulation of membrane potential [GO:0042391]	L-aspartate transmembrane transporter activity [GO:0015183]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; metal ion binding [GO:0046872]	GO:0001504; GO:0005314; GO:0005794; GO:0005886; GO:0005887; GO:0006811; GO:0007268; GO:0014047; GO:0015183; GO:0015810; GO:0015813; GO:0016020; GO:0042391; GO:0045111; GO:0046872; GO:0098712; GO:0098978; GO:0099056
A0A0R4IBK5	R213A_DANRE	reviewed	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	rnf213a	Danio rerio (Zebrafish) (Brachydanio rerio)	5209	blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]	cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]	ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0002040; GO:0004842; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0046872
Q6ZMT9	DTHD1_HUMAN	reviewed	Death domain-containing protein 1	DTHD1	Homo sapiens (Human)	781	signal transduction [GO:0007165]		signal transduction [GO:0007165]		GO:0007165
Q9Y264	ANGP4_HUMAN	reviewed	Angiopoietin-4 (ANG-4) (Angiopoietin-3) (ANG-3)	ANGPT4 ANG3 ANG4	Homo sapiens (Human)	503	Notch signaling pathway [GO:0007219]; angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; leukocyte migration [GO:0050900]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; leukocyte migration [GO:0050900]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; Notch signaling pathway [GO:0007219]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]	receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	GO:0001525; GO:0005576; GO:0005615; GO:0007219; GO:0010595; GO:0016525; GO:0030297; GO:0030971; GO:0043066; GO:0043536; GO:0043537; GO:0045766; GO:0050731; GO:0050900; GO:0071456
Q9P212	PLCE1_HUMAN	reviewed	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (EC 3.1.4.11) (Pancreas-enriched phospholipase C) (Phosphoinositide phospholipase C-epsilon-1) (Phospholipase C-epsilon-1) (PLC-epsilon-1)	PLCE1 KIAA1516 PLCE PPLC	Homo sapiens (Human)	2302	Ras protein signal transduction [GO:0007265]; activation of MAPK activity [GO:0000187]; calcium-mediated signaling [GO:0019722]; cell population proliferation [GO:0008283]; cytoskeleton organization [GO:0007010]; diacylglycerol biosynthetic process [GO:0006651]; epidermal growth factor receptor signaling pathway [GO:0007173]; glomerulus development [GO:0032835]; heart development [GO:0007507]; inositol phosphate metabolic process [GO:0043647]; inositol phosphate-mediated signaling [GO:0048016]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of Ras protein signal transduction [GO:0046578]; regulation of cell growth [GO:0001558]; regulation of protein kinase activity [GO:0045859]; regulation of smooth muscle contraction [GO:0006940]; release of sequestered calcium ion into cytosol [GO:0051209]	Golgi membrane [GO:0000139]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; Ras GTPase binding [GO:0017016]; activation of MAPK activity [GO:0000187]; calcium-mediated signaling [GO:0019722]; cell population proliferation [GO:0008283]; cytoskeleton organization [GO:0007010]; diacylglycerol biosynthetic process [GO:0006651]; epidermal growth factor receptor signaling pathway [GO:0007173]; glomerulus development [GO:0032835]; heart development [GO:0007507]; inositol phosphate metabolic process [GO:0043647]; inositol phosphate-mediated signaling [GO:0048016]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; Ras protein signal transduction [GO:0007265]; regulation of cell growth [GO:0001558]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein kinase activity [GO:0045859]; regulation of Ras protein signal transduction [GO:0046578]; regulation of smooth muscle contraction [GO:0006940]; release of sequestered calcium ion into cytosol [GO:0051209]	Ras GTPase binding [GO:0017016]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]	GO:0000139; GO:0000187; GO:0001558; GO:0004435; GO:0004629; GO:0005085; GO:0005829; GO:0005886; GO:0006651; GO:0006940; GO:0007010; GO:0007173; GO:0007200; GO:0007204; GO:0007265; GO:0007507; GO:0008277; GO:0008283; GO:0016042; GO:0017016; GO:0019722; GO:0019899; GO:0032835; GO:0032959; GO:0043647; GO:0045859; GO:0046578; GO:0046872; GO:0048015; GO:0048016; GO:0051209
Q8BX70	VP13C_MOUSE	reviewed	Vacuolar protein sorting-associated protein 13C	Vps13c Kiaa3021	Mus musculus (Mouse)	3748	mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		GO:0005741; GO:0005829; GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:1905090
Q8R4E0	IRF2_SIGHI	reviewed	Interferon regulatory factor 2 (IRF-2)	IRF2	Sigmodon hispidus (Hispid cotton rat)	349	cell population proliferation [GO:0008283]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; cell population proliferation [GO:0008283]	DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]	GO:0003700; GO:0005634; GO:0008283; GO:0044212
O95996	APCL_HUMAN	reviewed	Adenomatous polyposis coli protein 2 (Adenomatous polyposis coli protein-like) (APC-like)	APC2 APCL	Homo sapiens (Human)	2303	Wnt signaling pathway [GO:0016055]; activation of GTPase activity [GO:0090630]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of microtubule depolymerization [GO:0007026]; pattern specification process [GO:0007389]; positive regulation of protein catabolic process [GO:0045732]; regulation of cell differentiation [GO:0045595]	Golgi apparatus [GO:0005794]; actin filament [GO:0005884]; beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; lamellipodium membrane [GO:0031258]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]	actin filament [GO:0005884]; beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; lamellipodium membrane [GO:0031258]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; activation of GTPase activity [GO:0090630]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of microtubule depolymerization [GO:0007026]; pattern specification process [GO:0007389]; positive regulation of protein catabolic process [GO:0045732]; regulation of cell differentiation [GO:0045595]; Wnt signaling pathway [GO:0016055]	beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]	GO:0000226; GO:0001708; GO:0005737; GO:0005794; GO:0005829; GO:0005874; GO:0005884; GO:0007026; GO:0007389; GO:0008013; GO:0008017; GO:0015630; GO:0016055; GO:0016342; GO:0016477; GO:0030496; GO:0030877; GO:0031258; GO:0045171; GO:0045295; GO:0045595; GO:0045732; GO:0048471; GO:0090090; GO:0090630; GO:0098794
P70550	RAB8B_RAT	reviewed	Ras-related protein Rab-8B	Rab8b	Rattus norvegicus (Rat)	207	Golgi vesicle fusion to target membrane [GO:0048210]; Rab protein signal transduction [GO:0032482]; adherens junction organization [GO:0034332]; antigen processing and presentation [GO:0019882]; cellular response to insulin stimulus [GO:0032869]; intracellular protein transport [GO:0006886]; positive regulation of cell projection organization [GO:0031346]; positive regulation of corticotropin secretion [GO:0051461]; protein import into peroxisome membrane [GO:0045046]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]	cell tip [GO:0051286]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]	cell tip [GO:0051286]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signaling receptor binding [GO:0005102]; TPR domain binding [GO:0030911]; adherens junction organization [GO:0034332]; antigen processing and presentation [GO:0019882]; cellular response to insulin stimulus [GO:0032869]; Golgi vesicle fusion to target membrane [GO:0048210]; intracellular protein transport [GO:0006886]; positive regulation of cell projection organization [GO:0031346]; positive regulation of corticotropin secretion [GO:0051461]; protein import into peroxisome membrane [GO:0045046]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]	GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; TPR domain binding [GO:0030911]; signaling receptor binding [GO:0005102]	GO:0003924; GO:0005102; GO:0005525; GO:0005768; GO:0005778; GO:0005886; GO:0006886; GO:0006904; GO:0008021; GO:0009306; GO:0016604; GO:0017157; GO:0019003; GO:0019882; GO:0030140; GO:0030670; GO:0030911; GO:0031346; GO:0031410; GO:0032482; GO:0032869; GO:0034332; GO:0045046; GO:0045335; GO:0048210; GO:0048471; GO:0051286; GO:0051461; GO:0072659; GO:0098793
P04813	CTR2_CANLF	reviewed	Chymotrypsinogen 2 (EC 3.4.21.1) [Cleaved into: Chymotrypsin 2 chain A; Chymotrypsin 2 chain B; Chymotrypsin 2 chain C]	CTRB1 CTRB	Canis lupus familiaris (Dog) (Canis familiaris)	263	digestion [GO:0007586]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0007586
P18899	DDR48_YEAST	reviewed	Stress protein DDR48 (DNA damage-responsive protein 48) (DDRP 48) (Flocculent-specific protein) (YP 75)	DDR48 FSP YMR173W YM8010.03	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	430	DNA repair [GO:0006281]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATPase activity [GO:0016887]; GTPase activity [GO:0003924]; DNA repair [GO:0006281]	ATPase activity [GO:0016887]; GTPase activity [GO:0003924]	GO:0003924; GO:0005737; GO:0005829; GO:0006281; GO:0016887
Q8C6K9	CO6A6_MOUSE	reviewed	Collagen alpha-6(VI) chain	Col6a6	Mus musculus (Mouse)	2265	cell adhesion [GO:0007155]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; cell adhesion [GO:0007155]		GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023
Q08BB5	CTL2A_DANRE	reviewed	CTD small phosphatase-like protein 2-A (CTDSP-like 2-A) (EC 3.1.3.-)	ctdspl2a zgc:154017	Danio rerio (Zebrafish) (Brachydanio rerio)	469			phosphoprotein phosphatase activity [GO:0004721]	phosphoprotein phosphatase activity [GO:0004721]	GO:0004721
O08688	CAN5_MOUSE	reviewed	Calpain-5 (EC 3.4.22.-) (New calpain 3) (nCL-3)	Capn5 Ncl3	Mus musculus (Mouse)	640	proteolysis [GO:0006508]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; synapse [GO:0045202]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; synapse [GO:0045202]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]	GO:0004198; GO:0005737; GO:0006508; GO:0009986; GO:0045202
P50336	PPOX_HUMAN	reviewed	Protoporphyrinogen oxidase (PPO) (EC 1.3.3.4)	PPOX	Homo sapiens (Human)	477	heme biosynthetic process [GO:0006783]; oxidation-reduction process [GO:0055114]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to drug [GO:0042493]	integral component of mitochondrial inner membrane [GO:0031305]; intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	integral component of mitochondrial inner membrane [GO:0031305]; intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729]; heme biosynthetic process [GO:0006783]; oxidation-reduction process [GO:0055114]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to drug [GO:0042493]	flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729]	GO:0004729; GO:0005739; GO:0005758; GO:0006779; GO:0006782; GO:0006783; GO:0016491; GO:0031304; GO:0031305; GO:0031966; GO:0042493; GO:0050660; GO:0055114
Q92887	MRP2_HUMAN	reviewed	Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Multidrug resistance-associated protein 2) (EC 7.6.2.2)	ABCC2 CMOAT CMOAT1 CMRP MRP2	Homo sapiens (Human)	1545	benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; mercury ion transport [GO:0015694]; prostaglandin transport [GO:0015732]; response to arsenic-containing substance [GO:0046685]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; bilirubin transmembrane transporter activity [GO:0015127]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]; benzylpenicillin metabolic process [GO:1901086]; bile acid and bile salt transport [GO:0015721]; canalicular bile acid transport [GO:0015722]; cellular chloride ion homeostasis [GO:0030644]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; drug transmembrane transport [GO:0006855]; female pregnancy [GO:0007565]; mercury ion transport [GO:0015694]; prostaglandin transport [GO:0015732]; response to arsenic-containing substance [GO:0046685]; response to estrogen [GO:0043627]; response to glucagon [GO:0033762]; response to heat [GO:0009408]; response to methotrexate [GO:0031427]; response to oxidative stress [GO:0006979]; thyroid hormone transport [GO:0070327]; transmembrane transport [GO:0055085]	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATPase-coupled xenobiotic transmembrane transporter activity [GO:0008559]; bilirubin transmembrane transporter activity [GO:0015127]; organic anion transmembrane transporter activity [GO:0008514]; protein domain specific binding [GO:0019904]	GO:0005524; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0007565; GO:0008514; GO:0008559; GO:0009408; GO:0009986; GO:0015127; GO:0015694; GO:0015721; GO:0015722; GO:0015732; GO:0016020; GO:0016324; GO:0016887; GO:0019904; GO:0030644; GO:0031427; GO:0031526; GO:0033762; GO:0042626; GO:0043627; GO:0046581; GO:0046685; GO:0055085; GO:0070327; GO:0071222; GO:0071347; GO:0071354; GO:0071356; GO:0071549; GO:1901086
P15145	AMPN_PIG	reviewed	Aminopeptidase N (AP-N) (pAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (gp130) (CD antigen CD13)	ANPEP	Sus scrofa (Pig)	963	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]	GO:0001525; GO:0001618; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0016021; GO:0030154; GO:0042277; GO:0043171; GO:0070006
Q28C98	MESH1_XENTR	reviewed	Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 (EC 3.1.7.2) (HD domain-containing protein 3) (Metazoan SpoT homolog 1) (MESH1) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase)	hddc3 Mesh1 TGas061b07.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	179	guanosine tetraphosphate catabolic process [GO:0015971]		guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]; guanosine tetraphosphate catabolic process [GO:0015971]	guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]	GO:0008893; GO:0015971; GO:0046872
O74423	ENT1_SCHPO	reviewed	Epsin-1	ent1 SPCC162.07	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	702	actin cortical patch assembly [GO:0000147]; actin filament organization [GO:0007015]; endocytosis [GO:0006897]	actin cortical patch [GO:0030479]; membrane [GO:0016020]	actin cortical patch [GO:0030479]; membrane [GO:0016020]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; ubiquitin binding [GO:0043130]; actin cortical patch assembly [GO:0000147]; actin filament organization [GO:0007015]; endocytosis [GO:0006897]	clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; ubiquitin binding [GO:0043130]	GO:0000147; GO:0005546; GO:0006897; GO:0007015; GO:0016020; GO:0030276; GO:0030479; GO:0043130
C9ZN16	FAZ1_TRYB9	reviewed	Flagellar attachment zone protein 1	TbgDal_IV3690	Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972)	1748		motile cilium [GO:0031514]	motile cilium [GO:0031514]		GO:0031514
Q99M80	PTPRT_MOUSE	reviewed	Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (RPTPmam4) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) (mRPTPrho)	Ptprt	Mus musculus (Mouse)	1454	cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	STAT family protein binding [GO:0097677]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007156; GO:0007169; GO:0008013; GO:0009986; GO:0016790; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0050807; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:0098978; GO:0099061; GO:1904893; GO:1990264
Q9NJ15	PCSK5_BRACL	reviewed	Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase PC6-like) (aPC6)	PC6	Branchiostoma californiense (California lancelet) (Amphioxus)	1696		extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0005886; GO:0016021
Q15262	PTPRK_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	PTPRK PTPK	Homo sapiens (Human)	1439	cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to UV [GO:0034644]; cellular response to reactive oxygen species [GO:0034614]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]	adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]	beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041
A2VDP6	NXPE3_BOVIN	reviewed	NXPE family member 3 (Protein FAM55C)	NXPE3 FAM55C	Bos taurus (Bovine)	559		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576
O34954	YODH_BACSU	reviewed	Uncharacterized methyltransferase YodH (EC 2.1.1.-)	yodH yolB BSU19600	Bacillus subtilis (strain 168)	233			methyltransferase activity [GO:0008168]	methyltransferase activity [GO:0008168]	GO:0008168
O14522	PTPRT_HUMAN	reviewed	Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho)	PTPRT KIAA0283	Homo sapiens (Human)	1441	cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	STAT family protein binding [GO:0097677]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0070097; GO:0071354; GO:0097677; GO:1904893; GO:1990264
P35822	PTPRK_MOUSE	reviewed	Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48)	Ptprk Ptpk	Mus musculus (Mouse)	1457	cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to UV [GO:0034644]; cellular response to reactive oxygen species [GO:0034614]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]	axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]	axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]	beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]	GO:0001750; GO:0004725; GO:0005886; GO:0005911; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041
O15230	LAMA5_HUMAN	reviewed	Laminin subunit alpha-5 (Laminin-10 subunit alpha) (Laminin-11 subunit alpha) (Laminin-15 subunit alpha)	LAMA5 KIAA0533 KIAA1907	Homo sapiens (Human)	3695	angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell recognition [GO:0008037]; cell-cell adhesion [GO:0098609]; cilium assembly [GO:0060271]; cytokine-mediated signaling pathway [GO:0019221]; cytoskeleton organization [GO:0007010]; endothelial cell differentiation [GO:0045446]; extracellular matrix organization [GO:0030198]; focal adhesion assembly [GO:0048041]; hair follicle development [GO:0001942]; integrin-mediated signaling pathway [GO:0007229]; lung development [GO:0030324]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; muscle organ development [GO:0007517]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; protein localization to plasma membrane [GO:0072659]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; laminin-5 complex [GO:0005610]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; synaptic cleft [GO:0043083]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; laminin-5 complex [GO:0005610]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; synaptic cleft [GO:0043083]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell recognition [GO:0008037]; cell-cell adhesion [GO:0098609]; cilium assembly [GO:0060271]; cytokine-mediated signaling pathway [GO:0019221]; cytoskeleton organization [GO:0007010]; endothelial cell differentiation [GO:0045446]; extracellular matrix organization [GO:0030198]; focal adhesion assembly [GO:0048041]; hair follicle development [GO:0001942]; integrin-mediated signaling pathway [GO:0007229]; lung development [GO:0030324]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; muscle organ development [GO:0007517]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; protein localization to plasma membrane [GO:0072659]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	integrin binding [GO:0005178]	GO:0001525; GO:0001658; GO:0001738; GO:0001755; GO:0001942; GO:0005178; GO:0005576; GO:0005604; GO:0005610; GO:0005615; GO:0005634; GO:0007010; GO:0007229; GO:0007517; GO:0008037; GO:0008283; GO:0009887; GO:0009888; GO:0016331; GO:0016477; GO:0019221; GO:0030154; GO:0030155; GO:0030198; GO:0030324; GO:0030334; GO:0031594; GO:0034446; GO:0042127; GO:0042475; GO:0043083; GO:0043259; GO:0043260; GO:0045446; GO:0045995; GO:0048041; GO:0060271; GO:0060445; GO:0062023; GO:0070062; GO:0072659; GO:0098609
P30432	FUR2_DROME	reviewed	Furin-like protease 2 (Furin-2) (EC 3.4.21.75)	Fur2 CG18734	Drosophila melanogaster (Fruit fly)	1679	R8 cell fate specification [GO:0045464]; negative regulation of secretion [GO:0051048]; protein processing [GO:0016485]	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; negative regulation of secretion [GO:0051048]; protein processing [GO:0016485]; R8 cell fate specification [GO:0045464]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005802; GO:0005886; GO:0016020; GO:0016485; GO:0030173; GO:0045464; GO:0051048
O75095	MEGF6_HUMAN	reviewed	Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)	MEGF6 EGFL3 KIAA0815	Homo sapiens (Human)	1541		extracellular region [GO:0005576]	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576
P28828	PTPRM_MOUSE	reviewed	Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48)	Ptprm Kiaa4044	Mus musculus (Mouse)	1452	homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]	cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]	cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005913; GO:0006470; GO:0007156; GO:0007165; GO:0010596; GO:0010842; GO:0016021; GO:0016525; GO:0030027; GO:0031175; GO:0031290; GO:0042493; GO:0042802; GO:0045296; GO:0048471; GO:0097755
Q61292	LAMB2_MOUSE	reviewed	Laminin subunit beta-2 (Laminin-11 subunit beta) (Laminin-14 subunit beta) (Laminin-15 subunit beta) (Laminin-3 subunit beta) (Laminin-4 subunit beta) (Laminin-7 subunit beta) (Laminin-9 subunit beta) (S-laminin subunit beta) (S-LAM beta)	Lamb2 Lams	Mus musculus (Mouse)	1799	Schwann cell development [GO:0014044]; animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; metanephric glomerular basement membrane development [GO:0072274]; metanephric glomerular visceral epithelial cell development [GO:0072249]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; retina development in camera-type eye [GO:0060041]; substrate adhesion-dependent cell spreading [GO:0034446]; synapse organization [GO:0050808]; tissue development [GO:0009888]; visual perception [GO:0007601]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-3 complex [GO:0005608]; neuromuscular junction [GO:0031594]; synapse [GO:0045202]; synaptic cleft [GO:0043083]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-3 complex [GO:0005608]; neuromuscular junction [GO:0031594]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; metanephric glomerular basement membrane development [GO:0072274]; metanephric glomerular visceral epithelial cell development [GO:0072249]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; retina development in camera-type eye [GO:0060041]; Schwann cell development [GO:0014044]; substrate adhesion-dependent cell spreading [GO:0034446]; synapse organization [GO:0050808]; tissue development [GO:0009888]; visual perception [GO:0007601]	extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]	GO:0000904; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005608; GO:0005615; GO:0007411; GO:0007528; GO:0007601; GO:0009887; GO:0009888; GO:0014002; GO:0014044; GO:0016477; GO:0031175; GO:0031594; GO:0034446; GO:0043083; GO:0043256; GO:0045202; GO:0048677; GO:0050808; GO:0060041; GO:0062023; GO:0070831; GO:0072249; GO:0072274
P62870	ELOB_RAT	reviewed	Elongin-B (EloB) (Elongin 18 kDa subunit) (RNA polymerase II transcription factor SIII subunit B) (SIII p18) (Transcription elongation factor B polypeptide 2)	Elob Tceb2	Rattus norvegicus (Rat)	118	positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368]	VCB complex [GO:0030891]; elongin complex [GO:0070449]; transcription factor complex [GO:0005667]	elongin complex [GO:0070449]; transcription factor complex [GO:0005667]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368]	protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005667; GO:0006368; GO:0016567; GO:0030891; GO:0044877; GO:0045944; GO:0070449
Q8UVC3	INVS_CHICK	reviewed	Inversin	INVS	Gallus gallus (Chicken)	1106	Wnt signaling pathway [GO:0016055]; multicellular organism development [GO:0007275]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; calmodulin binding [GO:0005516]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005737; GO:0005856; GO:0007275; GO:0016055
Q03412	UNC7_CAEEL	reviewed	Innexin unc-7 (Uncoordinated protein 7)	unc-7 unc-12 unc-124 R07D5.1	Caenorhabditis elegans	522	gap junction assembly [GO:0016264]; ion transmembrane transport [GO:0034220]; locomotion [GO:0040011]; oviposition [GO:0018991]; regulation of pharyngeal pumping [GO:0043051]; response to anesthetic [GO:0072347]	cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]	cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; gap junction assembly [GO:0016264]; ion transmembrane transport [GO:0034220]; locomotion [GO:0040011]; oviposition [GO:0018991]; regulation of pharyngeal pumping [GO:0043051]; response to anesthetic [GO:0072347]	gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]	GO:0005243; GO:0005886; GO:0005911; GO:0005921; GO:0016021; GO:0016264; GO:0018991; GO:0032589; GO:0034220; GO:0040011; GO:0043051; GO:0055077; GO:0072347
E9Q5F9	SETD2_MOUSE	reviewed	Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.43) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2)	Setd2 Kiaa1732 Kmt3a	Mus musculus (Mouse)	2537	angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 methylation [GO:0010452]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]; vasculogenesis [GO:0001570]	chromosome [GO:0005694]; nucleus [GO:0005634]	chromosome [GO:0005694]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 methylation [GO:0010452]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]; vasculogenesis [GO:0001570]	alpha-tubulin binding [GO:0043014]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]	GO:0001525; GO:0001570; GO:0001763; GO:0001843; GO:0005634; GO:0005694; GO:0006298; GO:0006355; GO:0006368; GO:0010452; GO:0010468; GO:0010569; GO:0010793; GO:0016279; GO:0018023; GO:0018024; GO:0018026; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0046872; GO:0046975; GO:0048332; GO:0048568; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0097198; GO:0097676; GO:1902850; GO:1905634
P52900	ODPA_SMIMA	reviewed	Pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHE1-A) (EC 1.2.4.1) (Fragment)	PDHA	Sminthopsis macroura (Stripe-faced dunnart)	363	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; pyruvate dehydrogenase complex [GO:0045254]	mitochondrial matrix [GO:0005759]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase activity [GO:0004738]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099]	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase activity [GO:0004738]	GO:0004738; GO:0004739; GO:0005759; GO:0006006; GO:0006086; GO:0006099; GO:0045254
Q96L42	KCNH8_HUMAN	reviewed	Potassium voltage-gated channel subfamily H member 8 (ELK1) (hElk1) (Ether-a-go-go-like potassium channel 3) (ELK channel 3) (ELK3) (Voltage-gated potassium channel subunit Kv12.1)	KCNH8	Homo sapiens (Human)	1107	potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]	voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005886; GO:0005887; GO:0034765; GO:0042391; GO:0071805
Q868T3	CCAPR_DROME	reviewed	Cardioacceleratory peptide receptor (Crustacean cardioactive peptide receptor)	CCAP-R CcapR CG33344	Drosophila melanogaster (Fruit fly)	495	G protein-coupled receptor signaling pathway [GO:0007186]; ecdysis, chitin-based cuticle [GO:0018990]; neuropeptide signaling pathway [GO:0007218]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]; ecdysis, chitin-based cuticle [GO:0018990]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]	neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]	GO:0005000; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0016021; GO:0018990
P30622	CLIP1_HUMAN	reviewed	CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin)	CLIP1 CYLN1 RSN	Homo sapiens (Human)	1438	microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116]; protein transport into plasma membrane raft [GO:0044861]	centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; ruffle [GO:0001726]	centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; ruffle [GO:0001726]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116]; protein transport into plasma membrane raft [GO:0044861]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]	GO:0000278; GO:0000776; GO:0001578; GO:0001726; GO:0005635; GO:0005768; GO:0005813; GO:0005829; GO:0005874; GO:0005881; GO:0005882; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0035371; GO:0042802; GO:0042803; GO:0044861; GO:0046872; GO:0051010
Q7YW31	CTR1_OCTVU	reviewed	Cephalotocin receptor 1 (OC/CE-R 1) (OT/VP superfamily peptide receptor 1)	CTR1	Octopus vulgaris (Common octopus)	397	G protein-coupled receptor signaling pathway [GO:0007186]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-hormone receptor activity [GO:0016500]; vasopressin receptor activity [GO:0005000]; G protein-coupled receptor signaling pathway [GO:0007186]	protein-hormone receptor activity [GO:0016500]; vasopressin receptor activity [GO:0005000]	GO:0005000; GO:0005886; GO:0007186; GO:0016021; GO:0016500
Q92851	CASPA_HUMAN	reviewed	Caspase-10 (CASP-10) (EC 3.4.22.63) (Apoptotic protease Mch-4) (FAS-associated death domain protein interleukin-1B-converting enzyme 2) (FLICE2) (ICE-like apoptotic protease 4) [Cleaved into: Caspase-10 subunit p23/17; Caspase-10 subunit p12]	CASP10 MCH4	Homo sapiens (Human)	521	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981]	CD95 death-inducing signaling complex [GO:0031265]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ripoptosome [GO:0097342]	CD95 death-inducing signaling complex [GO:0031265]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; death effector domain binding [GO:0035877]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; death effector domain binding [GO:0035877]; ubiquitin protein ligase binding [GO:0031625]	GO:0004197; GO:0005737; GO:0005829; GO:0006915; GO:0006919; GO:0007166; GO:0031265; GO:0031625; GO:0035877; GO:0042981; GO:0043123; GO:0097153; GO:0097190; GO:0097194; GO:0097199; GO:0097342
Q8R066	C1QT4_MOUSE	reviewed	Complement C1q tumor necrosis factor-related protein 4 (C1q/TNF-related protein 4)	C1qtnf4 Ctrp4	Mus musculus (Mouse)	326	positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of tumor necrosis factor secretion [GO:1904469]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; cytokine activity [GO:0005125]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of tumor necrosis factor secretion [GO:1904469]	cytokine activity [GO:0005125]	GO:0005125; GO:0005615; GO:0032755; GO:0070105; GO:1901224; GO:1904469; GO:2000778
O35495	CDK14_MOUSE	reviewed	Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14) (Serine/threonine-protein kinase PFTAIRE-1)	Cdk14 Kiaa0834 Pftk1	Mus musculus (Mouse)	469	G2/M transition of mitotic cell cycle [GO:0000086]; Wnt signaling pathway [GO:0016055]; cell division [GO:0051301]; protein phosphorylation [GO:0006468]; regulation of canonical Wnt signaling pathway [GO:0060828]	cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; protein phosphorylation [GO:0006468]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000086; GO:0000308; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0016055; GO:0030332; GO:0051301; GO:0060828
P53355	DAPK1_HUMAN	reviewed	Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1)	DAPK1 DAPK	Homo sapiens (Human)	1430	apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of NMDA receptor activity [GO:2000310]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]	GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010506; GO:0010508; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0042981; GO:0043066; GO:0043280; GO:0046777; GO:0071346; GO:0071447; GO:0097190; GO:2000310
F1SRY5	UBP37_PIG	reviewed	Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37)	USP37	Sus scrofa (Pig)	982	G1/S transition of mitotic cell cycle [GO:0000082]; cell division [GO:0051301]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein deubiquitination [GO:0016579]; regulation of DNA replication [GO:0006275]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]	nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; regulation of DNA replication [GO:0006275]; ubiquitin-dependent protein catabolic process [GO:0006511]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0006275; GO:0006511; GO:0016579; GO:0035871; GO:0051301; GO:0071108
P08799	MYS2_DICDI	reviewed	Myosin-2 heavy chain (Myosin II heavy chain)	mhcA DDB_G0286355	Dictyostelium discoideum (Slime mold)	2116	actin-myosin filament sliding [GO:0033275]; aggregation involved in sorocarp development [GO:0031152]; bleb assembly [GO:0032060]; cell motility [GO:0048870]; chemotaxis [GO:0006935]; contractile actin filament bundle assembly [GO:0030038]; contractile vacuole organization [GO:0033298]; cortical actin cytoskeleton organization [GO:0030866]; culmination involved in sorocarp development [GO:0031154]; cytoplasmic actin-based contraction involved in forward cell motility [GO:0060328]; detection of mechanical stimulus [GO:0050982]; filopodium assembly [GO:0046847]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin filament assembly [GO:0031034]; negative regulation of actin filament polymerization [GO:0030837]; protein localization [GO:0008104]; pseudopodium retraction [GO:0031270]; regulation of cell shape [GO:0008360]; response to cAMP [GO:0051591]; response to differentiation-inducing factor 1 [GO:1903013]; response to hydrogen peroxide [GO:0042542]; response to mechanical stimulus [GO:0009612]; uropod retraction [GO:0034461]	actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell trailing edge [GO:0031254]; cortical actin cytoskeleton [GO:0030864]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early phagosome [GO:0032009]; equatorial cell cortex [GO:1990753]; extracellular matrix [GO:0031012]; myosin II complex [GO:0016460]; myosin filament [GO:0032982]; phagocytic cup base [GO:0097204]; uropod [GO:0001931]	actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell trailing edge [GO:0031254]; cortical actin cytoskeleton [GO:0030864]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early phagosome [GO:0032009]; equatorial cell cortex [GO:1990753]; extracellular matrix [GO:0031012]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; phagocytic cup base [GO:0097204]; uropod [GO:0001931]; 14-3-3 protein binding [GO:0071889]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; adenyl nucleotide binding [GO:0030554]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]; actin-myosin filament sliding [GO:0033275]; aggregation involved in sorocarp development [GO:0031152]; bleb assembly [GO:0032060]; cell motility [GO:0048870]; chemotaxis [GO:0006935]; contractile actin filament bundle assembly [GO:0030038]; contractile vacuole organization [GO:0033298]; cortical actin cytoskeleton organization [GO:0030866]; culmination involved in sorocarp development [GO:0031154]; cytoplasmic actin-based contraction involved in forward cell motility [GO:0060328]; detection of mechanical stimulus [GO:0050982]; filopodium assembly [GO:0046847]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin filament assembly [GO:0031034]; negative regulation of actin filament polymerization [GO:0030837]; protein localization [GO:0008104]; pseudopodium retraction [GO:0031270]; regulation of cell shape [GO:0008360]; response to cAMP [GO:0051591]; response to differentiation-inducing factor 1 [GO:1903013]; response to hydrogen peroxide [GO:0042542]; response to mechanical stimulus [GO:0009612]; uropod retraction [GO:0034461]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; adenyl nucleotide binding [GO:0030554]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; protein homodimerization activity [GO:0042803]	GO:0000146; GO:0000281; GO:0001931; GO:0003774; GO:0005516; GO:0005524; GO:0005826; GO:0005829; GO:0005856; GO:0005938; GO:0006935; GO:0006971; GO:0008104; GO:0008360; GO:0009612; GO:0016460; GO:0030038; GO:0030554; GO:0030837; GO:0030864; GO:0030866; GO:0030898; GO:0031012; GO:0031034; GO:0031152; GO:0031154; GO:0031254; GO:0031270; GO:0031410; GO:0032009; GO:0032060; GO:0032982; GO:0033275; GO:0033298; GO:0034461; GO:0042542; GO:0042641; GO:0042802; GO:0042803; GO:0045179; GO:0046847; GO:0048870; GO:0050982; GO:0051015; GO:0051591; GO:0060328; GO:0071889; GO:0097204; GO:1903013; GO:1990753
Q8IX30	SCUB3_HUMAN	reviewed	Signal peptide, CUB and EGF-like domain-containing protein 3	SCUBE3 CEGF3	Homo sapiens (Human)	993	extracellular matrix disassembly [GO:0022617]; positive regulation of smoothened signaling pathway [GO:0045880]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]	cell surface [GO:0009986]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; extracellular matrix disassembly [GO:0022617]; positive regulation of smoothened signaling pathway [GO:0045880]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005615; GO:0005886; GO:0009986; GO:0022617; GO:0045880; GO:0051260; GO:0051291
Q9BXJ4	C1QT3_HUMAN	reviewed	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	C1QTNF3 CTRP3 UNQ753/PRO1484	Homo sapiens (Human)	246	cellular triglyceride homeostasis [GO:0035356]; fat cell differentiation [GO:0045444]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; protein trimerization [GO:0070206]	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; cellular triglyceride homeostasis [GO:0035356]; fat cell differentiation [GO:0045444]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; protein trimerization [GO:0070206]		GO:0005581; GO:0005623; GO:0010629; GO:0016020; GO:0035356; GO:0045444; GO:0045721; GO:0050715; GO:0050728; GO:0070062; GO:0070165; GO:0070206; GO:0071638; GO:1900165; GO:1901223
Q9ES30	C1QT3_MOUSE	reviewed	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	C1qtnf3 Cors26 Ctrp3	Mus musculus (Mouse)	246	cellular triglyceride homeostasis [GO:0035356]; glucose homeostasis [GO:0042593]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of protein kinase B signaling [GO:0051897]; protein complex oligomerization [GO:0051259]; protein trimerization [GO:0070206]	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cell [GO:0005623]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; cellular triglyceride homeostasis [GO:0035356]; glucose homeostasis [GO:0042593]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein kinase B signaling [GO:0051897]; protein complex oligomerization [GO:0051259]; protein trimerization [GO:0070206]	identical protein binding [GO:0042802]	GO:0005576; GO:0005581; GO:0005615; GO:0005623; GO:0010629; GO:0035356; GO:0042593; GO:0042802; GO:0045721; GO:0050715; GO:0050728; GO:0051259; GO:0051897; GO:0070165; GO:0070206; GO:0070374; GO:0071638; GO:1900165; GO:1901223
P84173	PHB_CHICK	reviewed	Prohibitin	PHB	Gallus gallus (Chicken)	272	DNA biosynthetic process [GO:0071897]; cellular response to interleukin-6 [GO:0071354]; histone deacetylation [GO:0016575]; mitochondrion organization [GO:0007005]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription by competitive promoter binding [GO:0010944]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of cell death [GO:0010942]; positive regulation of complement activation [GO:0045917]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; protein stabilization [GO:0050821]	cell surface [GO:0009986]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cell surface [GO:0009986]; early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; complement component C3a binding [GO:0001850]; complement component C3b binding [GO:0001851]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; proteinase activated receptor binding [GO:0031871]; transcription regulatory region DNA binding [GO:0044212]; cellular response to interleukin-6 [GO:0071354]; DNA biosynthetic process [GO:0071897]; histone deacetylation [GO:0016575]; mitochondrion organization [GO:0007005]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell death [GO:0010942]; positive regulation of complement activation [GO:0045917]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; protein stabilization [GO:0050821]	DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; complement component C3a binding [GO:0001850]; complement component C3b binding [GO:0001851]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; proteinase activated receptor binding [GO:0031871]; transcription regulatory region DNA binding [GO:0044212]	GO:0000122; GO:0000981; GO:0001850; GO:0001851; GO:0005634; GO:0005654; GO:0005743; GO:0005769; GO:0005887; GO:0007005; GO:0008022; GO:0008285; GO:0009986; GO:0010942; GO:0010944; GO:0016575; GO:0030308; GO:0031871; GO:0042177; GO:0042826; GO:0044212; GO:0045745; GO:0045893; GO:0045917; GO:0050821; GO:0050847; GO:0060766; GO:0070373; GO:0070374; GO:0071354; GO:0071897; GO:2000323
Q96RW7	HMCN1_HUMAN	reviewed	Hemicentin-1 (Fibulin-6) (FIBL-6)	HMCN1 FIBL6	Homo sapiens (Human)	5635	cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]	basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]	calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]	GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062
P35448	TSP1_XENLA	reviewed	Thrombospondin-1 (Glycoprotein G)	thbs1 tsp1	Xenopus laevis (African clawed frog)	1173	cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to unfolded protein [GO:0006986]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to unfolded protein [GO:0006986]	calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]	GO:0005509; GO:0005615; GO:0005783; GO:0006954; GO:0006986; GO:0007155; GO:0008201; GO:0009986; GO:0016525; GO:0016529; GO:0031012; GO:0050840
Q6NVP8	FUT8_XENTR	reviewed	Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)	fut8	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	578	GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; protein glycosylation in Golgi [GO:0033578]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	SH3 domain binding [GO:0017124]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]	GO:0006487; GO:0008424; GO:0016021; GO:0017124; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0046368; GO:0046921
Q8IW40	CC103_HUMAN	reviewed	Coiled-coil domain-containing protein 103	CCDC103	Homo sapiens (Human)	242	axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158]	axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]	axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; protein homodimerization activity [GO:0042803]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158]	protein homodimerization activity [GO:0042803]	GO:0001947; GO:0003341; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007368; GO:0031514; GO:0036157; GO:0036158; GO:0036159; GO:0042803; GO:0060287; GO:0070286; GO:0071907
F1P4W9	CFA65_CHICK	reviewed	Cilia- and flagella-associated protein 65 (Coiled-coil domain-containing protein 108)	CFAP65 CCDC108	Gallus gallus (Chicken)	1775		integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021; GO:0031514
P18712	ZG16_XENLA	reviewed	Gastrula zinc finger protein XlCGF16.1 (Fragment)		Xenopus laevis (African clawed frog)	112		nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872
P49340	WNT1_BOMMO	reviewed	Protein Wnt-1	WNT-1	Bombyx mori (Silk moth)	392	Wnt signaling pathway [GO:0016055]; multicellular organism development [GO:0007275]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576; GO:0007275; GO:0016055
P22727	WNT6_MOUSE	reviewed	Protein Wnt-6	Wnt6 Wnt-6	Mus musculus (Mouse)	364	Wnt signaling pathway [GO:0016055]; animal organ morphogenesis [GO:0009887]; axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule development [GO:0072080]; nephron tubule formation [GO:0072079]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription, DNA-templated [GO:0045893]; signal transduction [GO:0007165]	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; frizzled binding [GO:0005109]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule development [GO:0072080]; nephron tubule formation [GO:0072079]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription, DNA-templated [GO:0045893]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	frizzled binding [GO:0005109]; signaling receptor binding [GO:0005102]	GO:0001658; GO:0005102; GO:0005109; GO:0005615; GO:0005788; GO:0007165; GO:0007267; GO:0009798; GO:0009887; GO:0009986; GO:0010628; GO:0016055; GO:0030182; GO:0031012; GO:0042475; GO:0045165; GO:0045893; GO:0060684; GO:0070172; GO:0072079; GO:0072080
P10108	WNT1_XENLA	reviewed	Protein Wnt-1 (XWnt-1) (XInt-1)	wnt1 int1	Xenopus laevis (African clawed frog)	371	Wnt signaling pathway [GO:0016055]; forebrain anterior/posterior pattern specification [GO:0021797]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell fate specification [GO:0014036]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; forebrain anterior/posterior pattern specification [GO:0021797]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell fate specification [GO:0014036]; Wnt signaling pathway [GO:0016055]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576; GO:0014036; GO:0016055; GO:0021797; GO:0045892
P48067	SC6A9_HUMAN	reviewed	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9)	SLC6A9	Homo sapiens (Human)	706	glycine secretion, neurotransmission [GO:0061537]; neurotransmitter uptake [GO:0001504]; regulation of synaptic transmission, glycinergic [GO:0060092]	hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; glycine secretion, neurotransmission [GO:0061537]; neurotransmitter uptake [GO:0001504]; regulation of synaptic transmission, glycinergic [GO:0060092]	glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]	GO:0001504; GO:0005886; GO:0005887; GO:0014069; GO:0015187; GO:0015375; GO:0016020; GO:0030285; GO:0060092; GO:0061537; GO:0098686; GO:0098688; GO:0099055; GO:0099056
P21369	PNCA_ECOLI	reviewed	Nicotinamidase (EC 3.5.1.19) (Nicotinamide deamidase) (NAMase) (Pyrazinamidase) (PZAase) (EC 3.5.1.-)	pncA nam ydjB b1768 JW1757	Escherichia coli (strain K12)	213	pyridine nucleotide salvage [GO:0019365]		metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; pyridine nucleotide salvage [GO:0019365]	metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]	GO:0008936; GO:0019365; GO:0046872
Q5BKR2	SL9B2_MOUSE	reviewed	Sodium/hydrogen exchanger 9B2 (NHA-oc) (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Soditlum/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2)	Slc9b2 Nha2 Nhedc2	Mus musculus (Mouse)	547	clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]	basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]	basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]	identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]	GO:0005743; GO:0005886; GO:0006814; GO:0010008; GO:0010348; GO:0015385; GO:0016021; GO:0016323; GO:0030054; GO:0030317; GO:0030672; GO:0031966; GO:0042802; GO:0061178; GO:0072583; GO:0097228; GO:0097708; GO:2001206
P07909	ROA1_DROME	reviewed	Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (PEN repeat clone P9) (hnRNP core protein A1-A)	Hrb98DE Pen9 CG9983	Drosophila melanogaster (Fruit fly)	365	compound eye morphogenesis [GO:0001745]; female germ-line stem cell population maintenance [GO:0036099]; negative regulation of RNA splicing [GO:0033119]; oogenesis [GO:0048477]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]	nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; ribonucleoprotein complex [GO:1990904]	nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; female germ-line stem cell population maintenance [GO:0036099]; negative regulation of RNA splicing [GO:0033119]; oogenesis [GO:0048477]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]	RNA binding [GO:0003723]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; sequence-specific DNA binding [GO:0043565]	GO:0000381; GO:0001745; GO:0003723; GO:0003729; GO:0005634; GO:0005703; GO:0033119; GO:0036099; GO:0043565; GO:0045727; GO:0048027; GO:0048477; GO:1990904
A0A1F4	EYS_DROME	reviewed	Protein eyes shut (Protein spacemaker)	eys spam CG33955	Drosophila melanogaster (Fruit fly)	2176	cell morphogenesis [GO:0000902]; rhabdomere development [GO:0042052]; temperature compensation of the circadian clock [GO:0010378]	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; non-motile cilium [GO:0097730]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; cell morphogenesis [GO:0000902]; rhabdomere development [GO:0042052]; temperature compensation of the circadian clock [GO:0010378]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0000902; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0009986; GO:0010378; GO:0016021; GO:0031012; GO:0042052; GO:0097730
Q08174	PCDH1_HUMAN	reviewed	Protocadherin-1 (Cadherin-like protein 1) (Protocadherin-42) (PC42)	PCDH1	Homo sapiens (Human)	1060	cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]	cell junction [GO:0030054]; cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cell junction [GO:0030054]; cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005634; GO:0005730; GO:0005886; GO:0005887; GO:0005911; GO:0007155; GO:0007156; GO:0007267; GO:0007399; GO:0030054; GO:0043231
P35324	SPRR1_RABIT	reviewed	Cornifin alpha (Small proline-rich protein I) (SPR-I)		Oryctolagus cuniculus (Rabbit)	126	keratinization [GO:0031424]; peptide cross-linking [GO:0018149]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; keratinization [GO:0031424]; peptide cross-linking [GO:0018149]		GO:0005737; GO:0018149; GO:0031424
Q8R2Y9	SOSB1_MOUSE	reviewed	SOSS complex subunit B1 (Nucleic acid-binding protein 2) (Oligonucleotide/oligosaccharide-binding fold-containing protein 2B) (Sensor of single-strand DNA complex subunit B1) (Sensor of ssDNA subunit B1) (SOSS-B1) (Single-stranded DNA-binding protein 1)	Nabp2 Obfc2b Ssb1	Mus musculus (Mouse)	212	DNA repair [GO:0006281]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; mitotic cell cycle checkpoint [GO:0007093]; positive regulation of telomere capping [GO:1904355]; response to ionizing radiation [GO:0010212]	SOSS complex [GO:0070876]; cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SOSS complex [GO:0070876]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; G-rich strand telomeric DNA binding [GO:0098505]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; mitotic cell cycle checkpoint [GO:0007093]; positive regulation of telomere capping [GO:1904355]; response to ionizing radiation [GO:0010212]	DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; G-rich strand telomeric DNA binding [GO:0098505]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000784; GO:0003677; GO:0003697; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0007093; GO:0010212; GO:0070182; GO:0070200; GO:0070876; GO:0098505; GO:1904355
Q9CX98	CP2U1_MOUSE	reviewed	Cytochrome P450 2U1 (EC 1.14.14.1)	Cyp2u1	Mus musculus (Mouse)	530	exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]	GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0042738; GO:0043231; GO:0055114; GO:0070330
Q4A1L5	BECN1_PIG	reviewed	Beclin-1 [Cleaved into: Beclin-1-C 35 kDa; Beclin-1-C 37 kDa]	BECN1 ATG6	Sus scrofa (Pig)	448	apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; cellular response to nitrogen starvation [GO:0006995]; defense response to virus [GO:0051607]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; protein localization by the Cvt pathway [GO:0032258]; regulation of cytokinesis [GO:0032465]	Golgi apparatus [GO:0005794]; autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]	autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; cellular response to nitrogen starvation [GO:0006995]; defense response to virus [GO:0051607]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; protein localization by the Cvt pathway [GO:0032258]; regulation of cytokinesis [GO:0032465]		GO:0000045; GO:0000407; GO:0005634; GO:0005776; GO:0005789; GO:0005794; GO:0005829; GO:0006897; GO:0006914; GO:0006915; GO:0006995; GO:0007049; GO:0010008; GO:0016236; GO:0019898; GO:0031966; GO:0032258; GO:0032465; GO:0034271; GO:0034272; GO:0035032; GO:0042149; GO:0045022; GO:0045324; GO:0051301; GO:0051607
O60427	FADS1_HUMAN	reviewed	Acyl-CoA (8-3)-desaturase (EC 1.14.19.44) (Delta(5) fatty acid desaturase) (D5D) (Delta(5) desaturase) (Delta-5 desaturase) (Fatty acid desaturase 1)	FADS1 FADSD5	Homo sapiens (Human)	444	alpha-linolenic acid metabolic process [GO:0036109]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; icosanoid biosynthetic process [GO:0046456]; linoleic acid metabolic process [GO:0043651]; phospholipid biosynthetic process [GO:0008654]; regulation of cell differentiation [GO:0045595]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]; unsaturated fatty acid biosynthetic process [GO:0006636]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; acyl-CoA delta5-desaturase activity [GO:0062076]; C-5 sterol desaturase activity [GO:0000248]; omega-6 fatty acid desaturase activity [GO:0045485]; oxidoreductase activity [GO:0016491]; alpha-linolenic acid metabolic process [GO:0036109]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; icosanoid biosynthetic process [GO:0046456]; linoleic acid metabolic process [GO:0043651]; phospholipid biosynthetic process [GO:0008654]; regulation of cell differentiation [GO:0045595]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]; unsaturated fatty acid biosynthetic process [GO:0006636]	C-5 sterol desaturase activity [GO:0000248]; acyl-CoA delta5-desaturase activity [GO:0062076]; omega-6 fatty acid desaturase activity [GO:0045485]; oxidoreductase activity [GO:0016491]	GO:0000248; GO:0005739; GO:0005789; GO:0006355; GO:0006636; GO:0007267; GO:0008654; GO:0009267; GO:0016020; GO:0016021; GO:0016491; GO:0019216; GO:0036109; GO:0043231; GO:0043651; GO:0045485; GO:0045595; GO:0046456; GO:0062076
O15460	P4HA2_HUMAN	reviewed	Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)	P4HA2 UNQ290/PRO330	Homo sapiens (Human)	535	peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]	L-ascorbic acid binding [GO:0031418]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]	GO:0004656; GO:0005506; GO:0005654; GO:0005783; GO:0005788; GO:0005829; GO:0009055; GO:0016702; GO:0018401; GO:0031418; GO:0043231
Q9VEG6	PERC_DROME	reviewed	Chorion peroxidase (EC 1.11.1.7) (Peroxinectin-related protein) (Dpxt)	Pxt CG7660	Drosophila melanogaster (Fruit fly)	809	chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; chorion-containing eggshell formation [GO:0007304]; eggshell chorion assembly [GO:0007306]; hydrogen peroxide catabolic process [GO:0042744]; hydrogen peroxide metabolic process [GO:0042743]; ovarian follicle cell development [GO:0030707]; prostaglandin biosynthetic process [GO:0001516]; response to oxidative stress [GO:0006979]	heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]	GO:0001516; GO:0004601; GO:0004666; GO:0005615; GO:0006979; GO:0007304; GO:0007306; GO:0020037; GO:0030707; GO:0042743; GO:0042744; GO:0046872
Q8K2X3	STN1_MOUSE	reviewed	CST complex subunit STN1 (Alpha-accessory factor of 44 kDa) (AAF-44) (AAF44) (Oligonucleotide/oligosaccharide-binding fold-containing protein 1) (Suppressor of cdc thirteen homolog)	Stn1 Obfc1	Mus musculus (Mouse)	378	negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]	CST complex [GO:1990879]; fibrillar center [GO:0001650]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	CST complex [GO:1990879]; fibrillar center [GO:0001650]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; telomeric DNA binding [GO:0042162]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]	single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; telomeric DNA binding [GO:0042162]	GO:0000723; GO:0000784; GO:0001650; GO:0003697; GO:0005634; GO:0005654; GO:0010833; GO:0016233; GO:0032211; GO:0042162; GO:0043047; GO:0043231; GO:0045111; GO:0045740; GO:1990879
P11247	PERM_MOUSE	reviewed	Myeloperoxidase (MPO) (EC 1.11.2.2) [Cleaved into: Myeloperoxidase light chain; Myeloperoxidase heavy chain]	Mpo	Mus musculus (Mouse)	718	aging [GO:0007568]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of growth of symbiont in host [GO:0044130]; oxidation-reduction process [GO:0055114]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to yeast [GO:0001878]	azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; secretory granule [GO:0030141]	azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; secretory granule [GO:0030141]; heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; aging [GO:0007568]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of growth of symbiont in host [GO:0044130]; oxidation-reduction process [GO:0055114]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to yeast [GO:0001878]	heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0001878; GO:0002149; GO:0002679; GO:0004601; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0007568; GO:0008201; GO:0009612; GO:0019430; GO:0020037; GO:0030141; GO:0032094; GO:0032496; GO:0034374; GO:0042582; GO:0042742; GO:0042744; GO:0043231; GO:0044130; GO:0046872; GO:0050832; GO:0055114; GO:1990268
Q6ZPS6	AKIB1_MOUSE	reviewed	Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31)	Ankib1 Kiaa1386	Mus musculus (Mouse)	1085	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0031624; GO:0032436; GO:0046872; GO:0061630
Q8K0U4	HS12A_MOUSE	reviewed	Heat shock 70 kDa protein 12A	Hspa12a Kiaa0417	Mus musculus (Mouse)	675			ATP binding [GO:0005524]	ATP binding [GO:0005524]	GO:0005524
Q80VL1	TDRKH_MOUSE	reviewed	Tudor and KH domain-containing protein (Tudor domain-containing protein 2)	Tdrkh Tdrd2	Mus musculus (Mouse)	560	DNA methylation involved in gamete generation [GO:0043046]; cell differentiation [GO:0030154]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; pi-body [GO:0071546]; piP-body [GO:0071547]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; pi-body [GO:0071546]; piP-body [GO:0071547]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005739; GO:0005829; GO:0007140; GO:0007283; GO:0009566; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0071546; GO:0071547
Q9WV04	KIF9_MOUSE	reviewed	Kinesin-like protein KIF9	Kif9	Mus musculus (Mouse)	790	extracellular matrix disassembly [GO:0022617]; microtubule-based movement [GO:0007018]; organelle disassembly [GO:1903008]; regulation of podosome assembly [GO:0071801]	cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; podosome [GO:0002102]; vesicle [GO:0031982]	cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; podosome [GO:0002102]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein dimerization activity [GO:0046983]; extracellular matrix disassembly [GO:0022617]; microtubule-based movement [GO:0007018]; organelle disassembly [GO:1903008]; regulation of podosome assembly [GO:0071801]	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein dimerization activity [GO:0046983]	GO:0002102; GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0022617; GO:0031982; GO:0046983; GO:0071801; GO:1903008
Q8WXB1	MT21A_HUMAN	reviewed	Protein N-lysine methyltransferase METTL21A (EC 2.1.1.-) (HSPA lysine methyltransferase) (HSPA-KMT) (Hepatocellular carcinoma-associated antigen 557b) (Methyltransferase-like protein 21A)	METTL21A FAM119A HCA557B	Homo sapiens (Human)	218	peptidyl-lysine methylation [GO:0018022]; protein methylation [GO:0006479]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]; protein methylation [GO:0006479]	ATPase binding [GO:0051117]; Hsp70 protein binding [GO:0030544]; heat shock protein binding [GO:0031072]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005654; GO:0005737; GO:0006479; GO:0008276; GO:0016279; GO:0018022; GO:0030544; GO:0031072; GO:0032991; GO:0051117
B3EWZ8	ECT_ACRMI	reviewed	Ectin (Fragment)		Acropora millepora (Staghorn coral) (Heteropora millepora)	400		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576
Q11011	PSA_MOUSE	reviewed	Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)	Npepps Psa	Mus musculus (Mouse)	920	cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0071456
P70168	IMB1_MOUSE	reviewed	Importin subunit beta-1 (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97) (SCG)	Kpnb1 Impnb	Mus musculus (Mouse)	876	Ran protein signal transduction [GO:0031291]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; kinesin binding [GO:0019894]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; Ran GTPase binding [GO:0008536]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; ribosomal protein import into nucleus [GO:0006610]	Hsp90 protein binding [GO:0051879]; Ran GTPase binding [GO:0008536]; enzyme binding [GO:0019899]; importin-alpha family protein binding [GO:0061676]; kinesin binding [GO:0019894]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]	GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0006610; GO:0007079; GO:0007080; GO:0008139; GO:0008536; GO:0010494; GO:0019894; GO:0019899; GO:0019904; GO:0030953; GO:0031291; GO:0031965; GO:0032991; GO:0040001; GO:0044877; GO:0045184; GO:0051879; GO:0061608; GO:0061676; GO:0071782; GO:0090307
Q76B49	CD63_FELCA	reviewed	CD63 antigen (CD antigen CD63)	CD63	Felis catus (Cat) (Felis silvestris catus)	238	cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]		GO:0002092; GO:0005765; GO:0005887; GO:0007160; GO:0009986; GO:0015031; GO:0016477; GO:0031226; GO:0031902; GO:0032585; GO:0035646; GO:0042470; GO:0048757; GO:0070062; GO:0097487; GO:1900746; GO:2001046
Q28EL0	CCYL1_XENTR	reviewed	Cyclin-Y-like protein 1	ccnyl1 TGas141j24.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	343	positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]	plasma membrane [GO:0005886]	plasma membrane [GO:0005886]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]	GO:0005886; GO:0016538; GO:0019901; GO:0045737
B2RY50	ARMC4_MOUSE	reviewed	Armadillo repeat-containing protein 4	Armc4	Mus musculus (Mouse)	1037	cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591]	axoneme [GO:0005930]; ciliary base [GO:0097546]	axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591]		GO:0003341; GO:0003356; GO:0005930; GO:0007368; GO:0007507; GO:0021591; GO:0036158; GO:0097546
Q6ZSM3	MOT12_HUMAN	reviewed	Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12)	SLC16A12 MCT12	Homo sapiens (Human)	516	creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]	creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]	GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881
Q9I7U4	TITIN_DROME	reviewed	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	I band [GO:0031674]; Z disc [GO:0030018]; condensed nuclear chromosome [GO:0000794]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007517; GO:0007519; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301
Q8WZ42	TITIN_HUMAN	reviewed	Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)	TTN	Homo sapiens (Human)	34350	cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	I band [GO:0031674]; M band [GO:0031430]; Z disc [GO:0030018]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	ATP binding [GO:0005524]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]	GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030017; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0071688; GO:0097493
Q23551	UNC22_CAEEL	reviewed	Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)	unc-22 ZK617.1	Caenorhabditis elegans	7158	adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]	A band [GO:0031672]; M band [GO:0031430]; Z disc [GO:0030018]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]	A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688]	ATP binding [GO:0005524]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]	GO:0004674; GO:0005516; GO:0005524; GO:0005865; GO:0006936; GO:0008307; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0030017; GO:0030018; GO:0031430; GO:0031672; GO:0035095; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051015; GO:0051371; GO:0051782; GO:0060298; GO:0071688
A2ASS6	TITIN_MOUSE	reviewed	Titin (EC 2.7.11.1) (Connectin)	Ttn	Mus musculus (Mouse)	35213	adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]	A band [GO:0031672]; I band [GO:0031674]; M band [GO:0031430]; Z disc [GO:0030018]; condensed nuclear chromosome [GO:0000794]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]	A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]	ATP binding [GO:0005524]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]	GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0071688; GO:1901897
P33450	FAT_DROME	reviewed	Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]	ft CG3352	Drosophila melanogaster (Fruit fly)	5147	Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis involved in differentiation [GO:0000904]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; peptide cross-linking [GO:0018149]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis involved in differentiation [GO:0000904]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; peptide cross-linking [GO:0018149]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0000904; GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0005887; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008283; GO:0008285; GO:0009888; GO:0010629; GO:0016021; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0018149; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045198; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0060071; GO:0090176; GO:0090251; GO:0098609
P27085	RS26_OCTVU	reviewed	40S ribosomal protein S26	RPS26	Octopus vulgaris (Common octopus)	127	cytoplasmic translation [GO:0002181]	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003735; GO:0022627; GO:0042788; GO:0098556
Q6PDN3	MYLK_MOUSE	reviewed	Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cardiovascular system development [GO:0072358]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; protein kinase activity [GO:0004672]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cardiovascular system development [GO:0072358]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	ATP binding [GO:0005524]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; protein kinase activity [GO:0004672]	GO:0001725; GO:0003779; GO:0004672; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005886; GO:0005911; GO:0006939; GO:0014820; GO:0015629; GO:0019899; GO:0030027; GO:0030335; GO:0032060; GO:0032154; GO:0035690; GO:0035865; GO:0046872; GO:0051928; GO:0060414; GO:0071277; GO:0071476; GO:0072358; GO:0090303
P46530	NOTC1_DANRE	reviewed	Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	notch1a notch	Danio rerio (Zebrafish) (Brachydanio rerio)	2437	Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor-mediated endocytosis [GO:0048259]; regulation of transcription, DNA-templated [GO:0006355]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514]	integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor-mediated endocytosis [GO:0048259]; regulation of transcription, DNA-templated [GO:0006355]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514]	calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]	GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0016021; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314
Q9LQU4	PCR2_ARATH	reviewed	Protein PLANT CADMIUM RESISTANCE 2 (AtPCR2)	PCR2 At1g14870 F10B6.27	Arabidopsis thaliana (Mouse-ear cress)	152	response to oxidative stress [GO:0006979]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; response to oxidative stress [GO:0006979]		GO:0005886; GO:0006979; GO:0016021
A0JMU8	CASC3_XENLA	reviewed	Protein CASC3 (Cancer susceptibility candidate gene 3 protein homolog) (Metastatic lymph node protein 51 homolog) (Protein MLN 51 homolog) (XlMLN51)	casc3 mln51	Xenopus laevis (African clawed frog)	686	mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]	U2-type catalytic step 1 spliceosome [GO:0071006]; cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; U2-type catalytic step 1 spliceosome [GO:0071006]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]	RNA binding [GO:0003723]	GO:0000184; GO:0000398; GO:0003723; GO:0005634; GO:0006417; GO:0010494; GO:0016607; GO:0030425; GO:0035145; GO:0048471; GO:0051028; GO:0071006
Q9H015	S22A4_HUMAN	reviewed	Solute carrier family 22 member 4 (Ergothioneine transporter) (ET transporter) (Organic cation/carnitine transporter 1)	SLC22A4 ETT OCTN1 UT2H	Homo sapiens (Human)	551	body fluid secretion [GO:0007589]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; sodium ion transport [GO:0006814]; triglyceride metabolic process [GO:0006641]	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; cation:cation antiporter activity [GO:0015491]; nucleotide binding [GO:0000166]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; symporter activity [GO:0015293]; body fluid secretion [GO:0007589]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; sodium ion transport [GO:0006814]; triglyceride metabolic process [GO:0006641]	ATP binding [GO:0005524]; PDZ domain binding [GO:0030165]; carnitine transmembrane transporter activity [GO:0015226]; cation:cation antiporter activity [GO:0015491]; nucleotide binding [GO:0000166]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; symporter activity [GO:0015293]	GO:0000166; GO:0005524; GO:0005739; GO:0005886; GO:0005887; GO:0006641; GO:0006814; GO:0007589; GO:0008513; GO:0009437; GO:0015226; GO:0015293; GO:0015491; GO:0015651; GO:0015695; GO:0015697; GO:0015879; GO:0016324; GO:0030165
Q6UXZ4	UNC5D_HUMAN	reviewed	Netrin receptor UNC5D (Protein unc-5 homolog 4) (Protein unc-5 homolog D)	UNC5D KIAA1777 UNC5H4 UNQ6012/PRO34692	Homo sapiens (Human)	953	apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; pyramidal neuron differentiation [GO:0021859]; regulation of neuron migration [GO:2001222]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; netrin receptor activity [GO:0005042]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; pyramidal neuron differentiation [GO:0021859]; regulation of neuron migration [GO:2001222]	netrin receptor activity [GO:0005042]	GO:0005042; GO:0005886; GO:0006915; GO:0007411; GO:0009986; GO:0016021; GO:0021859; GO:0098742; GO:2001222
Q0VAA2	LR74A_HUMAN	reviewed	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)	LRRC74A C14orf166B LRRC74	Homo sapiens (Human)	488					
P35441	TSP1_MOUSE	reviewed	Thrombospondin-1 (Glycoprotein G)	Thbs1 Tsp1	Mus musculus (Mouse)	1170	activation of MAPK activity [GO:0000187]; behavioral response to pain [GO:0048266]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to nitric oxide [GO:0071732]; endocardial cushion development [GO:0003197]; engulfment of apoptotic cell [GO:0043652]; growth plate cartilage development [GO:0003417]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; outflow tract morphogenesis [GO:0003151]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to unfolded protein [GO:0006986]; sprouting angiogenesis [GO:0002040]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix binding [GO:0050840]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; transforming growth factor beta binding [GO:0050431]; activation of MAPK activity [GO:0000187]; behavioral response to pain [GO:0048266]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell cycle arrest [GO:0007050]; cell migration [GO:0016477]; cellular response to nitric oxide [GO:0071732]; endocardial cushion development [GO:0003197]; engulfment of apoptotic cell [GO:0043652]; growth plate cartilage development [GO:0003417]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; outflow tract morphogenesis [GO:0003151]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to unfolded protein [GO:0006986]; sprouting angiogenesis [GO:0002040]	calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix binding [GO:0050840]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; transforming growth factor beta binding [GO:0050431]	GO:0000187; GO:0001786; GO:0001937; GO:0001953; GO:0001968; GO:0002040; GO:0002581; GO:0002605; GO:0003151; GO:0003197; GO:0003417; GO:0005178; GO:0005509; GO:0005577; GO:0005615; GO:0005737; GO:0005783; GO:0006954; GO:0006986; GO:0007050; GO:0007155; GO:0008201; GO:0008284; GO:0009612; GO:0009749; GO:0009897; GO:0009986; GO:0010595; GO:0010596; GO:0010748; GO:0010751; GO:0010754; GO:0010757; GO:0010759; GO:0010763; GO:0010811; GO:0016477; GO:0016525; GO:0016529; GO:0017134; GO:0018149; GO:0030141; GO:0030169; GO:0030194; GO:0030335; GO:0030511; GO:0031012; GO:0031091; GO:0032026; GO:0032695; GO:0034976; GO:0040037; GO:0042327; GO:0042535; GO:0043032; GO:0043066; GO:0043154; GO:0043236; GO:0043536; GO:0043537; GO:0043652; GO:0045727; GO:0045766; GO:0048266; GO:0048514; GO:0048661; GO:0050431; GO:0050840; GO:0050921; GO:0051592; GO:0051897; GO:0051918; GO:0062023; GO:0070051; GO:0070052; GO:0071636; GO:0071732; GO:0090051; GO:1902043; GO:1903588; GO:1903671; GO:2000353; GO:2000379; GO:2001027
Q9ESN4	C1QL3_MOUSE	reviewed	Complement C1q-like protein 3 (C1q and tumor necrosis factor-related protein 13) (C1q/TNF-related protein 13) (CTRP13) (Gliacolin)	C1ql3 C1ql Ctrp13	Mus musculus (Mouse)	255	regulation of synapse organization [GO:0050807]	collagen trimer [GO:0005581]; extracellular region [GO:0005576]	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; identical protein binding [GO:0042802]; regulation of synapse organization [GO:0050807]	identical protein binding [GO:0042802]	GO:0005576; GO:0005581; GO:0042802; GO:0050807
Q8VIK5	PEAR1_MOUSE	reviewed	Platelet endothelial aggregation receptor 1 (mPEAR1) (Jagged and Delta protein) (Protein Jedi) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12)	Pear1 Jedi Megf12	Mus musculus (Mouse)	1034	negative regulation of Notch signaling pathway [GO:0045746]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet aggregation [GO:0070527]; protein kinase B signaling [GO:0043491]; recognition of apoptotic cell [GO:0043654]	integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; negative regulation of Notch signaling pathway [GO:0045746]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet aggregation [GO:0070527]; protein kinase B signaling [GO:0043491]; recognition of apoptotic cell [GO:0043654]	signaling receptor activity [GO:0038023]	GO:0001891; GO:0005886; GO:0014065; GO:0016021; GO:0038023; GO:0043491; GO:0043654; GO:0045746; GO:0070527
Q9BTA9	WAC_HUMAN	reviewed	WW domain-containing adapter protein with coiled-coil	WAC KIAA1844	Homo sapiens (Human)	647	G1 DNA damage checkpoint [GO:0044783]; cellular response to DNA damage stimulus [GO:0006974]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]; cellular response to DNA damage stimulus [GO:0006974]; G1 DNA damage checkpoint [GO:0044783]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]	RNA polymerase II complex binding [GO:0000993]; chromatin binding [GO:0003682]	GO:0000993; GO:0003682; GO:0005634; GO:0005654; GO:0005681; GO:0006974; GO:0010390; GO:0016239; GO:0016567; GO:0016607; GO:0032435; GO:0044783; GO:0045893; GO:0071894
Q40375	PRP2_MEDTR	reviewed	Repetitive proline-rich cell wall protein 2	PRP2	Medicago truncatula (Barrel medic) (Medicago tribuloides)	371	multicellular organism development [GO:0007275]	cell wall [GO:0005618]; extracellular region [GO:0005576]	cell wall [GO:0005618]; extracellular region [GO:0005576]; structural constituent of cell wall [GO:0005199]; multicellular organism development [GO:0007275]	structural constituent of cell wall [GO:0005199]	GO:0005199; GO:0005576; GO:0005618; GO:0007275
P25145	Y432_LISMO	reviewed	Uncharacterized oxidoreductase Lmo0432 (EC 1.-.-.-) (ORFA)	lmo0432	Listeria monocytogenes serovar 1/2a (strain ATCC BAA-679 / EGD-e)	248			oxidoreductase activity [GO:0016491]	oxidoreductase activity [GO:0016491]	GO:0016491
O46385	SVIL_BOVIN	reviewed	Supervillin (Archvillin) (p205/p250)	SVIL	Bos taurus (Bovine)	2194	cytoskeleton organization [GO:0007010]; positive regulation of cytokinesis [GO:0032467]	cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; podosome [GO:0002102]	cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; podosome [GO:0002102]; actin filament binding [GO:0051015]; cytoskeleton organization [GO:0007010]; positive regulation of cytokinesis [GO:0032467]	actin filament binding [GO:0051015]	GO:0002102; GO:0005737; GO:0007010; GO:0030054; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0051015; GO:0071437
O01393	UNC9_CAEEL	reviewed	Innexin unc-9 (Uncoordinated protein 9)	unc-9 R12H7.1	Caenorhabditis elegans	386	ion transmembrane transport [GO:0034220]	cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transmembrane transport [GO:0034220]	gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]	GO:0005243; GO:0005886; GO:0005911; GO:0005921; GO:0016021; GO:0034220; GO:0055077
Q9BXJ5	C1QT2_HUMAN	reviewed	Complement C1q tumor necrosis factor-related protein 2	C1QTNF2 CTRP2 UNQ6349/PRO21054	Homo sapiens (Human)	285	activation of MAPK activity [GO:0000187]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]	collagen trimer [GO:0005581]; extracellular space [GO:0005615]	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; activation of MAPK activity [GO:0000187]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]	identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	GO:0000187; GO:0005102; GO:0005581; GO:0005615; GO:0042802; GO:0045725; GO:0046321; GO:0046326; GO:0051260; GO:0070208
Q20930	MIG17_CAEEL	reviewed	Metalloprotease mig-17 (EC 3.4.24.-) (Abnormal cell migration protein 17)	mig-17 F57B7.4	Caenorhabditis elegans	509	gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638]	basement membrane [GO:0005604]; extracellular space [GO:0005615]	basement membrane [GO:0005604]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004222; GO:0005604; GO:0005615; GO:0008104; GO:0008237; GO:0016540; GO:0030334; GO:0031638; GO:0035262; GO:0046872; GO:1903354
Q9GLP1	FA5_PIG	reviewed	Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]	F5	Sus scrofa (Pig)	2258	blood coagulation [GO:0007596]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; copper ion binding [GO:0005507]; blood coagulation [GO:0007596]	copper ion binding [GO:0005507]	GO:0005507; GO:0005576; GO:0007596
Q9IA79	BI1_PAROL	reviewed	Probable Bax inhibitor 1 (BI-1) (Testis-enhanced gene transcript protein homolog) (Transmembrane BAX inhibitor motif-containing protein 6)	tmbim6 tegt	Paralichthys olivaceus (Bastard halibut) (Hippoglossus olivaceus)	237	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; response to unfolded protein [GO:0006986]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; response to unfolded protein [GO:0006986]		GO:0005789; GO:0006915; GO:0006986; GO:0016021; GO:0043066
Q7KRY7	LAP4_DROME	reviewed	Protein lap4 (Protein scribble) (Protein smell-impaired)	scrib smi vart CG5462	Drosophila melanogaster (Fruit fly)	1851	Malpighian tubule development [GO:0072002]; R3/R4 cell fate commitment [GO:0007464]; anterior/posterior axis specification, follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of Notch signaling pathway [GO:0008593]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]	apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]	apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]; ionotropic glutamate receptor binding [GO:0035255]; anterior/posterior axis specification, follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of Notch signaling pathway [GO:0008593]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186]	ionotropic glutamate receptor binding [GO:0035255]	GO:0000122; GO:0000902; GO:0001708; GO:0001737; GO:0001738; GO:0005911; GO:0005913; GO:0005918; GO:0005923; GO:0005938; GO:0007318; GO:0007391; GO:0007464; GO:0007472; GO:0007608; GO:0007613; GO:0008283; GO:0008285; GO:0008593; GO:0014069; GO:0016323; GO:0016327; GO:0016328; GO:0016331; GO:0016332; GO:0016333; GO:0016334; GO:0016335; GO:0016336; GO:0019991; GO:0030054; GO:0030100; GO:0030707; GO:0030714; GO:0031594; GO:0035088; GO:0035255; GO:0042048; GO:0042058; GO:0042067; GO:0043113; GO:0045169; GO:0045175; GO:0045186; GO:0045197; GO:0045198; GO:0045202; GO:0045571; GO:0046425; GO:0048749; GO:0048863; GO:0050680; GO:0050803; GO:0051726; GO:0060581; GO:0072002; GO:0072089; GO:0097120; GO:0098609; GO:0098887; GO:0098968; GO:1990794
P34456	YMD2_CAEEL	reviewed	Uncharacterized protein F54H12.2	F54H12.2	Caenorhabditis elegans	419	deoxyribonucleotide biosynthetic process [GO:0009263]	cytosol [GO:0005829]	cytosol [GO:0005829]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]	ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]	GO:0004748; GO:0005829; GO:0009263
Q5RBK0	GIN1_PONAB	reviewed	Gypsy retrotransposon integrase-like protein 1 (GIN-1)	GIN1	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	522	DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074
Q8NEG2	CG057_HUMAN	reviewed	Uncharacterized protein C7orf57	C7orf57	Homo sapiens (Human)	295					
P21661	NEC2_MOUSE	reviewed	Neuroendocrine convertase 2 (NEC 2) (EC 3.4.21.94) (KEX2-like endoprotease 2) (Prohormone convertase 2) (Proprotein convertase 2) (PC2)	Pcsk2 Nec-2 Nec2	Mus musculus (Mouse)	637	enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; islet amyloid polypeptide processing [GO:0034231]; nervous system development [GO:0007399]; peptide hormone processing [GO:0016486]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]	dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; secretory granule lumen [GO:0034774]; transport vesicle [GO:0030133]	dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; secretory granule lumen [GO:0034774]; transport vesicle [GO:0030133]; endopeptidase activity [GO:0004175]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; islet amyloid polypeptide processing [GO:0034231]; nervous system development [GO:0007399]; peptide hormone processing [GO:0016486]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]	endopeptidase activity [GO:0004175]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005615; GO:0005634; GO:0005788; GO:0006508; GO:0007399; GO:0016020; GO:0016485; GO:0016486; GO:0016540; GO:0030070; GO:0030133; GO:0030425; GO:0034230; GO:0034231; GO:0034774; GO:0043005; GO:0043025; GO:0043204; GO:0043231; GO:0044877
P23377	FURIN_RAT	reviewed	Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE) (Prohormone convertase 3)	Furin Fur Pcsk3	Rattus norvegicus (Rat)	793	aging [GO:0007568]; peptide hormone processing [GO:0016486]; positive regulation of cell migration [GO:0030335]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 activation [GO:1901394]; protein processing [GO:0016485]	Golgi cisterna [GO:0031985]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi cisterna [GO:0031985]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; aging [GO:0007568]; peptide hormone processing [GO:0016486]; positive regulation of cell migration [GO:0030335]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 activation [GO:1901394]; protein processing [GO:0016485]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0005789; GO:0005802; GO:0005886; GO:0007568; GO:0010008; GO:0016020; GO:0016485; GO:0016486; GO:0030173; GO:0030335; GO:0030511; GO:0031985; GO:0046872; GO:1901394
Q86JP3	RAB5A_DICDI	reviewed	Ras-related protein Rab-5A	rab5A DDB_G0271984	Dictyostelium discoideum (Slime mold)	201	Rab protein signal transduction [GO:0032482]; intracellular protein transport [GO:0006886]	early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]	early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005525; GO:0005768; GO:0005769; GO:0005811; GO:0005886; GO:0006886; GO:0010008; GO:0030139; GO:0032482
B0UZC8	VWC2L_DANRE	reviewed	von Willebrand factor C domain-containing protein 2-like	vwc2l si:ch211-207d8.1	Danio rerio (Zebrafish) (Brachydanio rerio)	223	negative regulation of BMP signaling pathway [GO:0030514]; nervous system development [GO:0007399]	AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]	AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; negative regulation of BMP signaling pathway [GO:0030514]; nervous system development [GO:0007399]		GO:0005615; GO:0007399; GO:0030054; GO:0030514; GO:0032281; GO:0045202
P36017	VPS21_YEAST	reviewed	Vacuolar protein sorting-associated protein 21 (GTP-binding protein YPT51) (Vacuolar protein-targeting protein 12)	VPS21 VPS12 VPT12 YPT21 YPT51 YOR089C YOR3154C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	210	Golgi to endosome transport [GO:0006895]; Rab protein signal transduction [GO:0032482]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; multivesicular body assembly [GO:0036258]; protein localization to endosome [GO:0036010]; protein targeting to vacuole [GO:0006623]; reticulophagy [GO:0061709]; vacuole inheritance [GO:0000011]	cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endocytosis [GO:0006897]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; multivesicular body assembly [GO:0036258]; protein localization to endosome [GO:0036010]; protein targeting to vacuole [GO:0006623]; Rab protein signal transduction [GO:0032482]; reticulophagy [GO:0061709]; vacuole inheritance [GO:0000011]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0000011; GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0006623; GO:0006886; GO:0006895; GO:0006897; GO:0010008; GO:0030139; GO:0032482; GO:0032511; GO:0036010; GO:0036258; GO:0061709
Q9SID8	RAH1D_ARATH	reviewed	Ras-related protein RABH1d (AtRABH1d)	RABH1D At2g22290 T26C19.5	Arabidopsis thaliana (Mouse-ear cress)	207	Rab protein signal transduction [GO:0032482]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0000139; GO:0003924; GO:0005525; GO:0005739; GO:0005794; GO:0005829; GO:0006886; GO:0006890; GO:0006891; GO:0032482; GO:0042147
P16092	FGFR1_MOUSE	reviewed	Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331)	Fgfr1 Flg	Mus musculus (Mouse)	822	angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; cell maturation [GO:0048469]; central nervous system neuron development [GO:0021954]; chondrocyte differentiation [GO:0002062]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; motogenic signaling involved in postnatal olfactory bulb interneuron migration [GO:0021837]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell population proliferation [GO:0042127]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of sensory perception of pain [GO:0051930]; regulation of stem cell proliferation [GO:0072091]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; cell adhesion molecule binding [GO:0050839]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; cell maturation [GO:0048469]; central nervous system neuron development [GO:0021954]; chondrocyte differentiation [GO:0002062]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; motogenic signaling involved in postnatal olfactory bulb interneuron migration [GO:0021837]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell population proliferation [GO:0042127]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of sensory perception of pain [GO:0051930]; regulation of stem cell proliferation [GO:0072091]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640]	ATP binding [GO:0005524]; SH2 domain binding [GO:0042169]; cell adhesion molecule binding [GO:0050839]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; receptor-receptor interaction [GO:0090722]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0002053; GO:0002062; GO:0004713; GO:0004714; GO:0005007; GO:0005102; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007399; GO:0007420; GO:0007435; GO:0007605; GO:0008201; GO:0008284; GO:0008543; GO:0010468; GO:0010629; GO:0010763; GO:0010863; GO:0010966; GO:0010976; GO:0017134; GO:0018108; GO:0019827; GO:0021769; GO:0021837; GO:0021847; GO:0021954; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0035607; GO:0042127; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043235; GO:0043406; GO:0043410; GO:0043536; GO:0043583; GO:0044877; GO:0045597; GO:0045666; GO:0045668; GO:0045787; GO:0045944; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048471; GO:0048514; GO:0048699; GO:0048762; GO:0050839; GO:0051174; GO:0051930; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0060979; GO:0070640; GO:0072091; GO:0090080; GO:0090272; GO:0090722; GO:1903465; GO:1905564; GO:2000546; GO:2000830; GO:2001239
Q8WXX0	DYH7_HUMAN	reviewed	Dynein heavy chain 7, axonemal (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2)	DNAH7 KIAA0944	Homo sapiens (Human)	4024	cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]	axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]	axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]	ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]	GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005829; GO:0005858; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0036159; GO:0045503; GO:0045505; GO:0051959; GO:0060285
D4A055	CACB4_RAT	reviewed	Voltage-dependent L-type calcium channel subunit beta-4 (CAB4) (Calcium channel voltage-dependent subunit beta 4)	Cacnb4	Rattus norvegicus (Rat)	519	Peyer's patch development [GO:0048541]; T cell receptor signaling pathway [GO:0050852]; adult walking behavior [GO:0007628]; cAMP metabolic process [GO:0046058]; calcium ion transport [GO:0006816]; cellular response to leukemia inhibitory factor [GO:1990830]; chemical synaptic transmission [GO:0007268]; detection of light stimulus involved in visual perception [GO:0050908]; gamma-aminobutyric acid secretion [GO:0014051]; gamma-aminobutyric acid signaling pathway [GO:0007214]; muscle fiber development [GO:0048747]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of cell population proliferation [GO:0008285]; neuromuscular junction development [GO:0007528]; neuronal action potential propagation [GO:0019227]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; regulation of voltage-gated calcium channel activity [GO:1901385]; spleen development [GO:0048536]; synaptic transmission, glutamatergic [GO:0035249]; thymus development [GO:0048538]	cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; presynapse [GO:0098793]; voltage-gated calcium channel complex [GO:0005891]	cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; presynapse [GO:0098793]; voltage-gated calcium channel complex [GO:0005891]; high voltage-gated calcium channel activity [GO:0008331]; protein kinase binding [GO:0019901]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; adult walking behavior [GO:0007628]; calcium ion transport [GO:0006816]; cAMP metabolic process [GO:0046058]; cellular response to leukemia inhibitory factor [GO:1990830]; chemical synaptic transmission [GO:0007268]; detection of light stimulus involved in visual perception [GO:0050908]; gamma-aminobutyric acid secretion [GO:0014051]; gamma-aminobutyric acid signaling pathway [GO:0007214]; muscle fiber development [GO:0048747]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuromuscular junction development [GO:0007528]; neuronal action potential propagation [GO:0019227]; Peyer's patch development [GO:0048541]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; regulation of voltage-gated calcium channel activity [GO:1901385]; spleen development [GO:0048536]; synaptic transmission, glutamatergic [GO:0035249]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]	high voltage-gated calcium channel activity [GO:0008331]; protein kinase binding [GO:0019901]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]	GO:0005245; GO:0005730; GO:0005737; GO:0005891; GO:0006816; GO:0007214; GO:0007268; GO:0007528; GO:0007628; GO:0008285; GO:0008331; GO:0014051; GO:0016607; GO:0019227; GO:0019901; GO:0035249; GO:0046058; GO:0048536; GO:0048538; GO:0048541; GO:0048747; GO:0050852; GO:0050908; GO:0098793; GO:0098978; GO:0099635; GO:1901385; GO:1901387; GO:1904751; GO:1990830; GO:2000134
Q64729	TGFR1_MOUSE	reviewed	TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I)	Tgfbr1	Mus musculus (Mouse)	503	activation of MAPKK activity [GO:0000186]; activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pattern specification process [GO:0007389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein binding [GO:0043393]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]; response to cholesterol [GO:0070723]; response to estrogen [GO:0043627]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]	activin receptor complex [GO:0048179]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	activin receptor complex [GO:0048179]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell [GO:0005623]; cell surface [GO:0009986]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; activin binding [GO:0048185]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]; activation of MAPKK activity [GO:0000186]; activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pattern specification process [GO:0007389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein binding [GO:0043393]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]; response to cholesterol [GO:0070723]; response to estrogen [GO:0043627]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]	ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; SMAD binding [GO:0046332]; activin binding [GO:0048185]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]	GO:0000186; GO:0001501; GO:0001525; GO:0001701; GO:0001822; GO:0001824; GO:0001837; GO:0001937; GO:0001938; GO:0002088; GO:0003222; GO:0003223; GO:0004672; GO:0004674; GO:0005024; GO:0005025; GO:0005102; GO:0005114; GO:0005524; GO:0005623; GO:0005634; GO:0005768; GO:0005886; GO:0005887; GO:0005901; GO:0005923; GO:0006355; GO:0006468; GO:0006915; GO:0007165; GO:0007179; GO:0007389; GO:0007507; GO:0008284; GO:0008354; GO:0008584; GO:0009791; GO:0009952; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0010718; GO:0010862; GO:0016020; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0019838; GO:0030199; GO:0030307; GO:0030335; GO:0031396; GO:0031625; GO:0032331; GO:0032924; GO:0032991; GO:0035556; GO:0042118; GO:0043065; GO:0043066; GO:0043231; GO:0043235; GO:0043393; GO:0043542; GO:0043627; GO:0044877; GO:0045121; GO:0045602; GO:0045893; GO:0046332; GO:0046777; GO:0046872; GO:0046982; GO:0048179; GO:0048185; GO:0048538; GO:0048663; GO:0048701; GO:0048705; GO:0048762; GO:0048844; GO:0048870; GO:0050431; GO:0051272; GO:0051491; GO:0051496; GO:0051897; GO:0060017; GO:0060021; GO:0060037; GO:0060043; GO:0060317; GO:0060389; GO:0060391; GO:0060412; GO:0060978; GO:0060982; GO:0070411; GO:0070723; GO:0071560; GO:1902894; GO:1902895; GO:1905007; GO:1905075; GO:1905223; GO:2001235; GO:2001237
Q8BH75	RNF41_MOUSE	reviewed	E3 ubiquitin-protein ligase NRDP1 (EC 2.3.2.27) (RING finger protein 41) (RING-type E3 ubiquitin transferase NRDP1)	Rnf41 Flrf Nrdp1	Mus musculus (Mouse)	317	autophagy [GO:0006914]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitophagy [GO:1901525]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of MAPK cascade [GO:0043408]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of lymphocyte differentiation [GO:0045619]; regulation of myeloid cell differentiation [GO:0045637]; regulation of protein kinase B signaling [GO:0051896]; regulation of reactive oxygen species metabolic process [GO:2000377]	endoplasmic reticulum tubular network [GO:0071782]; perinuclear region of cytoplasm [GO:0048471]	endoplasmic reticulum tubular network [GO:0071782]; perinuclear region of cytoplasm [GO:0048471]; erythropoietin receptor binding [GO:0005128]; interleukin-3 receptor binding [GO:0005135]; protein domain specific binding [GO:0019904]; Ral GTPase binding [GO:0017160]; receptor tyrosine kinase binding [GO:0030971]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitophagy [GO:1901525]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of lymphocyte differentiation [GO:0045619]; regulation of MAPK cascade [GO:0043408]; regulation of myeloid cell differentiation [GO:0045637]; regulation of protein kinase B signaling [GO:0051896]; regulation of reactive oxygen species metabolic process [GO:2000377]	Ral GTPase binding [GO:0017160]; erythropoietin receptor binding [GO:0005128]; interleukin-3 receptor binding [GO:0005135]; protein domain specific binding [GO:0019904]; receptor tyrosine kinase binding [GO:0030971]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0004842; GO:0005128; GO:0005135; GO:0006914; GO:0008270; GO:0008285; GO:0010468; GO:0010498; GO:0016567; GO:0017160; GO:0019904; GO:0030336; GO:0030971; GO:0043408; GO:0045619; GO:0045637; GO:0045732; GO:0048471; GO:0051091; GO:0051865; GO:0051896; GO:0061630; GO:0071782; GO:0097191; GO:1901525; GO:2000114; GO:2000377; GO:2000379
Q8K078	SO4A1_MOUSE	reviewed	Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12)	Slco4a1 Oatp4a1 Oatpe Slc21a12	Mus musculus (Mouse)	723	organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403]	organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]	GO:0005887; GO:0008514; GO:0015347; GO:0015349; GO:0015711; GO:0042403; GO:0043252
Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; regulation of microtubule polymerization or depolymerization [GO:0031110]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060]	H zone [GO:0031673]; Z disc [GO:0030018]; actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; regulation of microtubule polymerization or depolymerization [GO:0031110]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060]	actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]	GO:0001725; GO:0003779; GO:0005198; GO:0005509; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005882; GO:0005925; GO:0005938; GO:0007155; GO:0007409; GO:0008017; GO:0008090; GO:0009898; GO:0014069; GO:0014704; GO:0015629; GO:0015630; GO:0016020; GO:0016021; GO:0030018; GO:0030056; GO:0030424; GO:0031110; GO:0031122; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042383; GO:0042803; GO:0045104; GO:0046907; GO:0048471; GO:0051010; GO:0060053; GO:0097038; GO:1904115
Q95N03	CLTR2_PIG	reviewed	Cysteinyl leukotriene receptor 2 (CysLTR2)	CYSLTR2 CYSLT2	Sus scrofa (Pig)	345	neuropeptide signaling pathway [GO:0007218]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; G protein-coupled peptide receptor activity [GO:0008528]; galanin receptor activity [GO:0004966]; leukotriene receptor activity [GO:0004974]; neuropeptide signaling pathway [GO:0007218]	G protein-coupled peptide receptor activity [GO:0008528]; galanin receptor activity [GO:0004966]; leukotriene receptor activity [GO:0004974]	GO:0004966; GO:0004974; GO:0005887; GO:0007218; GO:0008528
Q502K3	ANR52_DANRE	reviewed	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C)	ankrd52 zgc:112069	Danio rerio (Zebrafish) (Brachydanio rerio)	1071					
Q9UPN3	MACF1_HUMAN	reviewed	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)	MACF1 ABP620 ACF7 KIAA0465 KIAA1251	Homo sapiens (Human)	7388	Golgi to plasma membrane protein transport [GO:0043001]; Wnt signaling pathway [GO:0016055]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of axon extension [GO:0045773]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; wound healing [GO:0042060]	Golgi apparatus [GO:0005794]; actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; microtubule minus-end binding [GO:0051011]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]	ATPase activity [GO:0016887]; RNA binding [GO:0003723]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; microtubule minus-end binding [GO:0051011]; structural molecule activity [GO:0005198]	GO:0003723; GO:0003779; GO:0005198; GO:0005509; GO:0005737; GO:0005794; GO:0005856; GO:0005874; GO:0005886; GO:0010632; GO:0015629; GO:0016020; GO:0016055; GO:0016887; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0045296; GO:0045773; GO:0051011; GO:0051015; GO:0051893
D3ZHV2	MACF1_RAT	reviewed	Microtubule-actin cross-linking factor 1 (Actin cross-linking family 7)	Macf1 Acf7 Aclp7 Macf	Rattus norvegicus (Rat)	5430	Golgi to plasma membrane protein transport [GO:0043001]; Wnt signaling pathway [GO:0016055]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; wound healing [GO:0042060]	Golgi apparatus [GO:0005794]; actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule minus-end binding [GO:0051011]; structural molecule activity [GO:0005198]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]	ATPase activity [GO:0016887]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; microtubule minus-end binding [GO:0051011]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005886; GO:0010632; GO:0015629; GO:0016020; GO:0016055; GO:0016887; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0051011; GO:0051015; GO:0051893
Q9H8Y8	GORS2_HUMAN	reviewed	Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59)	GORASP2 GOLPH6	Homo sapiens (Human)	452	Golgi organization [GO:0007030]; cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]		GO:0000139; GO:0005789; GO:0005794; GO:0006996; GO:0007030; GO:0007283; GO:0016020; GO:0030154; GO:0034976; GO:0061951; GO:0070925
B3EWZ3	CADN_ACRMI	reviewed	Coadhesin (Fragment)		Acropora millepora (Staghorn coral) (Heteropora millepora)	1675		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021
P41263	RET4_CHICK	reviewed	Retinol-binding protein 4 (Plasma retinol-binding protein) (PRBP) (RBP)	RBP4	Gallus gallus (Chicken)	196	eye development [GO:0001654]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; maintenance of gastrointestinal epithelium [GO:0030277]; oocyte growth [GO:0001555]; positive regulation of insulin secretion [GO:0032024]; protein-containing complex assembly [GO:0065003]; response to estrogen [GO:0043627]; response to retinoic acid [GO:0032526]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; retinol metabolic process [GO:0042572]	clathrin-coated vesicle [GO:0030136]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; yolk [GO:0060417]; yolk plasma [GO:0060418]	clathrin-coated vesicle [GO:0030136]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; yolk [GO:0060417]; yolk plasma [GO:0060418]; protein domain specific binding [GO:0019904]; retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; signaling receptor binding [GO:0005102]; eye development [GO:0001654]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; maintenance of gastrointestinal epithelium [GO:0030277]; oocyte growth [GO:0001555]; positive regulation of insulin secretion [GO:0032024]; protein-containing complex assembly [GO:0065003]; response to estrogen [GO:0043627]; response to retinoic acid [GO:0032526]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; retinol metabolic process [GO:0042572]	protein domain specific binding [GO:0019904]; retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; signaling receptor binding [GO:0005102]	GO:0001555; GO:0001654; GO:0005102; GO:0005615; GO:0006094; GO:0009615; GO:0016918; GO:0019841; GO:0019904; GO:0030136; GO:0030277; GO:0032024; GO:0032526; GO:0033189; GO:0034632; GO:0042572; GO:0042593; GO:0043627; GO:0060417; GO:0060418; GO:0065003; GO:0070062
P97321	SEPR_MOUSE	reviewed	Prolyl endopeptidase FAP (EC 3.4.21.26) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]	Fap	Mus musculus (Mouse)	761	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; mitotic cell cycle arrest [GO:0071850]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of extracellular matrix organization [GO:1903054]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of collagen catabolic process [GO:0010710]	apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cell junction [GO:0030054]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cell junction [GO:0030054]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; dipeptidyl-peptidase activity [GO:0008239]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; mitotic cell cycle arrest [GO:0071850]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of extracellular matrix organization [GO:1903054]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of collagen catabolic process [GO:0010710]	dipeptidyl-peptidase activity [GO:0008239]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0001525; GO:0002020; GO:0004175; GO:0004252; GO:0005178; GO:0005615; GO:0005886; GO:0006508; GO:0007155; GO:0008233; GO:0008236; GO:0008239; GO:0009986; GO:0010710; GO:0010716; GO:0016021; GO:0030027; GO:0030054; GO:0031258; GO:0032587; GO:0042803; GO:0043542; GO:0045177; GO:0045178; GO:0051603; GO:0060244; GO:0071158; GO:0071438; GO:0071850; GO:0097325; GO:1900119; GO:1902362; GO:1903054
Q9Z218	DPP6_MOUSE	reviewed	Dipeptidyl aminopeptidase-like protein 6 (DPPX) (Dipeptidyl aminopeptidase-related protein) (Dipeptidyl peptidase 6) (Dipeptidyl peptidase IV-like protein) (Dipeptidyl peptidase VI) (DPP VI)	Dpp6 Dpp-6	Mus musculus (Mouse)	804	neuronal action potential [GO:0019228]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of potassium ion transport [GO:0043266]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; neuronal action potential [GO:0019228]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of potassium ion transport [GO:0043266]	potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]	GO:0005886; GO:0008076; GO:0008236; GO:0009986; GO:0015459; GO:0016020; GO:0016021; GO:0019228; GO:0042391; GO:0043025; GO:0043266; GO:0043268; GO:0072659; GO:1901379; GO:1901381; GO:1903078
O70421	FZD1_MOUSE	reviewed	Frizzled-1 (Fz-1) (mFz1)	Fzd1	Mus musculus (Mouse)	642	Wnt signaling pathway [GO:0016055]; autocrine signaling [GO:0035425]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; cell-cell signaling [GO:0007267]; epithelial cell differentiation [GO:0030855]; hard palate development [GO:0060022]; membranous septum morphogenesis [GO:0003149]; muscular septum morphogenesis [GO:0003150]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; non-canonical Wnt signaling pathway [GO:0035567]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of presynapse assembly [GO:1905606]; response to drug [GO:0042493]; ventricular septum morphogenesis [GO:0060412]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; frizzled binding [GO:0005109]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; autocrine signaling [GO:0035425]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; cell-cell signaling [GO:0007267]; epithelial cell differentiation [GO:0030855]; hard palate development [GO:0060022]; membranous septum morphogenesis [GO:0003149]; muscular septum morphogenesis [GO:0003150]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; non-canonical Wnt signaling pathway [GO:0035567]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of presynapse assembly [GO:1905606]; response to drug [GO:0042493]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway [GO:0016055]	G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	GO:0001934; GO:0003149; GO:0003150; GO:0003151; GO:0004930; GO:0005102; GO:0005109; GO:0005886; GO:0007267; GO:0009986; GO:0010976; GO:0016021; GO:0016055; GO:0017147; GO:0030165; GO:0030514; GO:0030855; GO:0035425; GO:0035567; GO:0042493; GO:0042802; GO:0042803; GO:0042813; GO:0043005; GO:0044338; GO:0044339; GO:0045892; GO:0045893; GO:0046982; GO:0051091; GO:0060022; GO:0060070; GO:0060412; GO:0090090; GO:0090179; GO:1903204; GO:1905606
Q6DDK2	FADS2_XENLA	reviewed	Fatty acid desaturase 2 (EC 1.14.19.-) (Delta(6) fatty acid desaturase) (D6D) (Delta(6) desaturase) (Delta-6 desaturase)	fads2	Xenopus laevis (African clawed frog)	446	unsaturated fatty acid biosynthetic process [GO:0006636]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]; unsaturated fatty acid biosynthetic process [GO:0006636]	oxidoreductase activity [GO:0016491]	GO:0005789; GO:0006636; GO:0016021; GO:0016491
Q9NRZ9	HELLS_HUMAN	reviewed	Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6)	HELLS PASG SMARCA6 Nbla10143	Homo sapiens (Human)	838	cell cycle [GO:0007049]; cell division [GO:0051301]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; methylation-dependent chromatin silencing [GO:0006346]; multicellular organism development [GO:0007275]; pericentric heterochromatin assembly [GO:0031508]	chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]	chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; cell division [GO:0051301]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; methylation-dependent chromatin silencing [GO:0006346]; multicellular organism development [GO:0007275]; pericentric heterochromatin assembly [GO:0031508]	ATP binding [GO:0005524]; helicase activity [GO:0004386]	GO:0000775; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006346; GO:0007049; GO:0007275; GO:0010216; GO:0031508; GO:0046651; GO:0051301
Q9J569	V162_FOWPN	reviewed	Putative ankyrin repeat protein FPV162	FPV162	Fowlpox virus (strain NVSL) (FPV)	603					
O75962	TRIO_HUMAN	reviewed	Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein)	TRIO	Homo sapiens (Human)	3097	G protein-coupled receptor signaling pathway [GO:0007186]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; negative regulation of fat cell differentiation [GO:0045599]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	cell projection [GO:0042995]; cytosol [GO:0005829]	cell projection [GO:0042995]; cytosol [GO:0005829]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of fat cell differentiation [GO:0045599]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	ATP binding [GO:0005524]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005085; GO:0005089; GO:0005524; GO:0005829; GO:0007185; GO:0007186; GO:0007411; GO:0007417; GO:0035023; GO:0042995; GO:0043065; GO:0045599; GO:0051056
P08953	TOLL_DROME	reviewed	Protein toll	Tl CG5490	Drosophila melanogaster (Fruit fly)	1097	Toll signaling pathway [GO:0008063]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; toll-like receptor signaling pathway [GO:0002224]	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]	TIR domain binding [GO:0070976]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]	GO:0002224; GO:0002225; GO:0002229; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0005887; GO:0006954; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0032991; GO:0035208; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0050830; GO:0061760; GO:0070976; GO:1902875
Q0KL02	TRIO_MOUSE	reviewed	Triple functional domain protein (EC 2.7.11.1)	Trio	Mus musculus (Mouse)	3102	axon guidance [GO:0007411]; central nervous system development [GO:0007417]; negative regulation of fat cell differentiation [GO:0045599]; regulation of Rho protein signal transduction [GO:0035023]	cell projection [GO:0042995]; early endosome [GO:0005769]	cell projection [GO:0042995]; early endosome [GO:0005769]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; negative regulation of fat cell differentiation [GO:0045599]; regulation of Rho protein signal transduction [GO:0035023]	ATP binding [GO:0005524]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; enzyme binding [GO:0019899]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005089; GO:0005524; GO:0005769; GO:0007411; GO:0007417; GO:0019899; GO:0035023; GO:0042995; GO:0045599
Q1LUA6	TRIO_DANRE	reviewed	Triple functional domain protein (EC 2.7.11.1)	trio si:dkey-158b13.2	Danio rerio (Zebrafish) (Brachydanio rerio)	3028	axon guidance [GO:0007411]; central nervous system development [GO:0007417]; regulation of Rho protein signal transduction [GO:0035023]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; regulation of Rho protein signal transduction [GO:0035023]	ATP binding [GO:0005524]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005089; GO:0005524; GO:0005737; GO:0007411; GO:0007417; GO:0035023
F1M0Z1	TRIO_RAT	reviewed	Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein)	Trio	Rattus norvegicus (Rat)	3100	axon guidance [GO:0007411]; central nervous system development [GO:0007417]; negative regulation of fat cell differentiation [GO:0045599]; regulation of Rho protein signal transduction [GO:0035023]	cell projection [GO:0042995]; cytoplasm [GO:0005737]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; negative regulation of fat cell differentiation [GO:0045599]; regulation of Rho protein signal transduction [GO:0035023]	ATP binding [GO:0005524]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; enzyme binding [GO:0019899]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005089; GO:0005524; GO:0005737; GO:0007411; GO:0007417; GO:0019899; GO:0035023; GO:0042995; GO:0045599
P09628	ACHD_XENLA	reviewed	Acetylcholine receptor subunit delta	chrnd	Xenopus laevis (African clawed frog)	521		cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]	acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0016021; GO:0022848; GO:0030054; GO:0045211
Q6PCJ9	PPT2A_XENLA	reviewed	Lysosomal thioesterase PPT2-A (PPT-2-A) (EC 3.1.2.-)	ppt2-a	Xenopus laevis (African clawed frog)	296		lysosome [GO:0005764]	lysosome [GO:0005764]; palmitoyl-(protein) hydrolase activity [GO:0008474]	palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0005764; GO:0008474
P17644	ACH2_DROME	reviewed	Acetylcholine receptor subunit alpha-like 2 (Nicotinic acetylcholine receptor alpha 2)	nAChRalpha2 Acr96Ab AcrE nAcRalpha-96Ab sad CG6844	Drosophila melanogaster (Fruit fly)	576	cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]	acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]	acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030054; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098655
G5EBQ8	CHS2_CAEEL	reviewed	Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)	chs-2 F48A11.1	Caenorhabditis elegans	1668	chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063]	chitin synthase activity [GO:0004100]	GO:0004100; GO:0005886; GO:0006031; GO:0007275; GO:0016021; GO:0061063
P25067	CO8A2_HUMAN	reviewed	Collagen alpha-2(VIII) chain (Endothelial collagen)	COL8A2	Homo sapiens (Human)	703	angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell-cell adhesion [GO:0098609]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]	basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; protein binding, bridging [GO:0030674]; angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell-cell adhesion [GO:0098609]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]	extracellular matrix structural constituent [GO:0005201]; protein binding, bridging [GO:0030674]	GO:0001525; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0030198; GO:0030674; GO:0031012; GO:0048593; GO:0050673; GO:0062023; GO:0098609
A6TFW3	PHNX_KLEP7	reviewed	Phosphonoacetaldehyde hydrolase (Phosphonatase) (EC 3.11.1.1) (Phosphonoacetaldehyde phosphonohydrolase)	phnX KPN78578_40230 KPN_04064	Klebsiella pneumoniae subsp. pneumoniae (strain ATCC 700721 / MGH 78578)	269	organic phosphonate catabolic process [GO:0019700]		magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]; organic phosphonate catabolic process [GO:0019700]	magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]	GO:0000287; GO:0019700; GO:0050194
Q8BTY2	S4A7_MOUSE	reviewed	Sodium bicarbonate cotransporter 3 (Solute carrier family 4 member 7)	Slc4a7 Nbc3	Mus musculus (Mouse)	1034	auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cochlear nucleus development [GO:0021747]; regulation of intracellular pH [GO:0051453]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal cell programmed cell death [GO:0046666]; visual perception [GO:0007601]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; synapse [GO:0045202]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; synapse [GO:0045202]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cochlear nucleus development [GO:0021747]; regulation of intracellular pH [GO:0051453]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal cell programmed cell death [GO:0046666]; visual perception [GO:0007601]	inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]	GO:0005452; GO:0005737; GO:0005886; GO:0005887; GO:0007601; GO:0008510; GO:0015701; GO:0016323; GO:0016324; GO:0021747; GO:0031410; GO:0032420; GO:0045202; GO:0046666; GO:0051453; GO:0060117; GO:0060219; GO:0061299
Q4LDE5	SVEP1_HUMAN	reviewed	Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)	SVEP1 C9orf13 CCP22 SELOB	Homo sapiens (Human)	3571	cell adhesion [GO:0007155]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]	calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]	GO:0003682; GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020
Q6PB44	PTN23_MOUSE	reviewed	Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48)	Ptpn23 Kiaa1471	Mus musculus (Mouse)	1692	cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]	protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0015031; GO:0016604; GO:0019901; GO:0032456; GO:0036064; GO:0043162; GO:0045022; GO:0060271; GO:0061357; GO:1903387; GO:1903393; GO:2000643
P25784	CYSP3_HOMAM	reviewed	Digestive cysteine proteinase 3 (EC 3.4.22.-)	LCP3	Homarus americanus (American lobster)	321			cysteine-type peptidase activity [GO:0008234]	cysteine-type peptidase activity [GO:0008234]	GO:0008234
A8E624	ENDUC_XENLA	reviewed	Poly(U)-specific endoribonuclease-C (EC 3.1.-.-) (Placental protein 11 homolog) (Protein endoU-C) (Uridylate-specific endoribonuclease-C) (XendoU-C)	endou-c pp11	Xenopus laevis (African clawed frog)	303		extracellular region [GO:0005576]	extracellular region [GO:0005576]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	RNA binding [GO:0003723]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]	GO:0003723; GO:0004521; GO:0005576; GO:0046872
Q9I8S4	AZIN2_XENLA	reviewed	Antizyme inhibitor 2 (AzI2) (Ornithine decarboxylase 2) (ODC 2) (xODC2) (Ornithine decarboxylase-like protein) (ODC-like protein) (ornithine decarboxylase paralog) (ODC-p)	azin2 azi2 odc1-b odc2	Xenopus laevis (African clawed frog)	456	negative regulation of protein catabolic process [GO:0042177]; polyamine biosynthetic process [GO:0006596]; positive regulation of catalytic activity [GO:0043085]; positive regulation of polyamine transmembrane transport [GO:1902269]; putrescine transport [GO:0015847]; trans-Golgi network membrane organization [GO:0098629]	axon [GO:0030424]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; granular vesicle [GO:1990005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]	axon [GO:0030424]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; granular vesicle [GO:1990005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; catalytic activity [GO:0003824]; ornithine decarboxylase activator activity [GO:0042978]; putrescine transmembrane transporter activity [GO:0015489]; negative regulation of protein catabolic process [GO:0042177]; polyamine biosynthetic process [GO:0006596]; positive regulation of catalytic activity [GO:0043085]; positive regulation of polyamine transmembrane transport [GO:1902269]; putrescine transport [GO:0015847]; trans-Golgi network membrane organization [GO:0098629]	catalytic activity [GO:0003824]; ornithine decarboxylase activator activity [GO:0042978]; putrescine transmembrane transporter activity [GO:0015489]	GO:0003824; GO:0005634; GO:0005737; GO:0005801; GO:0005802; GO:0006596; GO:0015489; GO:0015847; GO:0030133; GO:0030424; GO:0030425; GO:0031410; GO:0033116; GO:0042177; GO:0042978; GO:0043085; GO:0043204; GO:0048471; GO:0098629; GO:1902269; GO:1990005
Q92615	LAR4B_HUMAN	reviewed	La-related protein 4B (La ribonucleoprotein domain family member 4B) (La ribonucleoprotein domain family member 5) (La-related protein 5)	LARP4B KIAA0217 LARP5	Homo sapiens (Human)	738	positive regulation of translation [GO:0045727]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; positive regulation of translation [GO:0045727]	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0005829; GO:0010494; GO:0016020; GO:0042788; GO:0045727
Q86XZ4	SPAS2_HUMAN	reviewed	Spermatogenesis-associated serine-rich protein 2 (Serine-rich spermatocytes and round spermatid 59 kDa protein) (p59scr)	SPATS2 SCR59 SPATA10 Nbla00526	Homo sapiens (Human)	545		cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005829
Q8BVD5	MPP7_MOUSE	reviewed	MAGUK p55 subfamily member 7	Mpp7	Mus musculus (Mouse)	576	bicellular tight junction assembly [GO:0070830]; positive regulation of protein complex assembly [GO:0031334]; protein localization to adherens junction [GO:0071896]	MPP7-DLG1-LIN7 complex [GO:0097025]; adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; nucleoplasm [GO:0005654]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; MPP7-DLG1-LIN7 complex [GO:0097025]; nucleoplasm [GO:0005654]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; bicellular tight junction assembly [GO:0070830]; positive regulation of protein complex assembly [GO:0031334]; protein localization to adherens junction [GO:0071896]	molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]	GO:0005654; GO:0005912; GO:0005923; GO:0019904; GO:0030054; GO:0031334; GO:0046982; GO:0060090; GO:0070830; GO:0071896; GO:0097025
P35546	RET_MOUSE	reviewed	Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]	Ret	Mus musculus (Mouse)	1115	MAPK cascade [GO:0000165]; Peyer's patch morphogenesis [GO:0061146]; activation of MAPK activity [GO:0000187]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neurogenesis [GO:0022008]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to drug [GO:0042493]; response to pain [GO:0048265]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of MAPK activity [GO:0000187]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neurogenesis [GO:0022008]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to drug [GO:0042493]; response to pain [GO:0048265]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0000165; GO:0000187; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005829; GO:0005886; GO:0005887; GO:0006919; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0022008; GO:0030154; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042493; GO:0042551; GO:0043025; GO:0043231; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:2001241
Q90271	RARAA_DANRE	reviewed	Retinoic acid receptor alpha-A (RAR-alpha-A) (Nuclear receptor subfamily 1 group B member 1-A) (Retinoic acid receptor alpha) (zRAR alpha) (Retinoic acid receptor alpha-2.A) (RAR-alpha-2.A)	raraa nr1b1a rara2a zgc:109797	Danio rerio (Zebrafish) (Brachydanio rerio)	444	bone morphogenesis [GO:0060349]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; epithelium development [GO:0060429]; gland development [GO:0048732]; hindbrain morphogenesis [GO:0021575]; hormone-mediated signaling pathway [GO:0009755]; liver development [GO:0001889]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to lipid [GO:0033993]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]	RNA polymerase II transcription factor complex [GO:0090575]; nucleus [GO:0005634]	nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; bone morphogenesis [GO:0060349]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; epithelium development [GO:0060429]; gland development [GO:0048732]; hindbrain morphogenesis [GO:0021575]; hormone-mediated signaling pathway [GO:0009755]; liver development [GO:0001889]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to lipid [GO:0033993]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]	DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000976; GO:0000977; GO:0000981; GO:0001889; GO:0003707; GO:0004879; GO:0005634; GO:0007275; GO:0008134; GO:0008270; GO:0009755; GO:0021575; GO:0030154; GO:0030374; GO:0032526; GO:0033993; GO:0038023; GO:0045944; GO:0048384; GO:0048732; GO:0060349; GO:0060429; GO:0071300; GO:0090575
Q7M456	RNOY_CRAGI	reviewed	Ribonuclease Oy (RNase Oy) (EC 3.1.27.-)		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	213		extracellular region [GO:0005576]	extracellular region [GO:0005576]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723]	RNA binding [GO:0003723]; ribonuclease T2 activity [GO:0033897]	GO:0003723; GO:0005576; GO:0033897
P09543	CN37_HUMAN	reviewed	2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37)	CNP	Homo sapiens (Human)	421	adult locomotory behavior [GO:0008344]; aging [GO:0007568]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cyclic nucleotide catabolic process [GO:0009214]; forebrain development [GO:0030900]; microtubule cytoskeleton organization [GO:0000226]; oligodendrocyte differentiation [GO:0048709]; regulation of mitochondrial membrane permeability [GO:0046902]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]; substantia nigra development [GO:0021762]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule [GO:0005874]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; myelin sheath abaxonal region [GO:0035748]; myelin sheath adaxonal region [GO:0035749]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule [GO:0005874]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; myelin sheath abaxonal region [GO:0035748]; myelin sheath adaxonal region [GO:0035749]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; cyclic nucleotide binding [GO:0030551]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; aging [GO:0007568]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cyclic nucleotide catabolic process [GO:0009214]; forebrain development [GO:0030900]; microtubule cytoskeleton organization [GO:0000226]; oligodendrocyte differentiation [GO:0048709]; regulation of mitochondrial membrane permeability [GO:0046902]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]; substantia nigra development [GO:0021762]	2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; RNA binding [GO:0003723]; cyclic nucleotide binding [GO:0030551]	GO:0000226; GO:0003723; GO:0004113; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005743; GO:0005829; GO:0005874; GO:0005886; GO:0005902; GO:0007268; GO:0007409; GO:0007568; GO:0008344; GO:0009214; GO:0009636; GO:0016020; GO:0021762; GO:0030551; GO:0030900; GO:0031143; GO:0032496; GO:0035748; GO:0035749; GO:0042470; GO:0046902; GO:0048471; GO:0048709; GO:0070062
Q2S2F5	KYNB_SALRD	reviewed	Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF)	kynB SRU_1503	Salinibacter ruber (strain DSM 13855 / M31)	212	anthranilate metabolic process [GO:0043420]; tryptophan catabolic process to kynurenine [GO:0019441]		arylformamidase activity [GO:0004061]; formamidase activity [GO:0004328]; zinc ion binding [GO:0008270]; anthranilate metabolic process [GO:0043420]; tryptophan catabolic process to kynurenine [GO:0019441]	arylformamidase activity [GO:0004061]; formamidase activity [GO:0004328]; zinc ion binding [GO:0008270]	GO:0004061; GO:0004328; GO:0008270; GO:0019441; GO:0043420
Q53R41	FAKD1_HUMAN	reviewed	FAST kinase domain-containing protein 1, mitochondrial	FASTKD1 KIAA1800	Homo sapiens (Human)	847	cellular respiration [GO:0045333]; mitochondrial RNA metabolic process [GO:0000959]; regulation of mitochondrial mRNA stability [GO:0044528]	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; cellular respiration [GO:0045333]; mitochondrial RNA metabolic process [GO:0000959]; regulation of mitochondrial mRNA stability [GO:0044528]	RNA binding [GO:0003723]; protein kinase activity [GO:0004672]	GO:0000959; GO:0003723; GO:0004672; GO:0005739; GO:0044528; GO:0045333
Q15825	ACHA6_HUMAN	reviewed	Neuronal acetylcholine receptor subunit alpha-6	CHRNA6	Homo sapiens (Human)	494	chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]	acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]	acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]	acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]	GO:0005886; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0014059; GO:0015464; GO:0022848; GO:0030054; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0051899; GO:0098691; GO:0099055; GO:0099056; GO:2000300
P56962	STX17_HUMAN	reviewed	Syntaxin-17	STX17	Homo sapiens (Human)	302	Golgi organization [GO:0007030]; autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; intracellular protein transport [GO:0006886]; protein localization to phagophore assembly site [GO:0034497]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; ER to Golgi transport vesicle membrane [GO:0012507]; SNARE complex [GO:0031201]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; smooth endoplasmic reticulum membrane [GO:0030868]	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; smooth endoplasmic reticulum membrane [GO:0030868]; SNARE complex [GO:0031201]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein localization to phagophore assembly site [GO:0034497]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]	GO:0000149; GO:0000421; GO:0005484; GO:0005739; GO:0005776; GO:0005789; GO:0005793; GO:0005829; GO:0006886; GO:0006888; GO:0006906; GO:0007030; GO:0012505; GO:0012507; GO:0016021; GO:0016240; GO:0019901; GO:0019903; GO:0030134; GO:0030868; GO:0031201; GO:0033116; GO:0034497; GO:0044233; GO:0048278; GO:0097111; GO:0097352
A7Y2W8	SC6A9_XENLA	reviewed	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9)	slc6a9 glyt1	Xenopus laevis (African clawed frog)	633		integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]	amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]	GO:0005283; GO:0005328; GO:0005887
Q8CDU5	EFHB_MOUSE	reviewed	EF-hand domain-containing family member B	Efhb	Mus musculus (Mouse)	853	negative regulation of protein binding [GO:0032091]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of store-operated calcium entry [GO:2001256]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; calcium ion sensor activity [GO:0061891]; negative regulation of protein binding [GO:0032091]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of store-operated calcium entry [GO:2001256]	calcium ion sensor activity [GO:0061891]	GO:0005737; GO:0032091; GO:0061891; GO:0070884; GO:2001256
Q2KHU5	MACD1_BOVIN	reviewed	ADP-ribose glycohydrolase MACROD1 (MACRO domain-containing protein 1) (O-acetyl-ADP-ribose deacetylase MACROD1) (EC 3.5.1.-) (Protein LRP16) ([Protein ADP-ribosylaspartate] hydrolase MACROD1) (EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD1) (EC 3.2.2.-)	MACROD1 LRP16	Bos taurus (Bovine)	325	cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]	nucleus [GO:0005634]	nucleus [GO:0005634]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]	ADP-ribosylglutamate hydrolase activity [GO:0140293]; hydrolase activity, acting on glycosyl bonds [GO:0016798]	GO:0005634; GO:0006974; GO:0016798; GO:0051725; GO:0140291; GO:0140293
Q91Z53	GRHPR_MOUSE	reviewed	Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81)	Grhpr Glxr	Mus musculus (Mouse)	328	dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259]	NAD binding [GO:0051287]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]	GO:0005737; GO:0005829; GO:0007588; GO:0008465; GO:0016616; GO:0016618; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0050661; GO:0051259; GO:0051287; GO:0055114; GO:0070402
Q8BVT6	PP2D1_MOUSE	reviewed	Protein phosphatase 2C-like domain-containing protein 1	Pp2d1	Mus musculus (Mouse)	620		cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; MAP kinase serine/threonine phosphatase activity [GO:1990439]; protein serine/threonine phosphatase activity [GO:0004722]	MAP kinase serine/threonine phosphatase activity [GO:1990439]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0004724; GO:0005634; GO:0005829; GO:1990439
Q7ZU45	TTC25_DANRE	reviewed	Tetratricopeptide repeat protein 25 (TPR repeat protein 25)	ttc25	Danio rerio (Zebrafish) (Brachydanio rerio)	486	cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]		GO:0005737; GO:0005856; GO:0032474; GO:0042995; GO:0060271; GO:0061371
Q32NU8	TTC25_XENLA	reviewed	Tetratricopeptide repeat protein 25 (TPR repeat protein 25)	ttc25	Xenopus laevis (African clawed frog)	531		cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		GO:0005737; GO:0005856; GO:0042995
Q5R7L7	RAB5C_PONAB	reviewed	Ras-related protein Rab-5C	RAB5C	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	216	plasma membrane to endosome transport [GO:0048227]; protein transport [GO:0015031]	early endosome membrane [GO:0031901]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]	early endosome membrane [GO:0031901]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; plasma membrane to endosome transport [GO:0048227]; protein transport [GO:0015031]	GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005525; GO:0005811; GO:0005886; GO:0015031; GO:0019003; GO:0031901; GO:0048227
Q6UW60	PCSK4_HUMAN	reviewed	Proprotein convertase subtilisin/kexin type 4 (EC 3.4.21.-) (Proprotein convertase 4) (PC4)	PCSK4 PC4 UNQ2757/PRO6496	Homo sapiens (Human)	755	acrosome reaction [GO:0007340]; binding of sperm to zona pellucida [GO:0007339]; fertilization [GO:0009566]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; reproductive process [GO:0022414]; sperm capacitation [GO:0048240]	acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]	acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; acrosome reaction [GO:0007340]; binding of sperm to zona pellucida [GO:0007339]; fertilization [GO:0009566]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; reproductive process [GO:0022414]; sperm capacitation [GO:0048240]	serine-type endopeptidase activity [GO:0004252]	GO:0001669; GO:0002080; GO:0004252; GO:0005802; GO:0007339; GO:0007340; GO:0009566; GO:0016020; GO:0016485; GO:0016486; GO:0022414; GO:0030173; GO:0048240
Q13367	AP3B2_HUMAN	reviewed	AP-3 complex subunit beta-2 (Adaptor protein complex AP-3 subunit beta-2) (Adaptor-related protein complex 3 subunit beta-2) (Beta-3B-adaptin) (Clathrin assembly protein complex 3 beta-2 large chain) (Neuron-specific vesicle coat protein beta-NAP)	AP3B2	Homo sapiens (Human)	1082	anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	AP-3 adaptor complex [GO:0030123]; Golgi apparatus [GO:0005794]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; intracellular vesicle [GO:0097708]	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]		GO:0005794; GO:0006886; GO:0008089; GO:0016192; GO:0030123; GO:0030665; GO:0048490; GO:0097708; GO:1904115
C3YEM5	EFTS_BRAFL	reviewed	Elongation factor Ts, mitochondrial (EF-Ts) (EF-TsMt)	BRAFLDRAFT_84221	Branchiostoma floridae (Florida lancelet) (Amphioxus)	331	mitochondrial translational elongation [GO:0070125]	mitochondrial matrix [GO:0005759]	mitochondrial matrix [GO:0005759]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]	translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005759; GO:0070125
Q6P338	CX056_XENTR	reviewed	UPF0428 protein CXorf56 homolog	TNeu084h20.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	222		cell body [GO:0044297]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	cell body [GO:0044297]; cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0044297
Q99741	CDC6_HUMAN	reviewed	Cell division control protein 6 homolog (CDC6-related protein) (Cdc18-related protein) (HsCdc18) (p62(cdc6)) (HsCDC6)	CDC6 CDC18L	Homo sapiens (Human)	560	DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; cell division [GO:0051301]; cellular response to angiotensin [GO:1904385]; cellular response to vasopressin [GO:1904117]; mitotic DNA replication checkpoint [GO:0033314]; mitotic cell cycle [GO:0000278]; negative regulation of DNA replication [GO:0008156]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; traversing start control point of mitotic cell cycle [GO:0007089]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; kinase binding [GO:0019900]; nucleotide binding [GO:0000166]; cell division [GO:0051301]; cellular response to angiotensin [GO:1904385]; cellular response to vasopressin [GO:1904117]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic cell cycle [GO:0000278]; mitotic DNA replication checkpoint [GO:0033314]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; traversing start control point of mitotic cell cycle [GO:0007089]	ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; kinase binding [GO:0019900]; nucleotide binding [GO:0000166]	GO:0000076; GO:0000079; GO:0000082; GO:0000083; GO:0000166; GO:0000278; GO:0000922; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006270; GO:0007089; GO:0008156; GO:0008285; GO:0019900; GO:0030071; GO:0032467; GO:0033314; GO:0045737; GO:0048146; GO:0051233; GO:0051301; GO:0051984; GO:1904117; GO:1904385
Q8C5N3	CWC22_MOUSE	reviewed	Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog)	Cwc22 Ncm	Mus musculus (Mouse)	908	mRNA splicing, via spliceosome [GO:0000398]	U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0005829; GO:0016607; GO:0071005; GO:0071006; GO:0071007; GO:0071013
Q8CJ69	BMPER_MOUSE	reviewed	BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (mCV2)	Bmper Cv2	Mus musculus (Mouse)	685	blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of endothelial cell migration [GO:0010594]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; ureteric bud development [GO:0001657]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of endothelial cell migration [GO:0010594]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; ureteric bud development [GO:0001657]		GO:0001657; GO:0002043; GO:0005576; GO:0005615; GO:0010594; GO:0030514; GO:0042118; GO:0048839; GO:0060393; GO:0062023; GO:0070374; GO:1903672
Q811G0	PTHB1_MOUSE	reviewed	Protein PTHB1 (Bardet-Biedl syndrome 9 protein homolog) (Parathyroid hormone-responsive B1 gene protein homolog)	Bbs9 Pthb1	Mus musculus (Mouse)	885	cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]	BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; membrane [GO:0016020]; pericentriolar material [GO:0000242]	BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; membrane [GO:0016020]; pericentriolar material [GO:0000242]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]		GO:0000242; GO:0005929; GO:0015031; GO:0016020; GO:0034451; GO:0034464; GO:0035869; GO:0036064; GO:0045444; GO:0060170; GO:0060271; GO:0061512
Q6AXQ5	PDE12_RAT	reviewed	2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4)	Pde12	Rattus norvegicus (Rat)	608	mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]	GO:0000175; GO:0000288; GO:0004535; GO:0005739; GO:0005759; GO:0006397; GO:0046872
Q12852	M3K12_HUMAN	reviewed	Mitogen-activated protein kinase kinase kinase 12 (EC 2.7.11.25) (Dual leucine zipper bearing kinase) (DLK) (Leucine-zipper protein kinase) (ZPK) (MAPK-upstream kinase) (MUK) (Mixed lineage kinase)	MAP3K12 ZPK	Homo sapiens (Human)	859	JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; activation of JNKK activity [GO:0007256]; activation of JUN kinase activity [GO:0007257]; histone phosphorylation [GO:0016572]; intracellular signal transduction [GO:0035556]; negative regulation of motor neuron apoptotic process [GO:2000672]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of JNKK activity [GO:0007256]; activation of JUN kinase activity [GO:0007257]; histone phosphorylation [GO:0016572]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of motor neuron apoptotic process [GO:2000672]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]	GO:0000165; GO:0004672; GO:0004674; GO:0004706; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007254; GO:0007256; GO:0007257; GO:0016020; GO:0016572; GO:0018105; GO:0018107; GO:0019901; GO:0030426; GO:0035556; GO:0042803; GO:0045893; GO:0046777; GO:0070374; GO:2000672
Q8C0R9	LRRD1_MOUSE	reviewed	Leucine-rich repeat and death domain-containing protein 1	Lrrd1	Mus musculus (Mouse)	853		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737
A2RSX7	TYW5_MOUSE	reviewed	tRNA wybutosine-synthesizing protein 5 (EC 1.14.11.42) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase)	Tyw5	Mus musculus (Mouse)	315	wybutosine biosynthetic process [GO:0031591]		2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524]; wybutosine biosynthetic process [GO:0031591]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524]	GO:0000049; GO:0005506; GO:0016706; GO:0031591; GO:0042803; GO:0102524
O75165	DJC13_HUMAN	reviewed	DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)	DNAJC13 KIAA0678 RME8	Homo sapiens (Human)	2243	endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]		GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0043312; GO:0070062; GO:1902954; GO:2000641
Q7ZWU9	DBR1B_XENLA	reviewed	Lariat debranching enzyme B (EC 3.1.-.-)	dbr1-b	Xenopus laevis (African clawed frog)	533	RNA splicing, via transesterification reactions [GO:0000375]; mRNA processing [GO:0006397]	nucleus [GO:0005634]	nucleus [GO:0005634]; RNA lariat debranching enzyme activity [GO:0008419]; mRNA processing [GO:0006397]; RNA splicing, via transesterification reactions [GO:0000375]	RNA lariat debranching enzyme activity [GO:0008419]	GO:0000375; GO:0005634; GO:0006397; GO:0008419
Q6DD06	ZC3HF_XENLA	reviewed	Zinc finger CCCH domain-containing protein 15 (DRG family-regulatory protein 1)	zc3h15 dfrp1	Xenopus laevis (African clawed frog)	426		cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0005634; GO:0005737; GO:0046872
A0JM23	NPHP3_XENTR	reviewed	Nephrocystin-3	nphp3	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1311	Wnt signaling pathway [GO:0016055]; cilium assembly [GO:0060271]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]	cilium [GO:0005929]	cilium [GO:0005929]; cilium assembly [GO:0060271]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]		GO:0005929; GO:0016055; GO:0060271; GO:0090090; GO:2000095
P18519	TNR16_CHICK	reviewed	Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (p75 ICD)	NGFR TNFRSF16	Gallus gallus (Chicken)	416	Rho protein signal transduction [GO:0007266]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; circadian regulation of gene expression [GO:0032922]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein localization to nucleus [GO:1900182]	cell surface [GO:0009986]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; coreceptor activity [GO:0015026]; death receptor activity [GO:0005035]; nerve growth factor binding [GO:0048406]; neurotrophin binding [GO:0043121]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; circadian regulation of gene expression [GO:0032922]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein localization to nucleus [GO:1900182]; Rho protein signal transduction [GO:0007266]	calmodulin binding [GO:0005516]; coreceptor activity [GO:0015026]; death receptor activity [GO:0005035]; nerve growth factor binding [GO:0048406]; neurotrophin binding [GO:0043121]; ubiquitin protein ligase binding [GO:0031625]	GO:0005035; GO:0005516; GO:0005886; GO:0006919; GO:0007266; GO:0007399; GO:0009986; GO:0015026; GO:0016021; GO:0030154; GO:0030426; GO:0031625; GO:0032922; GO:0043121; GO:0043197; GO:0043204; GO:0048406; GO:0051402; GO:1900182; GO:1902895; GO:1903588; GO:1904646
Q6AZT7	NPHP3_XENLA	reviewed	Nephrocystin-3	nphp3	Xenopus laevis (African clawed frog)	1300	Wnt signaling pathway [GO:0016055]; cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]	cilium [GO:0005929]	cilium [GO:0005929]; cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]		GO:0005929; GO:0016055; GO:0060027; GO:0060271; GO:0090090; GO:2000095
Q9R0W9	ACHA6_MOUSE	reviewed	Neuronal acetylcholine receptor subunit alpha-6	Chrna6 Nica6	Mus musculus (Mouse)	494	chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of dopamine secretion [GO:0033603]; protein heterooligomerization [GO:0051291]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]	acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]	acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of dopamine secretion [GO:0033603]; protein heterooligomerization [GO:0051291]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]	acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0014059; GO:0016020; GO:0022848; GO:0030054; GO:0033603; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0051291; GO:0051899; GO:0098691; GO:0099055; GO:0099056; GO:2000300
Q8N608	DPP10_HUMAN	reviewed	Inactive dipeptidyl peptidase 10 (Dipeptidyl peptidase IV-related protein 3) (DPRP-3) (Dipeptidyl peptidase X) (DPP X) (Dipeptidyl peptidase-like protein 2) (DPL2)	DPP10 DPRP3 KIAA1492	Homo sapiens (Human)	796	positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]	membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]	ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]	GO:0005886; GO:0008076; GO:0008236; GO:0015459; GO:0016020; GO:0044325; GO:0072659; GO:1901379; GO:1903078
P00185	CP1A1_RAT	reviewed	Cytochrome P450 1A1 (CYP1A1) (EC 1.14.14.-) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Cytochrome P450MT2) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) [Cleaved into: Cytochrome P450MT2A; Cytochrome P450MT2B]	Cyp1a1 Cyp1a-1	Rattus norvegicus (Rat)	524	9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; developmental process [GO:0032502]; dibenzo-p-dioxin catabolic process [GO:0019341]; dibenzo-p-dioxin metabolic process [GO:0018894]; digestive tract development [GO:0048565]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; liver development [GO:0001889]; maternal process involved in parturition [GO:0060137]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; arachidonic acid monooxygenase activity [GO:0008391]; catalytic activity [GO:0003824]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; vitamin D 24-hydroxylase activity [GO:0070576]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; developmental process [GO:0032502]; dibenzo-p-dioxin catabolic process [GO:0019341]; dibenzo-p-dioxin metabolic process [GO:0018894]; digestive tract development [GO:0048565]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; liver development [GO:0001889]; maternal process involved in parturition [GO:0060137]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]	Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; arachidonic acid monooxygenase activity [GO:0008391]; catalytic activity [GO:0003824]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; vitamin D 24-hydroxylase activity [GO:0070576]	GO:0001666; GO:0001889; GO:0002933; GO:0003824; GO:0004497; GO:0005506; GO:0005737; GO:0005739; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0006778; GO:0007568; GO:0008210; GO:0008283; GO:0008391; GO:0008395; GO:0009308; GO:0009611; GO:0009615; GO:0009624; GO:0009635; GO:0009804; GO:0009812; GO:0010033; GO:0010041; GO:0014070; GO:0016491; GO:0016679; GO:0016711; GO:0016712; GO:0016829; GO:0017143; GO:0018894; GO:0019341; GO:0019899; GO:0020037; GO:0030544; GO:0032094; GO:0032451; GO:0032496; GO:0032502; GO:0033189; GO:0035902; GO:0042493; GO:0042572; GO:0042904; GO:0043010; GO:0043231; GO:0046677; GO:0046685; GO:0048565; GO:0050665; GO:0051879; GO:0055093; GO:0060137; GO:0070365; GO:0070576; GO:0071280; GO:0071407; GO:0101020; GO:0101021; GO:1900087
P98157	LRP1_CHICK	reviewed	Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR)	LRP1	Gallus gallus (Chicken)	4543		clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	alpha-2 macroglobulin receptor activity [GO:0016964]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005905; GO:0016021; GO:0016964
Q91ZX7	LRP1_MOUSE	reviewed	Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)]	Lrp1 A2mr	Mus musculus (Mouse)	4545	amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; lysosomal transport [GO:0007041]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; phagocytosis [GO:0006909]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of phospholipase A2 activity [GO:0032429]	apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]	apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of phospholipase A2 activity [GO:0032429]	alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]	GO:0002020; GO:0002265; GO:0003279; GO:0005509; GO:0005634; GO:0005768; GO:0005769; GO:0005887; GO:0005905; GO:0006898; GO:0006909; GO:0007041; GO:0007204; GO:0007205; GO:0008203; GO:0008283; GO:0010812; GO:0010875; GO:0010942; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0030136; GO:0030178; GO:0030425; GO:0032050; GO:0032092; GO:0032370; GO:0032374; GO:0032429; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044242; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048471; GO:0048691; GO:0048694; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060548; GO:0060976; GO:0061642; GO:0070374; GO:0097242; GO:0150093; GO:0150094; GO:1900149; GO:1903078; GO:1904109; GO:1904209; GO:1904646; GO:1904754; GO:1905167; GO:2000587
Q6ZQQ6	WDR87_HUMAN	reviewed	WD repeat-containing protein 87 (Testis development protein NYD-SP11)	WDR87	Homo sapiens (Human)	2873					
Q16600	ZN239_HUMAN	reviewed	Zinc finger protein 239 (Zinc finger protein HOK-2) (Zinc finger protein MOK-2)	ZNF239 HOK2 MOK2	Homo sapiens (Human)	458	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; metal ion binding [GO:0046872]	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003723; GO:0005634; GO:0006357; GO:0046872
Q29261	VILI_PIG	reviewed	Villin-1	VIL1 VIL	Sus scrofa (Pig)	827	actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]	actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]	actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]	GO:0001726; GO:0005509; GO:0005546; GO:0005737; GO:0005902; GO:0007173; GO:0008360; GO:0009617; GO:0010634; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0032233; GO:0032432; GO:0032433; GO:0035727; GO:0035729; GO:0042803; GO:0043027; GO:0045010; GO:0051014; GO:0051015; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0071364; GO:2000392
P97411	ICA69_MOUSE	reviewed	Islet cell autoantigen 1 (69 kDa islet cell autoantigen) (ICA69) (Islet cell autoantigen p69) (ICAp69) (p69)	Ica1 Icap69	Mus musculus (Mouse)	478	neurotransmitter transport [GO:0006836]; regulation of insulin secretion [GO:0050796]; regulation of neurotransmitter secretion [GO:0046928]; regulation of protein homodimerization activity [GO:0043496]	Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]	cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; protein domain specific binding [GO:0019904]; neurotransmitter transport [GO:0006836]; regulation of insulin secretion [GO:0050796]; regulation of neurotransmitter secretion [GO:0046928]; regulation of protein homodimerization activity [GO:0043496]	protein domain specific binding [GO:0019904]	GO:0000139; GO:0005795; GO:0005829; GO:0006836; GO:0019904; GO:0030054; GO:0030425; GO:0030667; GO:0030672; GO:0043231; GO:0043496; GO:0046928; GO:0048471; GO:0050796
Q64127	TIF1A_MOUSE	reviewed	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase Trim24) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	Trim24 Tif1 Tif1a	Mus musculus (Mouse)	1051	calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]	cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]	cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]	chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005737; GO:0006468; GO:0008270; GO:0008285; GO:0010628; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0043565; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796
P51397	DAP1_HUMAN	reviewed	Death-associated protein 1 (DAP-1)	DAP DAP1	Homo sapiens (Human)	102	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of autophagy [GO:0010507]; negative regulation of transcription, DNA-templated [GO:0045892]		death domain binding [GO:0070513]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; negative regulation of autophagy [GO:0010507]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]	death domain binding [GO:0070513]	GO:0006914; GO:0006915; GO:0006919; GO:0010507; GO:0032088; GO:0034198; GO:0045892; GO:0070513; GO:0097190
P61801	APTX_XENTR	reviewed	Aprataxin (EC 3.1.11.7) (EC 3.1.12.2) (Forkhead-associated domain histidine triad-like protein) (FHA-HIT)	aptx TEgg082k23.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	347	double-strand break repair [GO:0006302]; single strand break repair [GO:0000012]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA 5'-adenosine monophosphate hydrolase activity [GO:0033699]; DNA-3'-diphospho-5'-guanosine diphosphatase [GO:0120108]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mismatched DNA binding [GO:0030983]; single-strand break-containing DNA binding [GO:1990165]; single-stranded DNA binding [GO:0003697]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012]	DNA 5'-adenosine monophosphate hydrolase activity [GO:0033699]; DNA-3'-diphospho-5'-guanosine diphosphatase [GO:0120108]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mismatched DNA binding [GO:0030983]; single-strand break-containing DNA binding [GO:1990165]; single-stranded DNA binding [GO:0003697]	GO:0000012; GO:0003697; GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0006302; GO:0030983; GO:0033699; GO:0046872; GO:0120108; GO:1990165
Q6NXM2	RCBT1_MOUSE	reviewed	RCC1 and BTB domain-containing protein 1 (Regulator of chromosome condensation and BTB domain-containing protein 1)	Rcbtb1	Mus musculus (Mouse)	531	cell cycle [GO:0007049]; chromatin organization [GO:0006325]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]		GO:0005634; GO:0005737; GO:0006325; GO:0007049
Q5DRB3	PCDG7_PANTR	reviewed	Protocadherin gamma-A7 (PCDH-gamma-A7)	PCDHGA7	Pan troglodytes (Chimpanzee)	932	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156
P97353	SEC1_MOUSE	reviewed	Galactoside 2-alpha-L-fucosyltransferase 3 (EC 2.4.1.69) (Alpha(1,2)FT 3) (Fucosyltransferase 10) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 3) (Secretory blood group protein 1)	Sec1 Fut10	Mus musculus (Mouse)	368	carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486]	fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]	GO:0005975; GO:0006486; GO:0008107; GO:0008417; GO:0016021; GO:0032580; GO:0036065
Q9CW42	MARC1_MOUSE	reviewed	Mitochondrial amidoxime-reducing component 1 (mARC1) (EC 1.-.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 1) (MOSC domain-containing protein 1) (Moco sulfurase C-terminal domain-containing protein 1)	Marc1 Mosc1	Mus musculus (Mouse)	340	nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]; nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]	molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]	GO:0005739; GO:0005741; GO:0005743; GO:0008940; GO:0016021; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0055114
P20664	PRI1_MOUSE	reviewed	DNA primase small subunit (EC 2.7.7.-) (DNA primase 49 kDa subunit) (p49)	Prim1	Mus musculus (Mouse)	417	DNA replication, synthesis of RNA primer [GO:0006269]	alpha DNA polymerase:primase complex [GO:0005658]	alpha DNA polymerase:primase complex [GO:0005658]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; DNA replication, synthesis of RNA primer [GO:0006269]	DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0003896; GO:0005658; GO:0006269; GO:0046872
Q95Q62	IP3KH_CAEEL	reviewed	Inositol-trisphosphate 3-kinase homolog (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase homolog) (IP3 3-kinase) (IP3K) (InsP 3-kinase) (let-23 fertility effector 2)	lfe-2 C46H11.4	Caenorhabditis elegans	494	hermaphrodite genitalia morphogenesis [GO:0048815]; inositol phosphate biosynthetic process [GO:0032958]		ATP binding [GO:0005524]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; hermaphrodite genitalia morphogenesis [GO:0048815]; inositol phosphate biosynthetic process [GO:0032958]	ATP binding [GO:0005524]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]	GO:0005524; GO:0008440; GO:0032958; GO:0048815
O75581	LRP6_HUMAN	reviewed	Low-density lipoprotein receptor-related protein 6 (LRP-6)	LRP6	Homo sapiens (Human)	1613	Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]	Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]	caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]	Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]	GO:0001702; GO:0001843; GO:0001933; GO:0003344; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0005901; GO:0006469; GO:0007204; GO:0007268; GO:0009880; GO:0009952; GO:0009986; GO:0014029; GO:0014033; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021987; GO:0030326; GO:0030901; GO:0030917; GO:0031410; GO:0031901; GO:0034185; GO:0034392; GO:0035261; GO:0042475; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0051091; GO:0060021; GO:0060026; GO:0060059; GO:0060070; GO:0060325; GO:0060349; GO:0060444; GO:0060535; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090009; GO:0090090; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:1904886; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909
Q9VAC5	ADA17_DROME	reviewed	ADAM 17-like protease (EC 3.4.24.-)	Tace CG7908	Drosophila melanogaster (Fruit fly)	732	Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; membrane protein ectodomain proteolysis [GO:0006509]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0006509; GO:0007219; GO:0007220; GO:0016021; GO:0046872
Q95YJ5	TXND3_CIOIN	reviewed	Thioredoxin domain-containing protein 3 homolog (Dynein intermediate chain 3)	CiIC3	Ciona intestinalis (Transparent sea squirt) (Ascidia intestinalis)	653	CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]	cell [GO:0005623]	cell [GO:0005623]; nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]	nucleoside diphosphate kinase activity [GO:0004550]	GO:0004550; GO:0005623; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454
Q8N3P4	VPS8_HUMAN	reviewed	Vacuolar protein sorting-associated protein 8 homolog	VPS8 KIAA0804	Homo sapiens (Human)	1428	endosomal vesicle fusion [GO:0034058]; protein transport [GO:0015031]	CORVET complex [GO:0033263]; early endosome [GO:0005769]	CORVET complex [GO:0033263]; early endosome [GO:0005769]; metal ion binding [GO:0046872]; endosomal vesicle fusion [GO:0034058]; protein transport [GO:0015031]	metal ion binding [GO:0046872]	GO:0005769; GO:0015031; GO:0033263; GO:0034058; GO:0046872
Q8IUR7	ARMC8_HUMAN	reviewed	Armadillo repeat-containing protein 8	ARMC8 S863-2	Homo sapiens (Human)	673	neutrophil degranulation [GO:0043312]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	GID complex [GO:0034657]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; ubiquitin ligase complex [GO:0000151]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; GID complex [GO:0034657]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; ubiquitin ligase complex [GO:0000151]; neutrophil degranulation [GO:0043312]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]		GO:0000151; GO:0005576; GO:0005634; GO:0005737; GO:0034657; GO:0035580; GO:0043161; GO:0043312; GO:1904724
P13055	E75BB_DROME	reviewed	Ecdysone-induced protein 75B, isoform B (E75-C) (Nuclear receptor subfamily 1 group D member 3, isoform B)	Eip75B NR1D3 CG8127	Drosophila melanogaster (Fruit fly)	1412	antimicrobial humoral response [GO:0019730]; cell differentiation [GO:0030154]; ecdysis, chitin-based cuticle [GO:0018990]; hormone-mediated signaling pathway [GO:0009755]; molting cycle, chitin-based cuticle [GO:0007591]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of ecdysteroid metabolic process [GO:0007553]; regulation of gene expression [GO:0010468]; response to ecdysone [GO:0035075]; response to lipid [GO:0033993]	RNA polymerase II transcription factor complex [GO:0090575]; nucleus [GO:0005634]	nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heme binding [GO:0020037]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; antimicrobial humoral response [GO:0019730]; cell differentiation [GO:0030154]; ecdysis, chitin-based cuticle [GO:0018990]; hormone-mediated signaling pathway [GO:0009755]; molting cycle, chitin-based cuticle [GO:0007591]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of ecdysteroid metabolic process [GO:0007553]; regulation of gene expression [GO:0010468]; response to ecdysone [GO:0035075]; response to lipid [GO:0033993]	DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; heme binding [GO:0020037]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000976; GO:0000977; GO:0000981; GO:0003677; GO:0003707; GO:0004879; GO:0005634; GO:0007275; GO:0007553; GO:0007591; GO:0008134; GO:0008270; GO:0009755; GO:0010468; GO:0018990; GO:0019730; GO:0020037; GO:0030154; GO:0030374; GO:0033993; GO:0035075; GO:0038023; GO:0045944; GO:0048477; GO:0090575
O32210	GR_BACSU	reviewed	Glyoxal reductase (GR) (EC 1.1.1.-) (Methylglyoxal reductase) (EC 1.1.1.283)	yvgN BSU33400	Bacillus subtilis (strain 168)	276			methylglyoxal reductase (NADPH-dependent) activity [GO:0043892]	methylglyoxal reductase (NADPH-dependent) activity [GO:0043892]	GO:0043892
Q9GV41	PGFS_TRYBB	reviewed	9,11-endoperoxide prostaglandin H2 reductase (EC 1.1.1.-) (Prostaglandin F2-alpha synthase)		Trypanosoma brucei brucei	276	D-arabinose catabolic process [GO:0019571]; prostaglandin biosynthetic process [GO:0001516]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; aldo-keto reductase (NADP) activity [GO:0004033]; D-arabinose 1-dehydrogenase [NAD(P)+] activity [GO:0045290]; nucleotide binding [GO:0000166]; D-arabinose catabolic process [GO:0019571]; prostaglandin biosynthetic process [GO:0001516]	D-arabinose 1-dehydrogenase [NAD(P)+] activity [GO:0045290]; aldo-keto reductase (NADP) activity [GO:0004033]; nucleotide binding [GO:0000166]	GO:0000166; GO:0001516; GO:0004033; GO:0005737; GO:0019571; GO:0045290
O14088	YER5_SCHPO	reviewed	Uncharacterized oxidoreductase C2F3.05c (EC 1.-.-.-)	SPAC2F3.05c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	275	D-xylose catabolic process [GO:0042843]; arabinose catabolic process [GO:0019568]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; D-xylose:NADP reductase activity [GO:0032866]; L-arabinose:NADP reductase activity [GO:0032867]; arabinose catabolic process [GO:0019568]; D-xylose catabolic process [GO:0042843]	D-xylose:NADP reductase activity [GO:0032866]; L-arabinose:NADP reductase activity [GO:0032867]	GO:0005634; GO:0005829; GO:0019568; GO:0032866; GO:0032867; GO:0042843
P22411	DPP4_PIG	reviewed	Dipeptidyl peptidase 4 (EC 3.4.14.5) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form)]	DPP4 CD26	Sus scrofa (Pig)	766	T cell costimulation [GO:0031295]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; negative regulation of extracellular matrix disassembly [GO:0010716]; positive regulation of cell population proliferation [GO:0008284]	apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; membrane raft [GO:0045121]	apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; membrane raft [GO:0045121]; dipeptidyl-peptidase activity [GO:0008239]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; negative regulation of extracellular matrix disassembly [GO:0010716]; positive regulation of cell population proliferation [GO:0008284]; T cell costimulation [GO:0031295]	dipeptidyl-peptidase activity [GO:0008239]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]	GO:0002020; GO:0004252; GO:0005102; GO:0005576; GO:0007155; GO:0008239; GO:0008284; GO:0009986; GO:0010716; GO:0016021; GO:0016324; GO:0030027; GO:0030054; GO:0030139; GO:0031258; GO:0031295; GO:0042803; GO:0043542; GO:0045121; GO:0071438
Q9WVB4	SLIT3_MOUSE	reviewed	Slit homolog 3 protein (Slit-3) (Slit3)	Slit3	Mus musculus (Mouse)	1523	Roundabout signaling pathway [GO:0035385]; animal organ morphogenesis [GO:0009887]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; atrioventricular valve morphogenesis [GO:0003181]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to hormone stimulus [GO:0032870]; negative chemotaxis [GO:0050919]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; response to cortisol [GO:0051414]; ventricular septum morphogenesis [GO:0060412]	extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]	extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; atrioventricular valve morphogenesis [GO:0003181]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to hormone stimulus [GO:0032870]; negative chemotaxis [GO:0050919]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; response to cortisol [GO:0051414]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]	Roundabout binding [GO:0048495]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]	GO:0003180; GO:0003181; GO:0005102; GO:0005509; GO:0005615; GO:0005886; GO:0007411; GO:0008201; GO:0008285; GO:0009887; GO:0010629; GO:0016020; GO:0030308; GO:0032870; GO:0035385; GO:0048495; GO:0048846; GO:0050919; GO:0051414; GO:0060412; GO:0061364; GO:0070100
G5EGQ6	TEN1_CAEEL	reviewed	Teneurin-1	ten-1 R13F6.4	Caenorhabditis elegans	2684	axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; basement membrane assembly involved in embryonic body morphogenesis [GO:2001197]; basement membrane organization [GO:0071711]; cell migration [GO:0016477]; defecation [GO:0030421]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; female gonad development [GO:0008585]; gamete generation [GO:0007276]; gonad development [GO:0008406]; inductive cell migration [GO:0040039]; male gonad development [GO:0008584]; motor neuron axon guidance [GO:0008045]; pharynx development [GO:0060465]; post-embryonic animal organ morphogenesis [GO:0048563]; post-embryonic body morphogenesis [GO:0040032]; sexual reproduction [GO:0019953]	integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; basement membrane assembly involved in embryonic body morphogenesis [GO:2001197]; basement membrane organization [GO:0071711]; cell migration [GO:0016477]; defecation [GO:0030421]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; female gonad development [GO:0008585]; gamete generation [GO:0007276]; gonad development [GO:0008406]; inductive cell migration [GO:0040039]; male gonad development [GO:0008584]; motor neuron axon guidance [GO:0008045]; pharynx development [GO:0060465]; post-embryonic animal organ morphogenesis [GO:0048563]; post-embryonic body morphogenesis [GO:0040032]; sexual reproduction [GO:0019953]		GO:0005634; GO:0005886; GO:0007276; GO:0007411; GO:0007413; GO:0008045; GO:0008406; GO:0008584; GO:0008585; GO:0009792; GO:0010172; GO:0016021; GO:0016477; GO:0019953; GO:0030421; GO:0040032; GO:0040039; GO:0048563; GO:0060465; GO:0071711; GO:2001197
Q8K370	ACD10_MOUSE	reviewed	Acyl-CoA dehydrogenase family member 10 (ACAD-10) (EC 1.3.99.-)	Acad10	Mus musculus (Mouse)	1069		mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; hydrolase activity [GO:0016787]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]	flavin adenine dinucleotide binding [GO:0050660]; hydrolase activity [GO:0016787]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]	GO:0005739; GO:0016627; GO:0016787; GO:0050660
Q96C45	ULK4_HUMAN	reviewed	Serine/threonine-protein kinase ULK4 (EC 2.7.11.1) (Unc-51-like kinase 4)	ULK4	Homo sapiens (Human)	1275	microtubule cytoskeleton organization [GO:0000226]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein kinase C signaling [GO:0090036]		ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; microtubule cytoskeleton organization [GO:0000226]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein kinase C signaling [GO:0090036]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0000226; GO:0004674; GO:0005524; GO:0010975; GO:0043408; GO:0046328; GO:0090036; GO:1900744; GO:2001222
Q02880	TOP2B_HUMAN	reviewed	DNA topoisomerase 2-beta (EC 5.6.2.2) (DNA topoisomerase II, beta isozyme)	TOP2B	Homo sapiens (Human)	1626	DNA topological change [GO:0006265]; axonogenesis [GO:0007409]; forebrain development [GO:0030900]; mitotic DNA integrity checkpoint [GO:0044774]; neuron migration [GO:0001764]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; viral integration complex [GO:0019035]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; viral integration complex [GO:0019035]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase C binding [GO:0005080]; axonogenesis [GO:0007409]; DNA topological change [GO:0006265]; forebrain development [GO:0030900]; mitotic DNA integrity checkpoint [GO:0044774]; neuron migration [GO:0001764]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase C binding [GO:0005080]	GO:0000712; GO:0000819; GO:0001764; GO:0003677; GO:0003682; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006265; GO:0007409; GO:0008022; GO:0019035; GO:0019899; GO:0030900; GO:0042826; GO:0044774; GO:0045870; GO:0046872; GO:0046982; GO:1990904
Q8BV66	IFI44_MOUSE	reviewed	Interferon-induced protein 44 (Microtubule-associated protein 44)	Ifi44 Mtap44	Mus musculus (Mouse)	422	immune response [GO:0006955]; response to bacterium [GO:0009617]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]		GO:0005737; GO:0006955; GO:0009617
Q86TI4	WDR86_HUMAN	reviewed	WD repeat-containing protein 86	WDR86	Homo sapiens (Human)	376					
Q9UN73	PCDA6_HUMAN	reviewed	Protocadherin alpha-6 (PCDH-alpha-6)	PCDHA6 CNRS2	Homo sapiens (Human)	950	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005887; GO:0007155; GO:0007156; GO:0007399
Q0VA40	SP9_XENTR	reviewed	Transcription factor Sp9	sp9	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	422	embryonic limb morphogenesis [GO:0030326]; embryonic pectoral fin morphogenesis [GO:0035118]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; embryonic limb morphogenesis [GO:0030326]; embryonic pectoral fin morphogenesis [GO:0035118]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]	GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0030326; GO:0035118; GO:0045743; GO:0046872
Q96S96	PEBP4_HUMAN	reviewed	Phosphatidylethanolamine-binding protein 4 (PEBP-4) (hPEBP4) (Protein cousin-of-RKIP 1)	PEBP4 CORK1 UNQ1933/PRO4408	Homo sapiens (Human)	227		extracellular exosome [GO:0070062]; lysosome [GO:0005764]	extracellular exosome [GO:0070062]; lysosome [GO:0005764]		GO:0005764; GO:0070062
Q9Y5A7	NUB1_HUMAN	reviewed	NEDD8 ultimate buster 1 (Negative regulator of ubiquitin-like proteins 1) (Renal carcinoma antigen NY-REN-18)	NUB1 NYREN18	Homo sapiens (Human)	615	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; response to interferon-gamma [GO:0034341]; response to tumor necrosis factor [GO:0034612]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; response to interferon-gamma [GO:0034341]; response to tumor necrosis factor [GO:0034612]; ubiquitin-dependent protein catabolic process [GO:0006511]		GO:0005634; GO:0005829; GO:0006511; GO:0016567; GO:0032436; GO:0034341; GO:0034612; GO:0043687
P58421	FZD5_XENLA	reviewed	Frizzled-5 (Fz-5) (Xfz5)	fzd5 fz5	Xenopus laevis (African clawed frog)	559	camera-type eye development [GO:0043010]; neuron development [GO:0048666]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; camera-type eye development [GO:0043010]; neuron development [GO:0048666]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]	G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	GO:0000139; GO:0004930; GO:0005886; GO:0016021; GO:0017147; GO:0042127; GO:0042813; GO:0043010; GO:0045595; GO:0048666
Q9CWR2	SMYD3_MOUSE	reviewed	Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.43) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1)	Smyd3 Zmynd1	Mus musculus (Mouse)	428	cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]	RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]	GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0045184; GO:0045944; GO:0046872; GO:0071549
P56742	OXLA_CROAT	reviewed	L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2) (Apoxin I) (Apoxin-1)		Crotalus atrox (Western diamondback rattlesnake)	516	apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; hemolysis in other organism [GO:0044179]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; L-amino-acid oxidase activity [GO:0001716]; toxin activity [GO:0090729]; apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; hemolysis in other organism [GO:0044179]	L-amino-acid oxidase activity [GO:0001716]; toxin activity [GO:0090729]	GO:0001716; GO:0005576; GO:0006915; GO:0042742; GO:0044179; GO:0090729
Q96PB1	CASD1_HUMAN	reviewed	N-acetylneuraminate 9-O-acetyltransferase (EC 2.3.1.45) (CAS1 domain-containing protein 1) (Sialate O-acetyltransferase) (SOAT)	CASD1 C7orf12 Nbla04196	Homo sapiens (Human)	797	carbohydrate metabolic process [GO:0005975]	Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]	Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; acetyltransferase activity [GO:0016407]; N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity [GO:0047186]; carbohydrate metabolic process [GO:0005975]	N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity [GO:0047186]; acetyltransferase activity [GO:0016407]	GO:0005794; GO:0005975; GO:0016407; GO:0030173; GO:0047186
P42678	ETIF1_ANOGA	reviewed	Eukaryotic translation initiation factor eIF1 (Protein translation factor SUI1 homolog)	eIF1 AGAP006459	Anopheles gambiae (African malaria mosquito)	110		eukaryotic 43S preinitiation complex [GO:0016282]	eukaryotic 43S preinitiation complex [GO:0016282]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	RNA binding [GO:0003723]; ribosomal small subunit binding [GO:0043024]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003743; GO:0016282; GO:0043024
Q8WMX5	S15A1_CANLF	reviewed	Solute carrier family 15 member 1 (Intestinal H(+)/peptide cotransporter) (Oligopeptide transporter, small intestine isoform) (Peptide transporter 1)	SLC15A1 PEPT1	Canis lupus familiaris (Dog) (Canis familiaris)	708	protein transport [GO:0015031]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; dipeptide transmembrane transporter activity [GO:0071916]; oligopeptide transmembrane transporter activity [GO:0035673]; peptide transmembrane transporter activity [GO:1904680]; peptide:proton symporter activity [GO:0015333]; protein transport [GO:0015031]	dipeptide transmembrane transporter activity [GO:0071916]; oligopeptide transmembrane transporter activity [GO:0035673]; peptide transmembrane transporter activity [GO:1904680]; peptide:proton symporter activity [GO:0015333]	GO:0005887; GO:0015031; GO:0015333; GO:0016021; GO:0035673; GO:0071916; GO:1904680
Q9ULJ7	ANR50_HUMAN	reviewed	Ankyrin repeat domain-containing protein 50	ANKRD50 KIAA1223	Homo sapiens (Human)	1429	protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]	endosome [GO:0005768]	endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]		GO:0005768; GO:0015031; GO:1990126
Q6ZS30	NBEL1_HUMAN	reviewed	Neurobeachin-like protein 1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein)	NBEAL1 ALS2CR16 ALS2CR17	Homo sapiens (Human)	2694					
P55345	ANM2_HUMAN	reviewed	Protein arginine N-methyltransferase 2 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT2)	PRMT2 HMT1 HRMT1L1	Homo sapiens (Human)	433	developmental cell growth [GO:0048588]; histone arginine methylation [GO:0034969]; histone methylation [GO:0016571]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; estrogen receptor binding [GO:0030331]; histone methyltransferase activity [GO:0042054]; histone-arginine N-methyltransferase activity [GO:0008469]; peroxisome proliferator activated receptor binding [GO:0042975]; progesterone receptor binding [GO:0033142]; protein homodimerization activity [GO:0042803]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; developmental cell growth [GO:0048588]; histone arginine methylation [GO:0034969]; histone methylation [GO:0016571]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]	androgen receptor binding [GO:0050681]; estrogen receptor binding [GO:0030331]; histone methyltransferase activity [GO:0042054]; histone-arginine N-methyltransferase activity [GO:0008469]; peroxisome proliferator activated receptor binding [GO:0042975]; progesterone receptor binding [GO:0033142]; protein homodimerization activity [GO:0042803]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0006479; GO:0007165; GO:0008469; GO:0016274; GO:0016571; GO:0019919; GO:0030331; GO:0032088; GO:0033142; GO:0034969; GO:0035242; GO:0042054; GO:0042803; GO:0042974; GO:0042975; GO:0043065; GO:0044877; GO:0045892; GO:0045893; GO:0046966; GO:0048588; GO:0050681; GO:0060765; GO:2000134
P35224	CTNB_URECA	reviewed	Catenin beta (Beta-catenin)		Urechis caupo (Innkeeper worm) (Spoonworm)	818	cell adhesion [GO:0007155]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]	cadherin binding [GO:0045296]	GO:0005737; GO:0005856; GO:0007155; GO:0045296
A7MAZ3	UBA5_BOVIN	reviewed	Ubiquitin-like modifier-activating enzyme 5 (Ubiquitin-activating enzyme 5) (UFM1-activating enzyme) (Ubiquitin-activating enzyme E1 domain-containing protein 1)	UBA5 UBE1DC1	Bos taurus (Bovine)	404	neuromuscular process [GO:0050905]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]	Golgi apparatus [GO:0005794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; UFM1 activating enzyme activity [GO:0071566]; neuromuscular process [GO:0050905]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]	ATP binding [GO:0005524]; UFM1 activating enzyme activity [GO:0071566]; metal ion binding [GO:0046872]	GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0032446; GO:0033146; GO:0034976; GO:0046872; GO:0050905; GO:0071566; GO:0071569; GO:1990592
P49870	HR38_BOMMO	reviewed	Probable nuclear hormone receptor HR38 (bHR38) (Nuclear receptor subfamily 4 group A member 4) (Fragment)	HR38 NR4A4	Bombyx mori (Silk moth)	360		nucleus [GO:0005634]	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]	nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]	GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0043565
Q56R14	TRI33_XENLA	reviewed	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	trim33 ecto	Xenopus laevis (African clawed frog)	1091	protein ubiquitination [GO:0016567]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]	DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740
Q5WA50	CTR2_OCTVU	reviewed	Cephalotocin receptor 2	CTR2	Octopus vulgaris (Common octopus)	426	G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of hormone secretion [GO:0046887]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-hormone receptor activity [GO:0016500]; vasopressin receptor activity [GO:0005000]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of hormone secretion [GO:0046887]	protein-hormone receptor activity [GO:0016500]; vasopressin receptor activity [GO:0005000]	GO:0005000; GO:0005886; GO:0007186; GO:0016021; GO:0016500; GO:0046887
Q8IZF6	AGRG4_HUMAN	reviewed	Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112)	ADGRG4 GPR112	Homo sapiens (Human)	3080	G protein-coupled receptor signaling pathway [GO:0007186]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021
B7ZCC9	AGRG4_MOUSE	reviewed	Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112)	Adgrg4 Gpr112	Mus musculus (Mouse)	3073	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005887; GO:0007166; GO:0007189
Q8N2E2	VWDE_HUMAN	reviewed	von Willebrand factor D and EGF domain-containing protein	VWDE	Homo sapiens (Human)	1590	anatomical structure development [GO:0048856]	cell surface [GO:0009986]; extracellular region [GO:0005576]	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576; GO:0009986; GO:0048856
A0NLY7	ISAHY_LABAI	reviewed	Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b)	SIAM614_09648	Labrenzia aggregata (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614) (Stappia aggregata)	263	tryptophan catabolic process to kynurenine [GO:0019441]		arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145]; tryptophan catabolic process to kynurenine [GO:0019441]	arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145]	GO:0004061; GO:0016812; GO:0019441; GO:0030145
Q3B7N9	MYNN_BOVIN	reviewed	Myoneurin	MYNN	Bos taurus (Bovine)	581		nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872
O01761	UNC89_CAEEL	reviewed	Muscle M-line assembly protein unc-89 (Obscurin) (Uncoordinated protein 89)	unc-89 C09D1.1	Caenorhabditis elegans	8081	cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of Rho protein signal transduction [GO:0035023]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688]	A band [GO:0031672]; M band [GO:0031430]	A band [GO:0031672]; M band [GO:0031430]; ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of Rho protein signal transduction [GO:0035023]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688]	ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]	GO:0004672; GO:0005089; GO:0005524; GO:0010628; GO:0014722; GO:0017048; GO:0019902; GO:0030241; GO:0031034; GO:0031430; GO:0031672; GO:0034613; GO:0035023; GO:0040017; GO:0045214; GO:0045989; GO:0060298; GO:0071688; GO:0090736; GO:1905552; GO:1905905
A8DYP0	OBSCN_DROME	reviewed	Obscurin (EC 2.7.11.1) (Muscle M-line assembly protein Unc-89)	Unc-89 CG33519	Drosophila melanogaster (Fruit fly)	4218	adult somatic muscle development [GO:0007527]; multicellular organism development [GO:0007275]; protein localization to M-band [GO:0036309]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; sarcomere organization [GO:0045214]	M band [GO:0031430]; sarcomere [GO:0030017]	M band [GO:0031430]; sarcomere [GO:0030017]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; tropomyosin binding [GO:0005523]; adult somatic muscle development [GO:0007527]; multicellular organism development [GO:0007275]; protein localization to M-band [GO:0036309]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; sarcomere organization [GO:0045214]	ATP binding [GO:0005524]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; tropomyosin binding [GO:0005523]	GO:0005089; GO:0005523; GO:0005524; GO:0006468; GO:0007275; GO:0007527; GO:0016301; GO:0019901; GO:0030017; GO:0031430; GO:0035023; GO:0036309; GO:0045214; GO:0046872
Q08893	E75_MANSE	reviewed	Ecdysone-inducible protein E75 (Nuclear receptor subfamily 1 group D member 3)	E75 NR1D3	Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)	699		nucleus [GO:0005634]	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]	nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]	GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0043565
Q99PP7	TRI33_MOUSE	reviewed	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)	Trim33 Kiaa1113	Mus musculus (Mouse)	1142	negative regulation of BMP signaling pathway [GO:0030514]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]	nucleus [GO:0005634]	nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]	DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; co-SMAD binding [GO:0070410]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0017015; GO:0030514; GO:0070410; GO:0070412
Q6ZPZ3	ZC3H4_MOUSE	reviewed	Zinc finger CCCH domain-containing protein 4	Zc3h4 Kiaa1064	Mus musculus (Mouse)	1304	negative regulation of transcription, DNA-templated [GO:0045892]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; negative regulation of transcription, DNA-templated [GO:0045892]	DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; metal ion binding [GO:0046872]	GO:0001162; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0045892; GO:0046872
P0CB15	CRIS_PROFL	reviewed	Serotriflin		Protobothrops flavoviridis (Habu) (Trimeresurus flavoviridis)	221		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576
B3A0P4	USP26_LOTGI	reviewed	Uncharacterized shell protein 26 (BMSP-like protein) (Fragment)		Lottia gigantea (Giant owl limpet)	173		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576
Q25460	FP1_MYTED	reviewed	Adhesive plaque matrix protein (Foot protein 1) (MEFP1) (Polyphenolic adhesive protein) (Fragment)	FP1	Mytilus edulis (Blue mussel)	875		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576
P43143	ACHA6_RAT	reviewed	Neuronal acetylcholine receptor subunit alpha-6	Chrna6 Acra6	Rattus norvegicus (Rat)	493	chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of dopamine secretion [GO:0033603]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]	acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]	acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of dopamine secretion [GO:0033603]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]	acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0008144; GO:0016020; GO:0022848; GO:0030054; GO:0033603; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0051291; GO:0099055; GO:0099056
O14512	SOCS7_HUMAN	reviewed	Suppressor of cytokine signaling 7 (SOCS-7) (Nck, Ash and phospholipase C gamma-binding protein) (Nck-associated protein 4) (NAP-4)	SOCS7 NAP4 SOCS6	Homo sapiens (Human)	581	intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphorylation [GO:0046854]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]	cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; SH3 domain binding [GO:0017124]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphorylation [GO:0046854]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]	1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; SH3 domain binding [GO:0017124]	GO:0005634; GO:0005829; GO:0005886; GO:0005942; GO:0009968; GO:0016567; GO:0017124; GO:0035556; GO:0040008; GO:0046854; GO:0046935
Q28BR5	PREP_XENTR	reviewed	Presequence protease, mitochondrial (EC 3.4.24.-) (Pitrilysin metalloproteinase 1)	pitrm1 TNeu116i05.1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1027	protein processing [GO:0016485]; proteolysis [GO:0006508]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein processing [GO:0016485]; proteolysis [GO:0006508]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0016485; GO:0046872
Q8BXR9	OSBL6_MOUSE	reviewed	Oxysterol-binding protein-related protein 6 (ORP-6) (OSBP-related protein 6)	Osbpl6	Mus musculus (Mouse)	959		cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005789; GO:0005829; GO:0005886; GO:0008289; GO:0015248; GO:0015485; GO:0016020; GO:0031965; GO:0032934; GO:0043231; GO:0097038
D0PRN3	NRX3A_CHICK	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)		Gallus gallus (Chicken)	1693	cell adhesion [GO:0007155]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]	metal ion binding [GO:0046872]	GO:0007155; GO:0016021; GO:0046872
Q8TCT0	CERK1_HUMAN	reviewed	Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4)	CERK KIAA1646	Homo sapiens (Human)	537	ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]	ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0001729; GO:0003951; GO:0005524; GO:0005737; GO:0005886; GO:0006672; GO:0006687; GO:0016021; GO:0102773
B3EWZ6	MLRP2_ACRMI	reviewed	MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)		Acropora millepora (Staghorn coral) (Heteropora millepora)	7311		extracellular region [GO:0005576]; membrane [GO:0016020]	extracellular region [GO:0005576]; membrane [GO:0016020]		GO:0005576; GO:0016020
P0CY46	EGFR_APIME	reviewed	Epidermal growth factor receptor (Egfr) (EC 2.7.10.1)	Egfr	Apis mellifera (Honeybee)	1292	multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004714; GO:0005524; GO:0007169; GO:0007275; GO:0016021
D3ZAA9	MPP2_RAT	reviewed	MAGUK p55 subfamily member 2 (Protein MPP2)	Mpp2 rCG_34691	Rattus norvegicus (Rat)	552	excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein homooligomerization [GO:0051260]	Schaffer collateral - CA1 synapse [GO:0098685]; anchored component of postsynaptic density membrane [GO:0099031]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic shaft [GO:0043198]; dendritic spine membrane [GO:0032591]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]	anchored component of postsynaptic density membrane [GO:0099031]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic shaft [GO:0043198]; dendritic spine membrane [GO:0032591]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; ion channel binding [GO:0044325]; PDZ domain binding [GO:0030165]; structural constituent of postsynaptic density [GO:0098919]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein homooligomerization [GO:0051260]	PDZ domain binding [GO:0030165]; ion channel binding [GO:0044325]; structural constituent of postsynaptic density [GO:0098919]	GO:0005737; GO:0005856; GO:0014069; GO:0030054; GO:0030165; GO:0032591; GO:0043198; GO:0044325; GO:0051260; GO:0060079; GO:0060291; GO:0098685; GO:0098919; GO:0098978; GO:0099031
Q5R941	FKB14_PONAB	reviewed	Peptidyl-prolyl cis-trans isomerase FKBP14 (PPIase FKBP14) (EC 5.2.1.8) (FK506-binding protein 14) (FKBP-14) (Rotamase)	FKBP14	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	211		endoplasmic reticulum lumen [GO:0005788]	endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005509; GO:0005788
P13826	CSP_PLAVS	reviewed	Circumsporozoite protein (CS) (Fragment)		Plasmodium vivax (strain Salvador I)	343		cell surface [GO:0009986]	cell surface [GO:0009986]		GO:0009986
Q8TC21	ZN596_HUMAN	reviewed	Zinc finger protein 596	ZNF596	Homo sapiens (Human)	504	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006357; GO:0046872
Q08834	MGT5A_RAT	reviewed	Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]	Mgat5	Rattus norvegicus (Rat)	740	negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]	GO:0000139; GO:0004864; GO:0005576; GO:0005794; GO:0006487; GO:0016021; GO:0018279; GO:0030144; GO:0030145; GO:0030335; GO:1903614; GO:1904894
Q09328	MGT5A_HUMAN	reviewed	Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]	MGAT5 GGNT5	Homo sapiens (Human)	741	negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]	GO:0000139; GO:0004864; GO:0005794; GO:0006487; GO:0016020; GO:0016021; GO:0018279; GO:0030144; GO:0030145; GO:0030335; GO:0070062; GO:1903614; GO:1904894
P27169	PON1_HUMAN	reviewed	Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)	PON1 PON	Homo sapiens (Human)	355	aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lipoxygenase pathway [GO:0019372]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636]	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lipoxygenase pathway [GO:0019372]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636]	acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]	GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0008203; GO:0009636; GO:0010875; GO:0019372; GO:0019439; GO:0031667; GO:0032411; GO:0034364; GO:0034366; GO:0042803; GO:0043231; GO:0046395; GO:0046434; GO:0046470; GO:0051099; GO:0070062; GO:0070542; GO:0072562; GO:0102007; GO:1902617
Q8WU66	TSEAR_HUMAN	reviewed	Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)	TSPEAR C21orf29	Homo sapiens (Human)	669	regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; tooth mineralization [GO:0034505]	cell surface [GO:0009986]; ciliary membrane [GO:0060170]; extracellular region [GO:0005576]; stereocilium [GO:0032420]	cell surface [GO:0009986]; ciliary membrane [GO:0060170]; extracellular region [GO:0005576]; stereocilium [GO:0032420]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; tooth mineralization [GO:0034505]		GO:0005576; GO:0007605; GO:0008593; GO:0009986; GO:0032420; GO:0034505; GO:0060170
Q5RAJ6	DJB11_PONAB	reviewed	DnaJ homolog subfamily B member 11 (ER-associated DNAJ) (ER-associated Hsp40 co-chaperone) (Endoplasmic reticulum DNA J domain-containing protein 3) (ER-resident protein ERdj3) (ERdj3) (ERj3p)	DNAJB11	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	358	mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; protein folding [GO:0006457]; protein maturation [GO:0051604]	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; nucleus [GO:0005634]	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; nucleus [GO:0005634]; signaling receptor binding [GO:0005102]; unfolded protein binding [GO:0051082]; mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; protein folding [GO:0006457]; protein maturation [GO:0051604]	signaling receptor binding [GO:0005102]; unfolded protein binding [GO:0051082]	GO:0005102; GO:0005615; GO:0005634; GO:0005788; GO:0006457; GO:0016556; GO:0050768; GO:0051082; GO:0051604
Q14BI2	GRM2_MOUSE	reviewed	Metabotropic glutamate receptor 2 (mGluR2)	Grm2 Gprc1b Mglur2	Mus musculus (Mouse)	872	G protein-coupled glutamate receptor signaling pathway [GO:0007216]; chemical synaptic transmission [GO:0007268]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; regulation of synaptic transmission, glutamatergic [GO:0051966]	axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; presynaptic membrane [GO:0042734]	axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; regulation of synaptic transmission, glutamatergic [GO:0051966]	calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]	GO:0001641; GO:0005246; GO:0005887; GO:0007216; GO:0007268; GO:0008066; GO:0014047; GO:0030054; GO:0030424; GO:0030425; GO:0042734; GO:0043005; GO:0051966; GO:0090461; GO:0099055
Q2Y0W8	S4A8_HUMAN	reviewed	Electroneutral sodium bicarbonate exchanger 1 (Electroneutral Na(+)-driven Cl-HCO3 exchanger) (Solute carrier family 4 member 8) (k-NBC3)	SLC4A8 KIAA0739 NBC NBC3 NDCBE1	Homo sapiens (Human)	1093	bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]	anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]	GO:0005452; GO:0005886; GO:0005887; GO:0008510; GO:0015301; GO:0015701; GO:0032809; GO:0043005; GO:0051453
Q6IMK3	DJC27_DANRE	reviewed	DnaJ homolog subfamily C member 27 (Rab and DnaJ domain-containing protein)	dnajc27 rbj	Danio rerio (Zebrafish) (Brachydanio rerio)	273	Rab protein signal transduction [GO:0032482]; intracellular protein transport [GO:0006886]	nucleus [GO:0005634]	nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005525; GO:0005634; GO:0006886; GO:0032482
O88327	CTNL1_MOUSE	reviewed	Alpha-catulin (Alpha-catenin-related protein) (ACRP) (Catenin alpha-like protein 1)	Ctnnal1 Catnal1	Mus musculus (Mouse)	731	Rho protein signal transduction [GO:0007266]; cell adhesion [GO:0007155]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]	GO:0005829; GO:0005856; GO:0005886; GO:0007155; GO:0007266; GO:0045296; GO:0051015
P14943	EST2_RABIT	reviewed	Liver carboxylesterase 2 (EC 3.1.1.1)	CES2 ICE	Oryctolagus cuniculus (Rabbit)	532		endoplasmic reticulum lumen [GO:0005788]	endoplasmic reticulum lumen [GO:0005788]; methyl indole-3-acetate esterase activity [GO:0080030]	methyl indole-3-acetate esterase activity [GO:0080030]	GO:0005788; GO:0080030
Q14123	PDE1C_HUMAN	reviewed	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C (Cam-PDE 1C) (3',5'-cyclic-AMP phosphodiesterase) (EC 3.1.4.-) (3',5'-cyclic-GMP phosphodiesterase) (EC 3.1.4.35) (Hcam3)	PDE1C	Homo sapiens (Human)	709	signal transduction [GO:0007165]	cytosol [GO:0005829]; neuronal cell body [GO:0043025]	cytosol [GO:0005829]; neuronal cell body [GO:0043025]; calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; calmodulin-dependent cyclic-nucleotide phosphodiesterase activity [GO:0004117]; metal ion binding [GO:0046872]; signal transduction [GO:0007165]	calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; calmodulin-dependent cyclic-nucleotide phosphodiesterase activity [GO:0004117]; metal ion binding [GO:0046872]	GO:0004117; GO:0005516; GO:0005829; GO:0007165; GO:0043025; GO:0046872; GO:0048101
Q4V8E5	MFSD3_RAT	reviewed	Major facilitator superfamily domain-containing protein 3	Mfsd3	Rattus norvegicus (Rat)	416		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; solute:proton symporter activity [GO:0015295]	solute:proton symporter activity [GO:0015295]	GO:0015295; GO:0016021
Q15542	TAF5_HUMAN	reviewed	Transcription initiation factor TFIID subunit 5 (Transcription initiation factor TFIID 100 kDa subunit) (TAF(II)100) (TAFII-100) (TAFII100)	TAF5 TAF2D	Homo sapiens (Human)	800	DNA-templated transcription, initiation [GO:0006352]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]	actin cytoskeleton [GO:0015629]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]	actin cytoskeleton [GO:0015629]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; DNA-templated transcription, initiation [GO:0006352]; histone acetylation [GO:0016573]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]	RNA polymerase II general transcription initiation factor activity [GO:0016251]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transcription regulatory region DNA binding [GO:0044212]	GO:0000790; GO:0005634; GO:0005654; GO:0005669; GO:0006325; GO:0006352; GO:0006355; GO:0006366; GO:0006367; GO:0015629; GO:0016032; GO:0016251; GO:0016573; GO:0033276; GO:0042795; GO:0042802; GO:0044212; GO:0046983; GO:1901796
Q9Y2X3	NOP58_HUMAN	reviewed	Nucleolar protein 58 (Nucleolar protein 5)	NOP58 NOL5 NOP5 HSPC120	Homo sapiens (Human)	529	rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]	Cajal body [GO:0015030]; box C/D snoRNP complex [GO:0031428]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]	box C/D snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]	ATPase binding [GO:0051117]; RNA binding [GO:0003723]; TFIID-class transcription factor complex binding [GO:0001094]; snoRNA binding [GO:0030515]	GO:0001094; GO:0001650; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005732; GO:0005829; GO:0006364; GO:0015030; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0048254; GO:0051117; GO:0070761
Q5SSZ5	TENS3_MOUSE	reviewed	Tensin-3 (Tensin-like SH2 domain-containing protein 1)	Tns3 Tens1	Mus musculus (Mouse)	1440	cell migration [GO:0016477]; lung alveolus development [GO:0048286]; positive regulation of cell population proliferation [GO:0008284]	cytosol [GO:0005829]; focal adhesion [GO:0005925]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; cell migration [GO:0016477]; lung alveolus development [GO:0048286]; positive regulation of cell population proliferation [GO:0008284]		GO:0005829; GO:0005925; GO:0008284; GO:0016477; GO:0048286
Q96EH3	MASU1_HUMAN	reviewed	Mitochondrial assembly of ribosomal large subunit protein 1	MALSU1 C7orf30	Homo sapiens (Human)	234	negative regulation of mitochondrial translation [GO:0070130]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of translation [GO:0017148]; ribosomal large subunit biogenesis [GO:0042273]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribosomal large subunit binding [GO:0043023]; negative regulation of mitochondrial translation [GO:0070130]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of translation [GO:0017148]; ribosomal large subunit biogenesis [GO:0042273]	ribosomal large subunit binding [GO:0043023]	GO:0005739; GO:0005759; GO:0005829; GO:0017148; GO:0042273; GO:0043023; GO:0070130; GO:0090071
Q8WX93	PALLD_HUMAN	reviewed	Palladin (SIH002) (Sarcoma antigen NY-SAR-77)	PALLD KIAA0992 CGI-151	Homo sapiens (Human)	1383	actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; dendrite self-avoidance [GO:0070593]; epithelial cell morphogenesis [GO:0003382]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinocyte development [GO:0003334]	Z disc [GO:0030018]; actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; Z disc [GO:0030018]; actin binding [GO:0003779]; cell-cell adhesion mediator activity [GO:0098632]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; dendrite self-avoidance [GO:0070593]; epithelial cell morphogenesis [GO:0003382]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinocyte development [GO:0003334]	actin binding [GO:0003779]; cell-cell adhesion mediator activity [GO:0098632]; muscle alpha-actinin binding [GO:0051371]	GO:0001726; GO:0002102; GO:0003334; GO:0003382; GO:0003779; GO:0005634; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0007010; GO:0007156; GO:0007411; GO:0015629; GO:0016477; GO:0030018; GO:0030027; GO:0030036; GO:0030424; GO:0030426; GO:0051371; GO:0070593; GO:0098632
A8T6P4	MYRIP_DANRE	reviewed	Rab effector MyRIP (Exophilin-8) (Myosin VIIa- and Rab-interacting protein) (Synaptotagmin-like protein lacking C2 domains C) (SlaC2-c) (Slp homolog lacking C2 domains c)	myrip akap2 si:dkey-12l12.1 si:dkey-189e1.3	Danio rerio (Zebrafish) (Brachydanio rerio)	838	intracellular protein transport [GO:0006886]	cortical actin cytoskeleton [GO:0030864]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133]	cortical actin cytoskeleton [GO:0030864]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; Rab GTPase binding [GO:0017137]; intracellular protein transport [GO:0006886]	Rab GTPase binding [GO:0017137]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]	GO:0003779; GO:0006886; GO:0017022; GO:0017137; GO:0030133; GO:0030864; GO:0046872; GO:0048471
O77245	E75_METEN	reviewed	Nuclear hormone receptor E75 (Nuclear receptor subfamily 1 group D member 3)	E75 NR1D3	Metapenaeus ensis (Greasyback shrimp) (Penaeus ensis)	606		nucleus [GO:0005634]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]	DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]	GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0043565
Q6RVG2	S4A8_RAT	reviewed	Electroneutral sodium bicarbonate exchanger 1 (Electroneutral Na+-driven Cl-HCO3 exchanger) (Solute carrier family 4 member 8) (k-NBC3)	Slc4a8 Ndcbe1	Rattus norvegicus (Rat)	1067	bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]	anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]	GO:0005452; GO:0005887; GO:0008510; GO:0015301; GO:0015701; GO:0051453
O02769	MTR1A_BOVIN	reviewed	Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor) (Fragment)	MTNR1A	Bos taurus (Bovine)	257	circadian rhythm [GO:0007623]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502]; circadian rhythm [GO:0007623]	G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502]	GO:0004930; GO:0005886; GO:0007623; GO:0008502; GO:0016021
Q8MR37	KLFL_DROME	reviewed	Krueppel-like factor luna	luna CG33473	Drosophila melanogaster (Fruit fly)	570	cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; preblastoderm mitotic cell cycle [GO:0035185]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; preblastoderm mitotic cell cycle [GO:0035185]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]	GO:0000070; GO:0000981; GO:0005634; GO:0006357; GO:0035185; GO:0043565; GO:0046872; GO:0051301
Q6R7D0	IAP3_OSHVF	reviewed	Putative apoptosis inhibitor ORF99	ORF99	Ostreid herpesvirus 1 (isolate France) (OsHV-1) (Pacific oyster herpesvirus)	250					
Q7ZU42	OLA1_DANRE	reviewed	Obg-like ATPase 1	ola1 zgc:55768	Danio rerio (Zebrafish) (Brachydanio rerio)	396		cytoplasm [GO:0005737]; nucleolus [GO:0005730]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]	GO:0005524; GO:0005525; GO:0005730; GO:0005737; GO:0016887; GO:0043022; GO:0043023; GO:0046872
G5E8K5	ANK3_MOUSE	reviewed	Ankyrin-3 (ANK-3) (Ankyrin-G)	Ank3	Mus musculus (Mouse)	1961	Golgi to plasma membrane protein transport [GO:0043001]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]	T-tubule [GO:0030315]; Z disc [GO:0030018]; axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]	axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]	cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0005200; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:0140031; GO:1900827; GO:1902260; GO:2000651; GO:2001259
Q5ZJH7	CNPD1_CHICK	reviewed	Protein CNPPD1	CNPPD1 RCJMB04_3a20	Gallus gallus (Chicken)	439	regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; protein kinase binding [GO:0019901]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	protein kinase binding [GO:0019901]	GO:0000079; GO:0016021; GO:0019901
Q7SXP8	GMPAB_DANRE	reviewed	Mannose-1-phosphate guanyltransferase alpha-B (EC 2.7.7.13) (GDP-mannose pyrophosphorylase A-B) (GTP-mannose-1-phosphate guanylyltransferase alpha-b)	gmppab zgc:66135	Danio rerio (Zebrafish) (Brachydanio rerio)	422	GDP-mannose biosynthetic process [GO:0009298]		GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298]	GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]	GO:0004475; GO:0005525; GO:0009298
Q9Y2E4	DIP2C_HUMAN	reviewed	Disco-interacting protein 2 homolog C (DIP2 homolog C)	DIP2C KIAA0934	Homo sapiens (Human)	1556			catalytic activity [GO:0003824]	catalytic activity [GO:0003824]	GO:0003824
D3KCC4	CRNS1_CHICK	reviewed	Carnosine synthase 1 (EC 6.3.2.11) (ATP-grasp domain-containing protein 1)	CARNS1 ATPGD1	Gallus gallus (Chicken)	930	carnosine biosynthetic process [GO:0035499]		ATP binding [GO:0005524]; ATPase activity [GO:0016887]; carnosine synthase activity [GO:0047730]; FMN binding [GO:0010181]; homocarnosine synthase activity [GO:0102102]; metal ion binding [GO:0046872]; carnosine biosynthetic process [GO:0035499]	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; FMN binding [GO:0010181]; carnosine synthase activity [GO:0047730]; homocarnosine synthase activity [GO:0102102]; metal ion binding [GO:0046872]	GO:0005524; GO:0010181; GO:0016887; GO:0035499; GO:0046872; GO:0047730; GO:0102102
Q6ZPS2	CRNS1_MOUSE	reviewed	Carnosine synthase 1 (EC 6.3.2.11) (ATP-grasp domain-containing protein 1)	Carns1 Atpgd1 Kiaa1394	Mus musculus (Mouse)	827	carnosine biosynthetic process [GO:0035499]		ATP binding [GO:0005524]; ATPase activity [GO:0016887]; carnosine synthase activity [GO:0047730]; FMN binding [GO:0010181]; homocarnosine synthase activity [GO:0102102]; metal ion binding [GO:0046872]; carnosine biosynthetic process [GO:0035499]	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; FMN binding [GO:0010181]; carnosine synthase activity [GO:0047730]; homocarnosine synthase activity [GO:0102102]; metal ion binding [GO:0046872]	GO:0005524; GO:0010181; GO:0016887; GO:0035499; GO:0046872; GO:0047730; GO:0102102
A6QLU1	GPDM_BOVIN	reviewed	Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3)	GPD2	Bos taurus (Bovine)	727	glycerol catabolic process [GO:0019563]; glycerol-3-phosphate catabolic process [GO:0046168]	glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrion [GO:0005739]	glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate catabolic process [GO:0046168]	calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]	GO:0004367; GO:0004368; GO:0005509; GO:0005739; GO:0009331; GO:0019563; GO:0046168; GO:0052591
Q5RBR6	SPRY3_PONAB	reviewed	SPRY domain-containing protein 3	SPRYD3	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	442					
Q2HJ61	PLPP2_BOVIN	reviewed	Phospholipid phosphatase 2 (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 2) (PAP2-gamma) (PAP2-G) (Phosphatidate phosphohydrolase type 2c) (Phosphatidic acid phosphatase 2c) (PAP-2c) (PAP2c)	PLPP2 PPAP2C	Bos taurus (Bovine)	287	phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]	lipid phosphatase activity [GO:0042577]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]	GO:0005887; GO:0006644; GO:0008195; GO:0016791; GO:0042577; GO:0046839
P02707	LECH_CHICK	reviewed	Hepatic lectin		Gallus gallus (Chicken)	207	endocytosis [GO:0006897]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; endocytosis [GO:0006897]	carbohydrate binding [GO:0030246]	GO:0006897; GO:0016021; GO:0030246
B2RX12	MRP3_MOUSE	reviewed	Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multidrug resistance-associated protein 3)	Abcc3 Cmoat2 Mrp3	Mus musculus (Mouse)	1523	canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; drug transport [GO:0015893]; transmembrane transport [GO:0055085]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; canalicular bile acid transport [GO:0015722]; drug transmembrane transport [GO:0006855]; drug transport [GO:0015893]; transmembrane transport [GO:0055085]	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]	GO:0005524; GO:0005774; GO:0005887; GO:0006855; GO:0015722; GO:0015893; GO:0016020; GO:0016323; GO:0016887; GO:0042626; GO:0055085
Q5UPE2	YL063_MIMIV	reviewed	Putative ankyrin repeat protein L63	MIMI_L63	Acanthamoeba polyphaga mimivirus (APMV)	580					
Q9BS26	ERP44_HUMAN	reviewed	Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4)	ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075	Homo sapiens (Human)	406	cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; neutrophil degranulation [GO:0043312]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; neutrophil degranulation [GO:0043312]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005576; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0035580; GO:0043312; GO:0045454; GO:0070062
Q9HGN1	GCN2_SCHPO	reviewed	eIF-2-alpha kinase GCN2 (Serine/threonine-protein kinase gcn2) (EC 2.7.11.1) (Serine/threonine-protein kinase ppk28)	gcn2 ppk28 SPBC36B7.09 SPBP18G5.01	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	1576	G1 cell cycle arrest in response to nitrogen starvation [GO:0071849]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to hydrogen peroxide [GO:0070301]; cellular stress response to acidic pH [GO:1990451]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of cytoplasmic translational initiation in response to stress [GO:1990625]; regulation of translation involved in cellular response to UV [GO:1904803]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]	cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]	cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; tRNA binding [GO:0000049]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to hydrogen peroxide [GO:0070301]; cellular stress response to acidic pH [GO:1990451]; G1 cell cycle arrest in response to nitrogen starvation [GO:0071849]; mitotic G1 DNA damage checkpoint [GO:0031571]; negative regulation of cytoplasmic translational initiation in response to stress [GO:1990625]; regulation of translation involved in cellular response to UV [GO:1904803]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]	ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; tRNA binding [GO:0000049]	GO:0000049; GO:0004672; GO:0004694; GO:0005524; GO:0005829; GO:0022626; GO:0031571; GO:0034198; GO:0070301; GO:0071849; GO:0072431; GO:0072755; GO:1904803; GO:1990451; GO:1990625
Q04310	Y4629_STRCO	reviewed	Uncharacterized protein SCO4629	SCO4629 SCD39.29	Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145)	221		plasma membrane [GO:0005886]	plasma membrane [GO:0005886]; DNA binding [GO:0003677]	DNA binding [GO:0003677]	GO:0003677; GO:0005886
A4IF63	TRIM2_BOVIN	reviewed	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)	TRIM2	Bos taurus (Bovine)	744	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630
O50655	XERD_SELRU	reviewed	Integrase/recombinase xerD homolog	xerD	Selenomonas ruminantium	341	DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]		DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]	DNA binding [GO:0003677]	GO:0003677; GO:0006310; GO:0015074; GO:0044826; GO:0046718; GO:0075713
Q9D9R9	F186A_MOUSE	reviewed	Protein FAM186A	FAM186A Gm920	Mus musculus (Mouse)	1790					
Q9H0J4	QRIC2_HUMAN	reviewed	Glutamine-rich protein 2	QRICH2	Homo sapiens (Human)	1663					
P33300	SUR1_YEAST	reviewed	Mannosyl phosphorylinositol ceramide synthase SUR1 (EC 2.4.-.-)	SUR1 BCL21 CSG1 LPE15 YPL057C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	382	glycosphingolipid biosynthetic process [GO:0006688]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]; mannosyl-inositol phosphorylceramide metabolic process [GO:0006675]; sphingolipid biosynthetic process [GO:0030148]	fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]	fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; integral component of membrane [GO:0016021]; mannosyltransferase activity [GO:0000030]; glycosphingolipid biosynthetic process [GO:0006688]; mannosyl-inositol phosphorylceramide biosynthetic process [GO:0051999]; mannosyl-inositol phosphorylceramide metabolic process [GO:0006675]; sphingolipid biosynthetic process [GO:0030148]	mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0000324; GO:0000329; GO:0006675; GO:0006688; GO:0016021; GO:0030148; GO:0051999
Q6W5P4	NPSR1_HUMAN	reviewed	Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility)	NPSR1 GPR154 GPRA PGR14	Homo sapiens (Human)	371	G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]	neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]	GO:0005000; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007218; GO:0008188; GO:0051281
Q9EP71	RAI14_MOUSE	reviewed	Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14) (p125)	Rai14 Kiaa1334 Norpeg	Mus musculus (Mouse)	979	cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]		GO:0001650; GO:0005634; GO:0005739; GO:0005829; GO:0005856; GO:0005938; GO:0007283; GO:0030054; GO:0030154
P36940	TNFL6_RAT	reviewed	Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]	Faslg Apt1Lg1 Cd95l Fasl Tnfsf6	Rattus norvegicus (Rat)	278	T cell apoptotic process [GO:0070231]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular chloride ion homeostasis [GO:0030644]; endosomal lumen acidification [GO:0048388]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; immune response [GO:0006955]; inflammatory cell apoptotic process [GO:0006925]; necroptotic signaling pathway [GO:0097527]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of neuron apoptotic process [GO:0043525]; release of sequestered calcium ion into cytosol by endoplasmic reticulum [GO:1903514]; response to growth factor [GO:0070848]; response to lipopolysaccharide [GO:0032496]; retinal cell programmed cell death [GO:0046666]	caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle lumen [GO:0060205]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle lumen [GO:0060205]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cytokine activity [GO:0005125]; death receptor binding [GO:0005123]; tumor necrosis factor receptor binding [GO:0005164]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular chloride ion homeostasis [GO:0030644]; endosomal lumen acidification [GO:0048388]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; immune response [GO:0006955]; inflammatory cell apoptotic process [GO:0006925]; necroptotic signaling pathway [GO:0097527]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron apoptotic process [GO:0043525]; release of sequestered calcium ion into cytosol by endoplasmic reticulum [GO:1903514]; response to growth factor [GO:0070848]; response to lipopolysaccharide [GO:0032496]; retinal cell programmed cell death [GO:0046666]; T cell apoptotic process [GO:0070231]	cytokine activity [GO:0005125]; death receptor binding [GO:0005123]; tumor necrosis factor receptor binding [GO:0005164]	GO:0000122; GO:0005123; GO:0005125; GO:0005164; GO:0005634; GO:0005901; GO:0006919; GO:0006925; GO:0006955; GO:0008284; GO:0008625; GO:0009897; GO:0016021; GO:0016525; GO:0030644; GO:0031410; GO:0032496; GO:0043123; GO:0043202; GO:0043525; GO:0045121; GO:0045742; GO:0046666; GO:0048388; GO:0048471; GO:0060205; GO:0070062; GO:0070231; GO:0070848; GO:0097527; GO:1903514; GO:2000353
Q0DAE4	GRXC8_ORYSJ	reviewed	Glutaredoxin-C8 (Glutaredoxin-C4 homolog)	GRXC8 Os06g0659500 LOC_Os06g44910 B1047G05.35 OSJNBa0051O02.7	Oryza sativa subsp. japonica (Rice)	136	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]	electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0004362; GO:0005737; GO:0009055; GO:0015035; GO:0034599; GO:0045454
Q5RF54	CSN8_PONAB	reviewed	COP9 signalosome complex subunit 8 (Signalosome subunit 8)	COPS8 CSN8	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	209	COP9 signalosome assembly [GO:0010387]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; negative regulation of cell population proliferation [GO:0008285]; protein deneddylation [GO:0000338]; protein phosphorylation [GO:0006468]	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; COP9 signalosome assembly [GO:0010387]; negative regulation of cell population proliferation [GO:0008285]; protein deneddylation [GO:0000338]; protein phosphorylation [GO:0006468]		GO:0000338; GO:0005654; GO:0005829; GO:0006468; GO:0007250; GO:0008180; GO:0008285; GO:0010387; GO:0048471
Q19746	INX3_CAEEL	reviewed	Innexin-3 (Protein opu-3)	inx-3 opu-3 F22F4.2	Caenorhabditis elegans	420	embryonic morphogenesis [GO:0048598]; ion transport [GO:0006811]	cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; embryonic morphogenesis [GO:0048598]; ion transport [GO:0006811]	gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]	GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0016021; GO:0048598; GO:0055077
Q91X17	UROM_MOUSE	reviewed	Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]	Umod	Mus musculus (Mouse)	642	chemical homeostasis [GO:0048878]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]	Golgi apparatus [GO:0005794]; anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; spindle pole [GO:0000922]	anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; IgG binding [GO:0019864]; chemical homeostasis [GO:0048878]; excretion [GO:0007588]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ion homeostasis [GO:0050801]; leukocyte cell-cell adhesion [GO:0007159]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; neutrophil migration [GO:1990266]	IgG binding [GO:0019864]; calcium ion binding [GO:0005509]	GO:0000922; GO:0005509; GO:0005615; GO:0005794; GO:0005929; GO:0007157; GO:0007159; GO:0007588; GO:0016323; GO:0016324; GO:0019864; GO:0031225; GO:0031410; GO:0045121; GO:0045177; GO:0048878; GO:0050801; GO:0060170; GO:0072218; GO:0072221; GO:0072233; GO:1990266
Q498D6	FGFR4_RAT	reviewed	Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334)	Fgfr4	Rattus norvegicus (Rat)	800	cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; nervous system development [GO:0007399]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	Golgi apparatus [GO:0005794]; cell-cell junction [GO:0005911]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]	cell-cell junction [GO:0005911]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; nervous system development [GO:0007399]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004714; GO:0005007; GO:0005524; GO:0005768; GO:0005783; GO:0005794; GO:0005887; GO:0005911; GO:0007169; GO:0007399; GO:0008201; GO:0008284; GO:0008543; GO:0010628; GO:0010715; GO:0016477; GO:0017134; GO:0018108; GO:0019216; GO:0030133; GO:0042593; GO:0042632; GO:0043085; GO:0043235; GO:0045862; GO:0046777; GO:0055062; GO:0070374; GO:0070857; GO:2000573
P07439	LEC3_MEGRO	reviewed	Lectin BRA-3		Megabalanus rosa (Acorn barnacle)	162			carbohydrate binding [GO:0030246]	carbohydrate binding [GO:0030246]	GO:0030246
Q8HY02	CD209_SYMSY	reviewed	CD209 antigen (Dendritic cell-specific ICAM-3-grabbing non-integrin 1) (DC-SIGN1) (CD antigen CD209)	CD209	Symphalangus syndactylus (Siamang) (Hylobates syndactylus)	381	adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; innate immune response [GO:0045087]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; innate immune response [GO:0045087]	mannose binding [GO:0005537]; metal ion binding [GO:0046872]	GO:0002250; GO:0005537; GO:0006897; GO:0007155; GO:0016021; GO:0045087; GO:0046872
Q9QXZ9	OPN4_MOUSE	reviewed	Melanopsin (Opsin-4)	Opn4 Mop Mopn	Mus musculus (Mouse)	521	G protein-coupled receptor signaling pathway [GO:0007186]; cellular response to light stimulus [GO:0071482]; entrainment of circadian clock by photoperiod [GO:0043153]; phototransduction [GO:0007602]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhodopsin mediated signaling pathway [GO:0016056]; rhythmic process [GO:0048511]; visual perception [GO:0007601]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; cellular response to light stimulus [GO:0071482]; entrainment of circadian clock by photoperiod [GO:0043153]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhodopsin mediated signaling pathway [GO:0016056]; rhythmic process [GO:0048511]; visual perception [GO:0007601]	11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]	GO:0005502; GO:0005886; GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0016021; GO:0016056; GO:0018298; GO:0042752; GO:0043153; GO:0045938; GO:0048511; GO:0071482
P09241	OPSD_ENTDO	reviewed	Rhodopsin	RHO	Enteroctopus dofleini (North Pacific giant octopus) (Octopus dofleini)	455	phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; retinal binding [GO:0016918]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; visual perception [GO:0007601]	G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; retinal binding [GO:0016918]	GO:0004930; GO:0007601; GO:0007602; GO:0009881; GO:0016021; GO:0016918; GO:0018298
Q9UHM6	OPN4_HUMAN	reviewed	Melanopsin (Opsin-4)	OPN4 MOP	Homo sapiens (Human)	478	G protein-coupled receptor signaling pathway [GO:0007186]; cellular response to light stimulus [GO:0071482]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; visual perception [GO:0007601]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; photoreceptor disc membrane [GO:0097381]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; photoreceptor disc membrane [GO:0097381]; 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; visual perception [GO:0007601]	11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]	GO:0005502; GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0016021; GO:0018298; GO:0042752; GO:0048511; GO:0071482; GO:0097381
Q96EZ8	MCRS1_HUMAN	reviewed	Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2)	MCRS1 INO80Q MSP58	Homo sapiens (Human)	462	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; cellular protein modification process [GO:0006464]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]	Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844]; G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521]; cellular protein modification process [GO:0006464]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]	G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521]	GO:0000123; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005844; GO:0006281; GO:0006310; GO:0006464; GO:0008266; GO:0010521; GO:0016579; GO:0030425; GO:0031011; GO:0034046; GO:0043204; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045944; GO:0051974; GO:0071339; GO:1904357; GO:1904751
Q03650	CRAM_TRYBB	reviewed	Cysteine-rich, acidic integral membrane protein	CRAM	Trypanosoma brucei brucei	945	endocytosis [GO:0006897]	ciliary pocket [GO:0020016]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ciliary pocket [GO:0020016]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]		GO:0005886; GO:0006897; GO:0016021; GO:0020016
P46461	NSF1_DROME	reviewed	Vesicle-fusing ATPase 1 (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein 1) (NEM-sensitive fusion protein 1) (Protein comatose) (Vesicular-fusion protein NSF1) (dNsf-1) (NSF-1)	comt Nsf Nsf1 CG1618	Drosophila melanogaster (Fruit fly)	745	Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; SNARE complex disassembly [GO:0035494]; autophagy [GO:0006914]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]	Golgi stack [GO:0005795]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; neuromuscular junction of somatic muscle [GO:0098527]; presynaptic cytosol [GO:0099523]; terminal bouton [GO:0043195]	cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; neuromuscular junction [GO:0031594]; neuromuscular junction of somatic muscle [GO:0098527]; presynaptic cytosol [GO:0099523]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]	ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]	GO:0005524; GO:0005737; GO:0005795; GO:0006914; GO:0007030; GO:0007269; GO:0007274; GO:0016082; GO:0016887; GO:0031594; GO:0031629; GO:0035494; GO:0043001; GO:0043195; GO:0046872; GO:0048172; GO:0048211; GO:0070050; GO:0090160; GO:0098527; GO:0099504; GO:0099523; GO:1900073
Q9WTN6	S22AL_MOUSE	reviewed	Solute carrier family 22 member 21 (Organic cation/carnitine transporter 3) (Solute carrier family 22 member 9)	Slc22a21 Octn3 Slc22a9	Mus musculus (Mouse)	564	carnitine transport [GO:0015879]	integral component of membrane [GO:0016021]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]	integral component of membrane [GO:0016021]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; carnitine transport [GO:0015879]	ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; quaternary ammonium group transmembrane transporter activity [GO:0015651]	GO:0005524; GO:0005777; GO:0015226; GO:0015651; GO:0015879; GO:0016021; GO:0031231
Q8IXB1	DJC10_HUMAN	reviewed	DnaJ homolog subfamily C member 10 (EC 1.8.4.-) (Endoplasmic reticulum DNA J domain-containing protein 5) (ER-resident protein ERdj5) (ERdj5) (Macrothioredoxin) (MTHr)	DNAJC10 ERDJ5 UNQ495/PRO1012	Homo sapiens (Human)	793	cell redox homeostasis [GO:0045454]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATPase activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; disulfide oxidoreductase activity [GO:0015036]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATPase activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]	ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; Hsp70 protein binding [GO:0030544]; chaperone binding [GO:0051087]; disulfide oxidoreductase activity [GO:0015036]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0001671; GO:0001933; GO:0005783; GO:0005788; GO:0015035; GO:0015036; GO:0016020; GO:0016671; GO:0030433; GO:0030544; GO:0032781; GO:0034663; GO:0034975; GO:0034976; GO:0045454; GO:0051087; GO:0051117; GO:0051787; GO:0070059
P10076	ZFP26_MOUSE	reviewed	Zinc finger protein 26 (Zfp-26) (Protein mKR3)	Zfp26 Kiaa4196 Mkr3 Zfp-26	Mus musculus (Mouse)	861	regulation of transcription, DNA-templated [GO:0006355]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872
P34616	CADH3_CAEEL	reviewed	Cadherin-3	cdh-3 ZK112.7	Caenorhabditis elegans	3343	basement membrane disassembly [GO:0034769]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; morphogenesis of embryonic epithelium [GO:0016331]; nematode male tail tip morphogenesis [GO:0045138]	basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; structural molecule activity [GO:0005198]; basement membrane disassembly [GO:0034769]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; morphogenesis of embryonic epithelium [GO:0016331]; nematode male tail tip morphogenesis [GO:0045138]	calcium ion binding [GO:0005509]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007156; GO:0016323; GO:0016331; GO:0030054; GO:0034769; GO:0045138
Q9V5N8	STAN_DROME	reviewed	Protocadherin-like wing polarity protein stan (Protein flamingo) (Protein starry night)	stan fmi CG11895	Drosophila melanogaster (Fruit fly)	3579	R3/R4 cell fate commitment [GO:0007464]; R3/R4 development [GO:0048057]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; morphogenesis of a polarized epithelium [GO:0001738]; mushroom body development [GO:0016319]; ommatidial rotation [GO:0016318]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; regulation of axonogenesis [GO:0050770]; regulation of establishment of planar polarity [GO:0090175]; regulation of synapse assembly [GO:0051963]; regulation of tube length, open tracheal system [GO:0035159]; segment polarity determination [GO:0007367]	cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; morphogenesis of a polarized epithelium [GO:0001738]; mushroom body development [GO:0016319]; ommatidial rotation [GO:0016318]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; R3/R4 cell fate commitment [GO:0007464]; R3/R4 development [GO:0048057]; regulation of axonogenesis [GO:0050770]; regulation of establishment of planar polarity [GO:0090175]; regulation of synapse assembly [GO:0051963]; regulation of tube length, open tracheal system [GO:0035159]; segment polarity determination [GO:0007367]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]	G protein-coupled receptor activity [GO:0004930]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; transmembrane signaling receptor activity [GO:0004888]	GO:0001736; GO:0001738; GO:0004888; GO:0004930; GO:0005509; GO:0005886; GO:0005887; GO:0005911; GO:0007156; GO:0007367; GO:0007409; GO:0007411; GO:0007464; GO:0016021; GO:0016318; GO:0016319; GO:0016339; GO:0016358; GO:0035159; GO:0042067; GO:0045773; GO:0048057; GO:0048813; GO:0050770; GO:0050839; GO:0051963; GO:0060071; GO:0070593; GO:0090175; GO:0098609; GO:1902669
Q6P560	ZN182_MOUSE	reviewed	Zinc finger protein 182 (Zinc finger protein 21)	Znf182 Zfp182 Znf21	Mus musculus (Mouse)	627	regulation of transcription, DNA-templated [GO:0006355]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0046872
B1WBP0	MPPD2_RAT	reviewed	Metallophosphoesterase MPPED2 (EC 3.1.-.-) (239FB) (Fetal brain protein 239 homolog) (Metallophosphoesterase domain-containing protein 2)	Mpped2	Rattus norvegicus (Rat)	294			AMP binding [GO:0016208]; GMP binding [GO:0019002]; manganese ion binding [GO:0030145]; phosphoric diester hydrolase activity [GO:0008081]	AMP binding [GO:0016208]; GMP binding [GO:0019002]; manganese ion binding [GO:0030145]; phosphoric diester hydrolase activity [GO:0008081]	GO:0008081; GO:0016208; GO:0019002; GO:0030145
Q9D799	FMT_MOUSE	reviewed	Methionyl-tRNA formyltransferase, mitochondrial (MtFMT) (EC 2.1.2.9)	Mtfmt Fmt	Mus musculus (Mouse)	386	conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951]	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; methionyl-tRNA formyltransferase activity [GO:0004479]; conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951]	methionyl-tRNA formyltransferase activity [GO:0004479]	GO:0004479; GO:0005739; GO:0071951
Q7YR70	AAMP_CANLF	reviewed	Angio-associated migratory cell protein	AAMP	Canis lupus familiaris (Dog) (Canis familiaris)	435	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of endothelial cell migration [GO:0010595]; ribosomal large subunit biogenesis [GO:0042273]; smooth muscle cell migration [GO:0014909]	cell surface [GO:0009986]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; unfolded protein binding [GO:0051082]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of endothelial cell migration [GO:0010595]; ribosomal large subunit biogenesis [GO:0042273]; smooth muscle cell migration [GO:0014909]	unfolded protein binding [GO:0051082]	GO:0001525; GO:0005829; GO:0005886; GO:0009986; GO:0010595; GO:0014909; GO:0015630; GO:0030154; GO:0042273; GO:0045171; GO:0051082
Q10576	P4HA1_CAEEL	reviewed	Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1) (Protein dumpy-18)	dpy-18 phy-1 Y47D3B.10	Caenorhabditis elegans	559	collagen and cuticulin-based cuticle development [GO:0040002]; cuticle development involved in collagen and cuticulin-based cuticle molting cycle [GO:0042338]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation [GO:0019511]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of multicellular organism growth [GO:0040018]	cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen and cuticulin-based cuticle development [GO:0040002]; cuticle development involved in collagen and cuticulin-based cuticle molting cycle [GO:0042338]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation [GO:0019511]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of multicellular organism growth [GO:0040018]	L-ascorbic acid binding [GO:0031418]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]	GO:0004656; GO:0005506; GO:0005623; GO:0005783; GO:0005788; GO:0009792; GO:0010172; GO:0016702; GO:0018401; GO:0019511; GO:0031418; GO:0031545; GO:0040002; GO:0040018; GO:0042338; GO:0043412; GO:0055114
E9PVD3	PCD16_MOUSE	reviewed	Protocadherin-16 (Protein Dchs1) (Protein dachsous homolog 1)	Dchs1	Mus musculus (Mouse)	3291	anatomical structure morphogenesis [GO:0009653]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration [GO:0016477]; cell migration involved in endocardial cushion formation [GO:0003273]; cell-cell adhesion [GO:0098609]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; kidney development [GO:0001822]; mitral valve formation [GO:0003192]; mitral valve morphogenesis [GO:0003183]; nephron development [GO:0072006]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]	apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; anatomical structure morphogenesis [GO:0009653]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration [GO:0016477]; cell migration involved in endocardial cushion formation [GO:0003273]; cell-cell adhesion [GO:0098609]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; kidney development [GO:0001822]; mitral valve formation [GO:0003192]; mitral valve morphogenesis [GO:0003183]; nephron development [GO:0072006]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]	calcium ion binding [GO:0005509]	GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0003183; GO:0003192; GO:0003273; GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0007389; GO:0009653; GO:0016021; GO:0016477; GO:0021915; GO:0022008; GO:0035329; GO:0036342; GO:0043931; GO:0045177; GO:0048565; GO:0072006; GO:0072137; GO:0072659; GO:0090102; GO:0098609
P08012	PRP1_SOYBN	reviewed	Repetitive proline-rich cell wall protein 1	PRP1	Glycine max (Soybean) (Glycine hispida)	256	multicellular organism development [GO:0007275]	cell wall [GO:0005618]; extracellular region [GO:0005576]	cell wall [GO:0005618]; extracellular region [GO:0005576]; structural constituent of cell wall [GO:0005199]; multicellular organism development [GO:0007275]	structural constituent of cell wall [GO:0005199]	GO:0005199; GO:0005576; GO:0005618; GO:0007275
Q5RJV0	COQ9_XENTR	reviewed	Ubiquinone biosynthesis protein COQ9, mitochondrial	coq9	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	317	ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]	mitochondrial inner membrane [GO:0005743]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]; ubiquinone biosynthetic process [GO:0006744]	lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]	GO:0005743; GO:0006744; GO:0008289; GO:0042803
Q28021	ROCK2_BOVIN	reviewed	Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)	ROCK2	Bos taurus (Bovine)	1388	Rho protein signal transduction [GO:0007266]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; mitotic cytokinesis [GO:0000281]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of centrosome duplication [GO:0010825]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell junction assembly [GO:1901888]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; mitotic cytokinesis [GO:0000281]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of centrosome duplication [GO:0010825]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell junction assembly [GO:1901888]; regulation of circadian rhythm [GO:0042752]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]	ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000281; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006939; GO:0007266; GO:0010825; GO:0017049; GO:0018107; GO:0030036; GO:0030866; GO:0031032; GO:0032956; GO:0042752; GO:0046872; GO:0048511; GO:0048598; GO:0072518; GO:1901888
M3TYT0	ROCK2_PIG	reviewed	Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)	ROCK2	Sus scrofa (Pig)	1388	I-kappaB kinase/NF-kappaB signaling [GO:0007249]; Rho protein signal transduction [GO:0007266]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; cellular response to testosterone stimulus [GO:0071394]; cellular response to transforming growth factor beta stimulus [GO:0071560]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; mitotic cytokinesis [GO:0000281]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; regulation of cell junction assembly [GO:1901888]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of keratinocyte differentiation [GO:0045616]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; viral RNA genome replication [GO:0039694]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; cellular response to testosterone stimulus [GO:0071394]; cellular response to transforming growth factor beta stimulus [GO:0071560]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; regulation of cell junction assembly [GO:1901888]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of keratinocyte differentiation [GO:0045616]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; viral RNA genome replication [GO:0039694]	ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0000281; GO:0001934; GO:0003180; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006939; GO:0007249; GO:0007266; GO:0010595; GO:0010628; GO:0010825; GO:0016525; GO:0017049; GO:0018105; GO:0018107; GO:0030866; GO:0031032; GO:0035509; GO:0036464; GO:0039694; GO:0042752; GO:0045019; GO:0045616; GO:0046872; GO:0048511; GO:0048598; GO:0051298; GO:0051496; GO:0070168; GO:0071394; GO:0071560; GO:0072518; GO:0072659; GO:0150033; GO:1900182; GO:1901888; GO:1902004; GO:1902961; GO:1902966; GO:1903140; GO:1903347
Q9DAJ2	TEKT1_MOUSE	reviewed	Tektin-1	Tekt1	Mus musculus (Mouse)	418	cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]	microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]	microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]		GO:0005874; GO:0015630; GO:0060271; GO:0060294
E9Q555	RN213_MOUSE	reviewed	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213)	Rnf213 Mystr	Mus musculus (Mouse)	5152	angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]	ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051
Q63HN8	RN213_HUMAN	reviewed	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213)	RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR	Homo sapiens (Human)	5207	angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]	ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0046872; GO:0051260; GO:0051865; GO:2000051
